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ABSTRACT 
The literature has indicated that frequently examined patient variables at intake have 
shown mixed results in the prediction of dropout from outpatient substance abuse 
treatment. In this research sociodemographic characteristics, substance use and 
psychological problem severity at intake were examined as predictors of early dropout in 
411 patients enrolled in a 6-month outpatient substance abuse treatment program. Early 
dropout was defined as participation of less than 6 weeks, the first phase of treatment. 
Another focus of the research was to determine how patients who dropped out of 
treatment early fared in terms of substance use at 6 months compared to those retained 
longer. It was found that being younger, unmarried or not cohabitating, and having a 
greater severity of employment problems at intake were associated with early treatment 
dropout. Substance abuse and psychological problem severity at intake were not 
associated with dropout from the first phase of treatment. Patients who left treatment 
early had sorne reduction in alcohol consumption at 6-month follow-up, but overall, those 
retained in treatment longer had better alcohol and drug use outcomes at 6 months. Both 
the outcomes on retention and substance use were examined in order to explore possible 
solutions to dropout from the perspective of health services. Despite the improvements in 
substance abuse for patients retained longer than 6 weeks, it was determined that only 
\ 
40% of patients were retained for 6 months, thereby indicating that the majority of 
patients had not received the planned 6-month intervention. In response to the se facts, a 
brief intervention consisting of 5 individual therapy sessions based on coping skills and 
motivational enhancement strategies was designed and manualized with participation of 
the clinical staff. Following this, a randomized clinical trial was conducted with 72 
patients, and substance use at 6-month follow-up was compared between the brief 
11 
intervention and the conventional treatment groups. At 6 months, both the brief 
intervention and conventional treatment groups had reductions in alcohol use compared 
to intake, but no conclusions could be made about drug use. The implications of the 
findings for substance abuse treatment service delivery are discussed. 
111 
RÉSUMÉ 
Les études révèlent que la probabilité d'abandon de traitement pour abus de substance en 
milieu externe ne peut être prédit de façon fiable par les variables habituellement 
recueillit lors de l'entrevue de contact. Cette recherche a examiné les caractéristiques 
sociodemographiques, l'usage de substance et la sévérité de problèmes psychologiques 
au moment du premier contact comme pronostiqueurs d'abandon précoce chez les 411 
patients inscrits dans un programme de traitement de six mois pour abus de substance en 
milieu externe. L'abandon précoce fut défini par une participation d'une durée de moins 
de six semaines, soit la première phase du traitement. Un autre aspect d'intérêt était de 
connaître l'usage de substances après six mois chez ceux qui abandonnaient en début de 
la thérapie par rapport à ceux qui sont restés plus longtemps. Les résultats ont montré 
qu'être plus jeune, célibataire ou de ne pas être en cohabitation et avoir des problèmes 
d'emploi plus sérieux au moment de l'entrevue de contact étaient des facteurs associés à 
l'abandon précoce du traitement. L'abus de substances et la sévérité des problèmes 
psychologiques constatés au premier contact n'étaient pas associés à l'abandon dans la 
première phase du traitement. Les patients qui avaient quitté le programme thérapeutique 
de façon précoce avaient quelque peu réduit leur consommation d'alcool au suivie de six 
mois, mais de façon générale, ceux qui étaient restés le plus longtemps en thérapie 
avaient de meilleurs résultats thérapeutiques après six mois relatif à leur consommation 
d'alcool ou de drogues. Les résultats à l'égard de la durée de la thérapie et de l'usage de 
substances ont été examinés afin d'explorer des solutions possibles à l'abandon précoce 
de traitement du point de vu des services de santé. Malgré l'amélioration accrue tant qu'a 
l'abus de substances chez ·les patients demeurés en thérapie pour une plus longue période, 
seulement 40% de ces patients ont été retenus pour la durée totale de six mois tel que 
IV 
prévu. Pour combler à ces lacunes, une intervention de courte durée en raison de cinq 
sessions de thérapie individuelle basée sur des stratégies de l'augmention de la 
motivation et le talent d'adaptation, a été conçue et adaptée en manuel avec la 
participation du personnel clinique. Ensuite un essai clinique, randomisé fut mené avec 
72 patients. Au suivi de 6 mois, l'usage de substances a été comparé entre le groupe de 
thérapie conventionnel et celui de l'intervention de courte durée. Après six mois les deux 
groupes démontraient une diminution de la consommation d'alcool par rapport à la 
consommation à la visite de contact, mais aucune conclusion ne pouvait être tirée 
concernant l'usage de drogues. Une discussion sur l'implication de ces résultats sur le 
traitement de l'abus de substance suivra. 
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Outpatient Treatment For Substance Dependence: 
Using Empirical Findings About Retention And Substance Use Outcomes To Shape 
Treatment Services 
Introduction 
In a climate of escalating health care costs, streamlining and coordinating health 
and social services and the development and evaluation of effective and efficient 
treatment interventions in health care are a high priority (Health Canada, 1997~ Romanow 
Commission, 2002). A proactive stance in designing, implementing, and evaluating 
treatment interventions allows researchers and clinicians to main tain a prominent role in 
decisions about resource management and future policy directions for treatment 
(Solesbury, 2001). Knowledge about treatment effectiveness also places clinicians on 
firmer ground with patients when recommending treatment because valid and reliable 
information about treatment options can be provided (Pendergast & Podus, 2000; 
Solesbury, 2001). Although major advances have been made towards improving the 
treatment of substance use disorders in the past 20 years, there are still many unanswered 
questions about the effective and efficient delivery of treatment services (Iowa Practice 
Improvement Collaborative, 2003). 
The evidence-based movement with the primary focus on outcomes is currently 
the dominant paradigm in the assessment of health care (Evidence-based Medicine 
Working Group, 1992; Davies & Crombie, 1997). Evidence-based decision-making is the 
systematic application of the best available evidence to the evaluation of options and to 
decision-making in clinical, management, and policy settings (Health Canada, 1997). The 
1 
goal of the evidence-based movement is to develop a body of empirical knowledge of 
treatment effectiveness and disseminate the information to practitioners in order to 
improve the quality and efficiency of health care. While research findings pertaining to 
treatment effectiveness are important to clinicians, they may not translate into concrete 
changes in existing treatment programs. Barriers to the use of evidence in the health care 
system include: lack of useful evidence, lack of consensus, inappropriate use of evidence, 
and lag time in diffusion and uptake of information (Health Canada, 1997). 
The field of treatment for substance dependence shares the common concern of 
the entire National Health Care system about the gap between what is known empirically 
and what is practiced clinically. Examples of empirically validated treatments for 
chemical dependence that have failed to gain wide acceptance in practice include: 
methadone maintenance for opiate dependence, contingency management for cocaine 
dependence, as weIl as social skills training, naltrexone (Revia), and brief intervention for 
a1cohol dependence (Miller & Hester, 1986; Miller et a1.l995; Miller & Wilbourne, 2002; 
Carroll & Rounsaville, 2003). In the U.S., methods which remain widely used in the 
treatment of a1cohol dependence are those associated with the 12-Step Minnesota model 
using the principles of A1coholics Anonymous, as weIl as methods of confrontation and 
education, which have received little empirical support (Miller et. al., 1995; Morgenstern, 
2000). Sorne reasons for the gap between research and practice may be related to 
methodological issues of treatment evaluation research and the failure of research to 
connect with clinical settings (Carroll & Rounsaville, 2003). A greater emphasis on 
effectiveness research conducted in the field has been proposed as a strategy to bridge the 
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gap between research and practice (lnstitute of Medicine, 1998). Despite the fact that 
methods for conducting outcome-based evaluations through randomized controlled trials 
have been weIl defined (Rounsaville, Carroll, & Onken, 2001; Prien & Robinson, 1994; 
Institute of Medicine, 2001), the nature of what constitutes sound effectiveness research 
for substance dependence treatment is not as straightforward (Carroll, 1997a; Carroll & 
Rounsaville, 2003). The emerging field of health services research pro vides sorne 
guidelines that can be applied in the evaluation of treatment effectiveness. 
Health services research is a discipline that has been evolving over time and 
several recent definitions pro vide a description of the field's scope of investigation. 
Health services research comprises many different activities with differing aims and 
methods, and inc1udes not only assessment of how effective a treatment is, but also the 
consequences of the care given for patients and the community as a whole (Crombie, 
1996). The Institute of Medicine (1995) stated that "Health services research is a 
multidisciplinary field of inquiry, both basic and applied, that examines the use, costs, 
quality, accessibility, delivery, organization, financing, and outcomes of health care 
services to increase knowledge and understanding of structure, processes, and effects of 
health services for individuals and populations" (p.3). The Board of the Academy for 
Health Services Research and Health Policy (Lohr & Steinwachs, 2002) in the U.S. 
broadened the definition further and proposed that "Health services research is the 
multidisciplinary field of scientific investigation that studies how social factors, financing 
systems, organizational structures and processes, health technologies, and personal 
behaviours affect access to health care, the quality and co st of health care, and ultimately 
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our health and well-being. Its research and domains are individuals, families, 
organizations, institutions, communities, and populations" (p.16). These definitions 
describe a field of research that is weIl suited to effectiveness research in addiction 
treatment. Health services research in substance dependence treatment examines the 
effectiveness of interventions in unrestricted patient populations in clinical settings, and 
the interventions are evaluated by a range of more general outcomes as weIl as drug use, 
including health status, psychological status, and employment status (Booth, Stanton, & 
Leukefeld, 2001). In addition to examination of interventions that have been shown to be 
efficacious in randomized clinical trials, health services research can examine innovative 
interventions focused on prevention, early intervention, or methods to improve access or 
engagement in treatment (Booth et al., 2001). 
Process measures are elements involved in service delivery that can influence the 
effectiveness of treatment and are sensitive indicators of the quality of care (Crombie & 
Davies, 1995; Crombie & Davies, 1998). Process is the collective term for aIl the 
activities which occur within health care, and covers the means by which patients access 
care, the investigations and diagnoses made, treatments received, and the method of 
discharge or referral (Donabedian, 1968). Questions about process ask "What was done?" 
as weIl as, "Was the action done weIl, justified, and in a timely manner?" (Crombie & 
Davies, 1998). Studies of process provide empirical data about how the treatment will 
confer a measurable benefit to a treatment-seeking population in actual clinical practice. 
Studies of process measures may also point to more obvious actions that need to be taken 
to improve care, but the study of process measures, in contrast with the study of outcome 
4 
measures, has been somewhat left behind in the research arena (Crombie & Davies, 
1998). The study of performance measures in evaluating addiction services on levels of 
prevention/education, problem recognition, treatment, and maintenance of change has 
lagged behind that of other chronic medical conditions (Garnick et al., 2002). 
The Problem of Dropout from Treatment and the Question of Optimal Treatment 
Duration 
Unnecessary resource use is a measure of process that is open to investigation, 
and may be examined in terms of ordering of laboratory tests, radiological investigations, 
surgical procedures, as weIl as treatments that are inappropriate or unnecessary (Crombie 
& Davies, 1998). It has been noted that in Canada, "The health care system is data-rich, 
and information-poor: there is little that tells management, the public, or providers about 
the quality of their labours in relation to agreed-upon goals and standards. There are no 
benchmarks for either utilization (how many procedures should be do ne in a population) 
or outcomes (what difference should we expect from a service, what is an acceptable 
failure rate)" (p.45) (Fyke, 2001). Similarly, in the field of addiction, examination of 
service duplication or inappropriate treatmènt is complex due to the wide range and 
severity of disorders, the multi-faceted etiology of addiction, the co-existence of private 
and public treatment services, and diverse modalities and philosophies of care. These 
characteristics of addiction treatment result in a lack of a shared understanding across the 
field regarding the dynamics of addiction and an absence of agreed upon guidelines and 
standards that define effective treatment (Institute of Medicine, 1998). The practical 
questions for a treatment pro gram for substance dependence are how to deliver the most 
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effective treatment to a wide selection of patients in an efficient manner. These questions 
require knowledge of what constitutes the "best" treatment, when treatment involves 
unnecessary use of resources, and if treatment is delivered in the appropriate manner. 
Both questions of process and outcomes may be addressed in an examination of treatment 
effectiveness. Despite the lack of consensus about "standard" treatment for addiction, it is 
possible to measure if the treatment provided was delivered in the way that it was 
intended. It is also possible to detennine if the outcomes support the design of the 
treatment. The former is a question of process evaluation, the latter one addresses 
outcomes. 
A problem identified in the delivery of services in an outpatient treatment c1inic 
for substance dependence (the Addictions Unit of the Mc Gill University Health Centre) 
provided the basis for the research conducted herein. Specifically, the problem identified 
was dropout, which is pervasive across health care settings, but is particularly evident in 
substance dependence treatment (Stark, 1992). Treatment at the clinic was based on the 
philosophy that improvement in substance dependence was accompli shed over time 
through a series of behavioural changes facilitated by therapy (Prochaska & Di Clemente, 
1992; Wallace, 1992; Tatarsky & Washton, 1992), and treatment services were designed 
to be administered over a minimum period of 6 months. One study examining rates of 
attendance of a sample of consecutively admitted patients to the clinic's standard 
treatment program found that only 40% of patients remained in treatment for the full 
duration of 6 months (Gauthier, Paraherakis, & Gill, 1997). Those who reported more 
health problems, had more education, and higher rates of employment, and lower scores 
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on the Beck Depression Inventory at intake were more likely to complete 6 months of 
treatment. However, little more was known about the early dropouts, and it appeared that 
many patients were not participating in the treatment pro gram as it was designed. Clinical 
interest was sparked by these facts and questions about the potential impact of this 
problem on treatment effectiveness and efficiency were raised. The clinical team was 
interested in examining the factors leading to dropout, as weIl as its impact on treatment 
effectiveness and service delivery. TraditionaIly, few researchers have been attracted to 
the study of dropout and how it affects treatment services, leaving clinicians and policy 
makers with little feedback about their activities from quantitative research (Mammo & 
Weinbaum, 1993). 
The principal goals of this thesis were to: (a) determine whether patients who left 
treatment before 6 weeks (Early Dropouts) differed from those who stayed in treatment 
longer than 6 weeks (Retained) on sociodemographic, substance use, and psychological 
variables at baseline; (b) determine if additional psychological factors of motivation, self-
efficacy, and personality characteristics were associated with early dropout; (c) identify 
sociodemographic, substance use, and psychological predictors of early dropout; (d) 
determine whether sociodemographic, substance use, psychological factors, and length of 
stay in treatment were associated with substance use outcome variables at 6-month 
follow-up; (e) compare substance use at 6 months between the Early Dropouts and 
Retained; (f) evaluate treatment services from the perspective of health services criteria 
of acceptability, equity, effectiveness, and efficiency; and (g) determine the effectiveness 
of a brief treatment compared to conventional treatment. 
7 
The first six objectives were examined within the context of a naturalistic follow-
up study. The last objective was addressed within the context of a randomized treatment 
study specifically designed for this thesis. 
Towards these goals, the thesis is divided into eight chapters. The first chapter 
begins with a general overview of the consequences associated with substance 
dependence in Canada in order to illustrate the pressing need to examine the effectiveness 
of existing programs and services for patients who seek treatment for substance 
dependence. Treatment effectiveness, the problem of dropout, and a review of the 
literature pertinent to factors influencing retention in treatment and substance use 
outcomes are also discussed in Chapter 1. The factors reviewed are: demographic 
characteristics, social support, substance use problem severity, psychological problem 
severity, and additional cognitive psychological factors. The last section of Chapter 1 
presents the study objectives and hypotheses. Chapter 2 describes the methodology, 
procedures, and statist.ical plan for the study. Chapter 3 pro vides the results of the 
analyses on early dropout, as weIl as attrition from treatment over time. Chapter 4 reports 
the results of the analyses on substance use and psychological outcomes at 6 months, 
with comparisons between the Early Dropouts and the Retained. This is followed by an 
examination of demographic, substance use, and psychological factors as well as 
treatment retention to determine if there was an association with substance use outcomes 
at 6 months. Chapter 5 discusses the results on retention and substance use outcomes, and 
evaluation of findings from a health services perspective that led to the plan to conduct a 
brief intervention. Chapter 6 begins with an overview of the literature on brief 
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interventions III substance dependence treatment, followed by the rationale, study 
objectives, and hypotheses. Subsequently, the methodology of the brief intervention 
study is presented. The next section of the chapter presents the results of the brief 
intervention study. Chapter 7 pro vides a summary of combined results and discussion 
with methodological considerations. Chapter 8, the final chapter, presents the conclusions 
with clinical implications for the treatment of substance dependence and applications as 
they relate to the health care system. 
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Chapter 1 
The Prevalence of Substance Abuse 
Substance dependence is the most prevalent serious mental disorder in North 
America, with lifetime prevalence rates ranging from 13.5% in U.S. samples (Regier, 
Farmer, Locke, Keith, Judd, & Goodwin, 1990; Grant et al., 2004) to as high as 18.0% in 
sorne regions of northem Canada (Bland, Newman, & Om, 1992). A more recent survey 
on the 12-month prevalence of any substance use disorder using DSM-IV (APA, 1994) 
criteria estimated rates of 9.5% in a representative sample of 43,000 Americans (Grant et 
al., 2004). An overview of substance use in the Canadian public is provided by the 
Canadian Addiction Survey (CAS) (CCSA, 2004), the first major survey on the use of 
alcohol and drugs in Canada since 1994. A total of 13,909 Canadians over the age of 15 
across the 10 provinces participated in the telephone survey. The results indicate that the 
use of alcohol, cannabis, and other drugs has increased in the past decade. Most 
Canadians drink in moderation, but about 23% exceeded low-risk drinking guidelines 
defined as 14 standard drinks for males and 9 standard drinks for females weekly. Based 
on the Alcohol Use Disorders Identification Test (AUDIT) 17% of current drinkers, or 
13.6% of Canadians, were considered to be high-risk drinkers. The high-risk drinkers 
were predominately males under the age of 25. The rate of cannabis use doubled in the 
past 10 years, and 14% of Canadians reported smoking cannabis in the past year. 
Although most illicit drug consumption is limited to cannabis, about 3% reported using 
cocaine or other illicit drugs including heroin, hallucinogens, speed, inhalants, or MMDA 
(Ecstacy) in the past year. 
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A provincial report stated that the percentage of people consuming alcohol in 
Quebec has also been on the rise (CPLT, 2000). Heavy drinking, defined as 5 drinks or 
more per occasion, more than 5 times a year, was reported by one in 13 Quebecers over 
the age of 15. Heavy drinking was also more common among males and youths aged 15 
to 24. 
The CAS (2004) survey found that over 16% of Quebec residents used illicit 
drugs in the last year, which is the highest prevalence in Canada, and an increase from the 
13% reported by the earlier Quebec survey (CPLT, 2000). Cannabis was the most 
frequently consumed illicit drug, with 70% of drug users consuming marijuana or hashish 
exclusively. Cocaine was the most frequently injected substance among the 23,000 
people in Quebec who used drugs intravenously (Remis et al., 1998). Dual substance 
dependence was more common in drug abusers who were also the largest consumers of 
alcohol, drinking regularly and in large quantities (CPLT, 2000). 
The Canadian Community Health Survey: Mental Health and Well-Being 
(Statistics Canada, 2002) found that 10% of Canadians over the age of 15 reported 
symptoms consistent with a psychiatrie disorder during the 12 months prior to the 
interview. The disorders included: alcohol or drug dependence, depression, mania, panic 
disorder, agoraphobia, or social phobia. The overall prevalence of substance use has 
increased across Canada in the last decade, and the costs and consequences of untreated 
long-term substance dependence will continue to rise and exact a toll on the Canadian 
health care system, the economy, and community and sociallife. 
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The Costs and Consequences Associated with Untreated Substance Abuse 
Long-term complications arising from unremitting substance use disorders result 
in adverse medical, psychological, and social consequences for the individual, family 
members, and the community. It has been estimated that annually in Canada over 6,000 
deaths and 80,000 hospitalizations are associated with akohol use, and over 800 deaths 
are caused by illicit drug use (Single, Rehm, Robson, & Truong, 2000). 
The CAS (2004) also asked participants about harm to self or others resulting 
from akohol and/or drug use. The responses were compared to the 1989 National 
Akohol and Other Drugs Survey (NADS)(Eliany, Giesbrecht, & Nelson, 1990) and the 
1994 Canada's Akohol and Other Drugs Survey (CADS)(MacNeil & Webster, 1997). 
There was a general trend towards more drinkers in 2004 reporting harm from their own 
or others' drinking compared to the previous surveys. In 2004 close to 10% of CUITent 
drinkers reported that they experienced negative effects on their health or social lives in 
the past year. Almost one third of the survey respondents reported that they were harmed 
in the last year because of someone else's drinking. Individuals experienced family or 
marital problems (10%), verbal abuse (40%), serious arguments (15%), and physical 
assault (15%). About 5% of Canadians in the survey reported concern about cannabis 
use, primarily related to failing to control their use, and a strong desire to consume. For 
CUITent users of any drugs other than cannabis, the commonly reported negative 
consequences were harm to physical health, reported by 24%, followed by problems with 
home, social life, finances, and work. The Canadian picture reflects a similar one in 
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Quebec, with an 8-fold increase in the risk of social problems for heavy drinkers (Demers 
& Vallee, 1999). 
Research on substance abuse and suicide is rare in Quebec. Tousignant and 
Payette (1997) summarized findings from key European and North American studies on 
the association between suicide and substance abuse and extrapolated findings in order to 
provide a picture of the situation in Quebec. Conservatively, psychoactive substance 
disorders play a role in 30 to 50% of aIl suicides (Lesage et al., 1994; Henriksson, Aro, 
Marttunen, & Heikkinen, 1993). Approximately one quarter of people who commit 
suicide have an a1cohol disorder, and the average duration of a1coholism before suicide is 
19 years (Murphy & Wetzel, 1990). Cocaine users were found to be at 45 times higher 
risk of committing suicide than the population without a substance use or psychiatric 
disorder (Marzuk, et al., 1992). 
The consequences resulting from substance dependence disorders inc1uding 
morbidity, mortality, motor vehic1e accidents, legal problems, suicide, family 
dysfunction, and lost employment place a heavy burden on the Canadian economy and 
the health care system (Choi, Robson, & Single, 1997). The total cost oftobacco, a1cohol, 
and drug dependence to the Canadian economy has been an estimated $18.45 billion 
annually (Single et al., 1996). The Canadian Community Mental Health Survey (Statistics 
Canada, 2002) reported that mental disorders inc1uding substance use disorders were the 
third highest source of direct health care costs after heart disease and cancer. It was 
estimated that the total cost of tobacco, a1cohol and drug abuse in Quebec alone was 4.4 
billion annually (Desjardins, 1997). The majority of Quebec government funds delegated 
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to substance abuse was spent on hospitalization for the medieal and psychiatrie sequelae 
of substance use disorders, with less than 10% of funding provided for specialized 
treatment services. As health care and social serviee costs continue to escalate, and 
scrutiny about resource allocation increases, provision of empirically supported 
treatments has become a major objective of the health care delivery system. 
Clearly, the consequences of untreated substance use disorders result in 
tremendous health, social, and economie costs that touch all levels of society. Of key 
importance is the fact that drug and alcohol consumption in the Canadian population is on 
the rise, and many of the severe consequences such as illness, death, or violence occur at 
the end of a long trajectory of chronic use and relapse. Effective treatment intervention 
has a major role to play in the reduction and prevention of long-term negative 
consequences for the individu al and the community at large. 
The next section outlines what is known about treatment effectiveness and 
discusses factors associated with retention and substance use outcomes. 
Background Literature Review and Rationale for the Present Studies 
Treatment for Substance Dependence: Factors Influencing Outcomes 
The issue of treatment efficacy is of utmost importance to aIl medical and 
psychosocial services. Positive outcomes associated with treatment for substance 
dependence include decreased hospitalizations, emergency room visits, motor vehicle 
accidents, and traffic and cri min al offences (Hoffman & Miller, 1993). Numerous 
reviews have identified a set of treatment approaches with positive outcomes for alcohol 
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problems, including cognitive behavioural therapy, behavioural couples therapy, 
behavioural self-control, brief interventions, community reinforcement, and social skills 
training (APA, 1995; Miller et al., 1995; Roth & Fanagy, 1996; Miller & Wilbourne, 
2002). Miller & Wilbourne (2002) reviewed 46 different treatment modalities for alcohol 
dependence and found that brief interventions, social skills training, and community 
reinforcement were among the top 5 empirically validated treatments in clinical 
populations. However, Miller & Wilbourne's criteria for rating studies automatically 
inflated the effect sizes of studies with a placebo or no-treatment-control group, thereby 
placing studies with two active treatments comparisons, the research design typically 
used in c1inic settings, at a disadvantage in their rating system. 
The Task Force on Promotion and Dissemination of Psychological Procedures of 
the American Psychological Association (Chambless et al., 1996), failed to identify any 
empirically validated or probably-efficacious treatments for a1cohol-use disorders 
(McCrady, 2000). The report of the Task Force in 1996 did inc1ude 4 treatments for 
substance use disorders that were listed as probably-efficacious: contingency 
management for cocaine abuse (Higgins et al., 1993), brief dynamic therapy and 
cognitive therapy for opiate dependence (Woody, Luborsky, Mc1ellan, & O'Brien, 1990), 
and cognitive-behavioural therapy for benzodiazepine withdrawal in panic disorder 
patients (Otto, Pollack, Sachs, Reiter, & Rosenbaum, 1993; Spiegel, Bruce, Gregg, & 
Nunzello, 1994). McCrady (2000) applied the criteria of the Task Force to her own 
review of 62 studies of treatment conducted in the alcoholism field up until 1998 and 
found that only 2 of the 13 treatment modalities studied-brief intervention and relapse 
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prevention-met the Task Force criteria of empirically validated treatments. Motivational 
enhancement therapy met criteria for a probably-efficacious treatment. For these 3 
treatments, definitive studies meeting the Task Force criteria were published after 1996, 
demonstrating that research methodology in the study of alcoholism treatment has only 
recently met rigorous criteria. 
Based on reviews of drug dependence treatment in the V.S., it has been shown 
that those who attend treatment have reduced drug use and crime, as weIl as improved 
social adjustment, employment, family relationships, and psychological adjustment, and 
that treatment efficacy is positively related to the length of time spent in treatment 
(National Institute on Drug Abuse, 1999; Etheridge & Hubbard, 2000; Pendergast & 
Podus, 2000). Despite many positive reports of outcomes, there is still considerable 
variability in a wide range of outcomes from substance use to psychosocial measures 
within given treatment modalities (McLeIlan et al., 1994; Breslin, Sobell, Sobell & 
Sobell, 1997). These variations may be related to patient differences, pro gram 
management, staffing, treatment delivery, measurement of outcomes, and these factors 
de serve consideration before drawing conclusions regarding treatment outcomes 
(Etheridge & Hubbard, 2000; Schildhaus, Gerstein, Dugoni, Brittingham, & Cerbone, 
2000). 
The question "Is treatment effective?" is too general and needs to be reduced to 
questions of "What treatment?", "What problem?", "What patient?", and "What 
outcome?" (Roth & Fanagy, 1996). The following section summarizes commonly studied 
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factors and their association with effectiveness for substance dependence treatment in 
outpatient settings. 
Overview of Factors Associated with Treatment Outcomes in Outpatient Settings 
Over the past three decades, the literature on treatment outcomes for substance 
use disorders has burgeoned. A review of outcome variables in 357 alcohol treatment 
trials from 1968 to 1998 concluded that "Overall, the variety of outcome variables 
assessed in alcohol treatment research makes it difficult to compare results across studies 
and to identify 'best' treatment approaches" (Finney, Moyer, & Swearington, 2003, 
p.1677). Due to the vast number of studies on alcoholism, Miller and Wilbourne (2002) 
point out that it has been necessary to summarize the outcome literature by categories 
focusing on specific clinical issues, examining subsets of treatment approaches, or by 
conducting meta-analyses. Evaluation of outcomes for drug use disorders has followed a 
similar trend, with examination of patient variables, certain clinical features, type of 
treatment pro gram, specific drug of abuse, program structure, and more recently, 
measures of the patient-treatment process, resulting in a wide array of predictor and 
outcome variables (Etheridge & Hubbard, 2000). 
Etheridge and Hubbard (2000) proposed a seven-Ievel empirically grounded 
framework that involves a multidisciplinary approach for the study of drug dependency 
treatment structure and process. The seven levels of variables and factors are: external 
policy environment, treatment and service systems, structural and operational features of 
the program, treatment/service interventions, patient characteristics, patient social 
environment, and patient outcomes. Since it is not possible for alI variables to be studied 
17 
in a single research project, the framework provides the investigator with a mechanism 
for selection of variables of greatest research, policy, and practice interest, as well as a 
context for discussion and interpretation (Etheridge & Hubbard, 2000). 
The two first levels of variables chosen for the present study were patient 
characteristics and patient outcomes, and results from these analyses were then examined 
for their implications on a third level, that of treatment and service systems. The literature 
review that follows is described in the context of determining what is known about sorne 
of the most frequently examined predictors of retention and substance use outcomes in 
outpatient treatment for substance dependence. These predictors include 
sociodemographic characteristics, social support, substance use problem severity, 
psychiatric comorbidity, and additional psychological factors of motivation, self-efficacy, 
and personality features. 
Treatment Retention - The Definition and Prevalence of Dropout 
Comparison of dropout rates across studies is problematic because different time 
frames are used to distinguish dropouts from completers based on the design and length 
of the specific treatment pro gram under study (Stark, 1992). Due to the variable 
definitions of dropout based on duration, a definition that combines therapist judgment of 
appropriateness of termination plus a time classification that distinguishes early from 
later dropouts may be more comprehensive (Pekarik & Zimmer, 1992). This combined 
definition allows examination of predictors that are associated with dropout at different 
stages. The literature indicates that factors associated with early and later dropout may 
differ, with early dropouts being younger and less socially stable in terms of employment 
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and living situation (Pekarik & Zimmer, 1992; Gottheil, Sterling, & Weinstein, 1997; 
Gottheil, Weinstein, Sterling, Lundy, & Serota, 1998). Differences between early and 
later dropouts on the degree of psychological distress have been inconsistent, with sorne 
studies finding that those less distressed were likely to leave treatment early (Siqueland et 
al., 1998), while others have found the opposite (Simpson, Joe, Broome, Hiller, Knight & 
Rowan-Szal, 1997). 
The actual number of dropouts in any given study is often omitted or unc1ear. In a 
study of treatment methodology it was determined that only half of the 61 alcohol 
treatment studies reviewed from 1989 to 1993 provided attrition rates (Breslin et al., 
1997). However, it is universally known that many who st art treatment drop out early, 
before receiving planned interventions (Stark, 1992). Due to the divergent definitions of 
dropout, different populations studied, and different expectations of participation across 
treatment modalities, comparisons of the rates of retention across studies do not pro vide 
yardsticks for c1inicians to measure success of their programs. 
Why Examine Dropout? 
The basic and pragmatic question " Why does treatment attrition matter?" 
deserves a response prior to an examination of dropout in substance dependence 
treatment. The answer is three-fold. As described in the Introduction, there are long-term 
negative consequences of untreated substance abuse, and the first reason to examine 
dropout is that an association between positive outcomes and longer stays in treatment 
has been found. The second reason to examine dropout is that high attrition rates cast 
doubt on the positive reports of outcomes from treatment. The third reason to examine 
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dropout is related to a health care perspective of inefficient use of treatment services that 
are designed with longer treatment goals. Each reason is briefly outlined in the following 
section. 
The Association Between Treatment Retention and Reduced Substance Use 
Although no causal relationship can be drawn, links between treatment retention 
and reduction of substance use have been found in the majority of studies (Mammo & 
Weinbaum, 1993; Hubbard, Craddock, Flynn, Anderson, & Etheridge, 1997; Gottheil et 
al., 1998 ; Siqueland et a1.1998; Etheridge & Hubbard, 2000; Hubbard, Craddock, & 
Anderson, 2003). The following discussion pro vides more detail about studies that have 
reported an association between improved substance use outcomes and time spent in 
treatment. 
In a study examining factors associated with dropout from outpatient treatment 
for alcoholism it was found that those who completed treatment had significantly greater 
reductions in drinking, improved health status, and marginal improvements in family 
situations and legal status compared to noncompleters (Mammo & Weinbaum, 1993). 
The study was an examination of admissions and discharges from the New Jersey State 
Department of Health Division of Alcoholism, Drug Abuse and Addiction Services and 
was based on outpatient treatment services for patients admitted and followed up to one 
year. Treatment was considered "completed" when the patient fini shed the initially 
agreed upon treatment plan or a revised plan that was developed while treatment was in 
progress. If a patient left against staff advice or contact was lost, the person was 
considered a dropout. Forty-nine per cent of the males completed treatment, and at 
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follow-up 67% of the completers were abstinent and 25% had reduced their drinking. 
Among the male dropouts, 35% were abstinent and only 7.8% had reduced their drinking. 
Among the female subjects, only 37.8% were defined as treatment completers. Of these, 
74% had stopped drinking compared to 42% of the dropouts. In summary, 92% of the 
completers and 44% of the dropouts had improved their drinking status at one-year 
follow-up. 
The Drug Abuse Treatment Outcome Study (DATOS) was a prospective 
epidemiological study that examined correlates of treatment outcome and effects by 
subgroups of patients. Four treatment modalities including short-term inpatient, 
methadone maintenance, long term residential, and outpatient drug free, as delivered in 
76 programs across the United States, were examined (Hubbard et al., 1997, Etheridge & 
Hubbard, 2000; Hubbard, Craddock, & Anderson, 2003). Only the outcomes for retention 
in the Outpatient Drug Free (ODF) programs (N = 24) are described here (Hubbard, et al., 
1997; Hubbard, Craddock, & Anderson, 2003). More detail about this large scale study is 
provided below. 
Patients were assessed at intake, at 7 tolO days into treatment, and at 1, 3, and 6 
months of treatment. An additional interview was conducted at the 12-month follow-up. 
The overall one-year follow-up rate was 70%, resulting in 764 subjects being interviewed 
from the 24 ODF programs. Cocaïne was the primary substance of abuse, and many 
patients were also drinking and smoking cannabis as weil. At one-year follow-up, cocaine 
and alcohol use were reduced by 50%, and less than 10% reported weekly or more 
frequent use of marijuana, compared to 25% at intake. The follow-up sample was further 
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divided into categories of those who remained in treatment < 3 months (N = 240), and 
those who stayed in treatment > 3 months (N= 524) in order to examine the association 
between treatment duration and substance use outcomes. Of those who remained in 
treatment < 3 months, 55% were still using cocaine, 53% had sorne drug use, 15% were 
using alcohol, and over half had spent sorne time in jail. Of those who remained in 
treatment> 3 months, only 28% were still using cocaine, 19% had sorne drug use, 9% 
were using alcohol, and one quarter had spent sorne time in jail. The results indicated that 
longer stays in outpatient treatment were significantly associated with improved 
substance use, social, and behavioural outcomes. 
There are limitations to the DA TOS reports on ODF treatment including the fact 
that there was no control and monitoring of treatment or randomization to treatment 
condition, and that substance use outcomes cannot be attributed to treatment per se. 
However, the association of improved outcomes with longer time spent in treatment 
deserves further consideration. One-year follow-up data from the DATOS group 
indicated that 3-month retention was associated with improved substance use outcomes in 
the ODF programs (Hubbard et al., 1997), and 5-year follow-up data indicated that 6 
months of treatment was associated with reduced cocaine use in both Long-Term 
Residential (LTR) and ODF programs (Hubbard, Craddock, & Anderson, 2003). Thus, 
better treatment retention overall is generally associated with improvement in substance 
use outcomes at longer follow-up periods. 
Randomized clinical trials have also found a positive association between 
improved substance use outcomes and treatment retention. More session attendance and 
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longer retention in outpatient treatment for cocaine abuse in a publicly funded inner-city 
pro gram in Philadelphia were associated with better substance use outcomes (Gottheil et 
al., 1998). In this randomized controlIed trial comparing the effectiveness of intensive 
outpatient treatment with individu al counselling there were no significant differences 
among three treatment conditions of varying intensity, but those who stayed in treatment 
longer had better substance use outcomes. At 9-month follow-up patients who remained 
in treatment more than 6 weeks had an average reduction of 75% in the number of days 
of cocaine use in the previous month, compared to a 50% reduction for those who 
remained in treatment for less than 6 weeks. Those who attended more treatment, in 
addition to a significant reduction of cocaine and alcohol problems, also had reduced 
employment and psychological problems, and were more likely to be attending self-help 
meetings, continuing in outpatient treatment, or school. 
Another randomized trial study compared the effectiveness of high 
standardization cognitive-behavioural treatment, low standardization CBT, and treatment 
as usual for substance abuse in a community setting (Morgenstern, Blanchard, Morgan, 
Labouvie, & Hayaki, 2001). AlI three treatment conditions consisted of 12 weekly 
individual therapy sessions. At 6-month follow-up the average increase in percentage of 
days abstinent from cocaine was 30%, and although no significant differences across the 
three treatment conditions emerged, those who attended more sessions in any of the 
conditions had improved outcomes. 
Although longer stays in treatment have been linked to improved outcomes, the 
conclusions drawn about treatment effectiveness require skepticism because high dropout 
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rates may result in data provided by a select group of patients at follow-up. 
The Effect of Dropout Rates on Evaluation of Treatment Efficacy 
Dropout rates have a major impact on the quality and reliability of data gathered 
in clinical trials because missing data are non-random and can lead to distortion or biases 
in outcome results (Lavori, 1992; Harris, 1998; Nick & Carroll, 2002). 
Details of the dropout rates in the following study are provided because they 
illustrate how attrition over time reduces the sample to a select set of participants who 
may not be representative of the original treatment-seeking group of patients. 
A multi-site randomized psychotherapy outcome study for patients with cocaine 
dependence funded by the National InstÏtute on Drug Abuse (NIDA) examined predictors 
of dropout from psychosocial treatment of cocaine dependence (Siqueland et al., 1998). 
Prior to treatment initiation, attrition of eligible participants occurred after telephone 
screening, the first interview, and during the stabilization phase that was required pre-
randomization. Of 1386 patients who were eligible for the study, a little more than half 
carne for the initial interview, and another 13% were lost before beginning the 
stabilization phase. Completion of the 20-day stabilization phase required attendance to 
an average of 3 individual sessions per week and provision of 3 consecutive drug-free 
urine screens as a prerequisite for randomization to the study treatment. Only 46% of 
patients (286) completed this phase and were randomized to treatment. The dropout rate 
from the time of initial telephone screening to randomization into the study was 84%. 
Fu rtherrnore , only half of the randomized patients in the three treatment conditions 
completed the full 6 months of treatment, with dropout rates of 15% at 1 month, 33% by 
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the third month, and 49% by the sixth mon th. Recognizing the impact of missing data and 
the selection bias that resulted from these high rates of dropout, the investigators changed 
the prerequisites of abstinence and reduced the session attendance required during the 
stabilization phase in order to engage more patients in future research. 
Due to high rates of attrition throughout treatment and study protocols, resulting 
in loss of follow-up data, outcomes examined may be based on only a fraction of patients 
who originally applied for and were adherent to treatment, thereby overestimating 
optimistic outcomes. 
The Effect of Dropout from the Perspective of Health Services 
Retention can be conceived of as an important treatment outcome that reflects a 
"good fit" between the patient, therapist, treatment, and setting (Carroll, 1997). Despite 
the caution required to interpret the association between treatment and positive outcomes, 
treatment utilization may be considered as an interrnediate end-point to the goal of 
improving outcomes (Booth et al., 2001). 
Although the association between more time in treatment for drug dependence 
and better outcomes has generally been accepted by researchers and policy makers, the 
validity of these conclusions has been questioned on the basis of lack of control for self-
selection (De Leon, 1998). Patients who seek treatment for substance dependence differ 
from those who do not (Sobell, Ellingstad, & Sobell, 2001), and those who remain in 
treatment differ from those who leave. De Leon (1998) de scribes self-selection as a 
concept in research methodology that refers to factors that affect sample bias, but in 
treatment, refers to individu al differences in seeking, engaging or remaining in treatment. 
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In fact, active "treatment shoppers" have shown better outcomes in psychotherapy than 
passive recipients (Seligman, 1995). Treatment effectiveness, defined by outcomes of 
retention and reduction of substance abuse, reflects a dynamic and interactional process 
between patient self-selection factors and treatment factors (Miller, 1985; De Leon, 
1998). Understanding more about patient characteristics that may be associated with 
choices for leaving treatment, or dropout, also necessitates an examination of the 
treatment services provided. Describing rates of dropout without examining the quality 
and appropriateness of services leaves out elements that are useful for further 
understanding of factors influencing dropoul. It has been suggested that rather than the 
usual negative view of treatment attrition, from a services perspective, substance abusers 
seeking treatment may be regarded as requiring a range of services that may not 
necessarily be met in a single treatment episode (Booth et aL, 2001). 
Although the definitions and rates of dropout may vary, dropout in treatment is a 
univers al fact that raises doubt about the positive outcomes associated with treatment 
since only a fraction of people who seek treatment actually complete il. From a health 
services perspective, knowing more about dropout helps to determine if treatment 
services are being utilized in the manner in which they were designed, and are benefiting 
a wide range of patients in the best manner possible. 
In the following section, a summary of the most commonly examined predictors 
of outpatient treatment retention and substance use outcomes is provided. 
Predictors of Retention and Substance Use Outcomes 
There are few consistent findings demonstrating a clear relationship between 
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sociodemographic characteristics and dropout and substance use outcomes, but there are 
sorne trends that can be described. 
Age: Age is a characteristic that can be confounded with other factors including 
problem severity. Hser, Grella, Hsieh, Anglin, and Brown (1999) found that older 
patients were often more treatment-experienced, had more severe substance use and 
social problems, were less likely to follow program instructions, and attended less 
individu al counselling sessions. Subjective ratings of problem severity may be less for 
those who are younger since they may have had fewer years of problem use. Although 
several studies found no association between age and early dropout (Pekarik & Zimmer, 
1992; Gottheil et al., 1997; McCaul, Svikis, & Moore, 2001), it has frequently been 
observed that younger patients tend to drop out of outpatient treatment sooner and have 
poorer treatment outcomes (Mammo & Weinbaum, 1993; Siqueland et al., 1998; Joe, 
Simpson & Broome, 1998; Grella, Hser, Joshi, & Anglin, 1999; Momas & GuaI, 2000; 
Neilsen, Nielsen, & Wraae, 2000; Harrison & Ashe, 2001). 
Gender: Caution is also needed when drawing conclusions about gender and 
dropout from substance abuse treatment since many studies have had a small proportion 
of female patients and difficulty gathering an adequate sample size for analysis (McCaul 
et al., 2001). A number of studies found an association between female gender and early 
dropout from outpatient substance abuse treatment (Anglin, Hser, & Booth, 1987; 
Arfken, Klein, di Menza, & Schuster, 2001; McCaul, et al., 2001; Mammo & Weinbaum, 
1993). Other studies found no differential dropout rates for males and females (Kleinman 
et al., 1992; Gottheil, Sterling, & Weinstein, 1997; Pekarik & Zimmer, 1992), or that 
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females stayed longer in treatment (Monras & GuaI, 2000). The lack of gender-sensitive 
treatments could have an effect on retention in outpatient treatment for women (Vanicelli, 
1984; Institute of Medicine, 1990; McCaul et al., 2001; Office of Applied Studies, 1997). 
One randomized controlled trial found that females treated in a women specific pro gram 
had higher rates of treatment completion and reported improved substance use outcomes 
(Dahlgren & Willander, 1989). Gender may also be confounded with problem severity. It 
has been noted that women may do less weIl in treatment because they have more severe 
social, substance use, and psychiatric problems at intake (Arfken et al., 2001; Harrison & 
Asche, 2001; Brown, Seraganian, & Tremblay, 1994). Whereas male retention is strongly 
related to personal factors such as social stability, female retention is more often related 
to treatment factors like service modality and help for health-related problems (Stark, 
1992; Kingree, 1995). 
Socioeconomic Status: The classification of socioeconomic status differs from 
study to study. Usually, a combination of factors including educational background, 
income, and occupation comprise socioeconomic status. More education, higher income, 
and employment have been found to be positively correlated with retention in outpatient 
treatment (Mammo & Weinbaum, 1993; Siqueland et al., 1998). Using state archivaI 
data, Pekarik and Zimmer (1992) examined discharge records for 1,424 consecutively 
terminated outpatients who had been treated for alcohol-related problems in state public 
community mental health drug and alcohol programs. Although the single strongest 
predictor of outpatient treatment completion was referral by the criminal justice system, 
social class variables of higher income and education were also strongly associated with 
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continuance in treatment. In a study examining treatment outcomes for adult outpatients 
in the state of Minnesota, lower severity of substance abuse, older age, higher education, 
and white race predicted treatment completion (Harrison & Asche, 2001). 
Socioeconomic status will likely be relevant to dropout if factors related to 
personal, financial, and cultural needs limit the accessibility and availability of resources 
required to continue in treatment. If the treatment pro gram offered presents barriers to 
attendance and does not address the special needs of patients including childcare, 
language flexibility, social services, scheduling flexibility, and financial assistance, it 
may be more likely that premature termination will occur. Those who have less stable 
social, employment, and living situations tend to have poorer treatment outcomes, but 
these factors may aiso be confounded by problem severity. 
The findings for demographic characteristics as predictors for substance use 
outcomes in most studies parallel those for dropout from treatment. Those who are 
younger (18 to 35 years old), unmarried, or residentially unstable tend to have poorer 
treatment outcomes (Ornstein & Cherepon, 1985; McLellan et al., 1994, Phibbs, Swindle, 
& Racine, 1997; Hendryx, Dyck, & Strebnik, 1999; Moos, Moos, & Finney, 2001; Moos, 
NichoI, & Moos, 2002). There is sorne evidence that those who are less educated may 
have poorer treatment outcomes (Ornstein & Cherepon, 1985; McLellan et al., 1994), but 
this may be confounded by factors related to pro gram structure and treatment delivery. 
Social Support: Despite the assumption that many substance abusers are isolated 
and estranged from family, it was found that most were in close contact with a family 
member at least weekly, and many lived with or saw a family member daily (Stanton, 
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1997). Cocaine users living alone were more likely to leave treatment early compared to 
those living with others (Gainey et aL, 1993), and those who were married were more 
likely to remain longer in treatment (Carroll et al., 1994; Moos, Nichol, & Moos, 2002). 
A naturalistic follow-up study of 206 patients conducted at the Addictions Unit of 
the McGill University Health Centre (MUHC) found that patients who had more social 
support stayed in treatment significantly longer. However, higher levels of social support 
failed to predict reduction in drug abuse, and accounted for only 6% of the variance in 
outcomes for reduction of alcohol abuse at 6-month follow-up (Dobkin, De Civita, 
Paraherakis, & Gill, 2002). 
Social support is a complex construct and a distinction between the general 
quality of social support and specific support for reduced substance use may help clarify 
sorne of the contradictory findings in the literature (Beattie & Longabaugh, 1999). 
Alcoholics highly committed to relationships with others who provided low support for 
abstinence were more likely to experience problems during recovery (Longabaugh, 
Beattie, Noel, Stout, & Malloy; 1993). While general friendship quality may be important 
for overall well-being, friends' support for abstinence is a better predictor of substance 
use behaviour (Beattie & Longabaugh, 1997; Humphreys, Mankowski, Moos, & Finney, 
1999). 
Problem Severity: Sorne studies have found that those with more severe drug or 
alcohol problems leave outpatient treatment sooner (Stark, 1992; Gainey et al., 1993; 
Simpson, Joe, Broome, Hiller, Knight, & Rowan-Szal, 1997; Joe, Simpson, & Broome, 
1999; Mulvaney, Alterman, Boardman, & Kampman, 1999). It could be that the 
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consequences of substance abuse including health, financial, social, psychiatrie, and legal 
problems interfere with treatment attendance. It is also possible that treatment programs 
with a goal of abstinence overtly or covertly discourage those with more severe substance 
use from attending since they are unable to achieve this goal early in treatment (Marlatt, 
Tucker, Donovan, & Vuchinich, 1997). Lack of agreement between patient and treatment 
provider about the goals of treatment could play a role in the patient's early departure 
from treatment. Although retention, engagement, and adherence are problems inherent in 
the treatment of all medical and mental disorders, the nature of substance abuse disorders 
presents sorne especially challenging obstacles for retention. Many people seek treatment 
in order to eliminate the negative consequences of substance abuse, but not to stop using 
drugs and a1cohol altogether (Onken, Blaine, & Boren, 1997). 
Cocaine abusers have been noted to be difficult to retain in outpatient treatment, 
with drop-out rates increasing dramatically as the treatment progresses (Kleinman, Kang, 
Woody, Kemp, & Millman, 1992; Gainey, Wells, Hawkins, & Catalano, 1993; Covi, 
Hess, Schroeder, & Preston, 2002), although there have been sorne promising results for 
increasing retention with contingency management approaches (Higgins et al., 1991; 
Higgins, Budney, Bickel, Hughes, Foerg, Badger, 1993; Roozen, Boulogne, van Tulder, 
van den Brink, De Jong, Kerkhof, 2004). 
Sorne cocaine dependent patients may leave treatment early because they are 
unable or unmotivated to achieve abstinence. Several studies have reported that urine 
toxicology positive for cocaine on the first test was predictive of outpatient treatment 
attrition for cocaine abuse, indicating that those with a more severe problem may be 
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unable to achieve even a very short period of abstinence prior to treatment (Higgins, 
Budney, Bickel, Foerg, Donham, & Badger, 1994; Alterman, McKay, Mulvaney, & 
McLellan, 1996; Mulvaney, Alterman, Boardman, & Kampman, 1999). It may be that 
continued participation in treatment is related to early success in treatment. Remission 
from cocaine and alcohol dependence during a 4-week intensive outpatient program for 
male veterans predicted greater participation in aftercare (McKay, McLellan, Alterman, 
Cacciols, Rutherford, & O'Brien, 1998), and corroborated other reports that continued 
substance use early in treatment has a negative impact on treatment completion 
(Alterman et al., 1996; Siqueland et al., 1998). Those who are more severely dependent 
on cocaine and alcohol may opt for self-help attendance over formai treatment that 
requires ongoing abstinence as a condition of participation (Carpenter, Miele, & Hasin, 
2002). 
A study of 239 patients admitted for treatment at the Addictions Unit of the 
MURC examined primary drug as a predictor of treatment retention (Paraherakis, 
Chamey & Gill, 2000). Five drug categories were compared for treatment attendance and 
substance use outcomes at 6 months. These categories were: alcohol, aIcohol +, cocaine, 
opiates, and sedatives. The results at 6 months indicated that retention in treatment was 
significantly different among drug groups. The primary substance of abuse was the 
largest predictor of dropout. In the opiate group, 52% dropped out of treatment within the 
first month, compared to dropout rates of 15% to 35% for the other drug groups. The 
opiate group also had significantly higher rates of positive urine screens compared to the 
other drug groups. The study showed that the first month of substance abuse treatment 
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seemed to be critical for longer-term recovery, and that primary substance of abuse was a 
factor associated with retention and substance use outcomes. 
Greater severity of substance abuse has been associated with poorer substance use 
outcomes at follow-up (McLellan et al., 1994). In a study examining problem severity 
related to substance use outcomes McLellan et al. (1994) reviewed data from a total of 22 
inpatient, outpatient, and methadone maintenance programs in the Philadelphia area. The 
authors reported no significant differences in outcomes between inpatient and outpatient 
treatment, and most of the analyses were conducted on three primary drug groups of 
opiates, cocaine, and a1cohol, irrespective of treatment modality. The outcome variables 
used were the composite scores from the 6-month Addiction Severity Index. For both the 
inpatient and outpatient groups, greater severity of a1cohol and drug use at admission was 
associated with greater post-treatment substance use at 6-month follow-up. Polydrug use 
has also been associated with less improvement of substance abuse at follow-up. It was 
found that patients dually-addicted to a1cohol and cocaine had lower rates of abstinence 
compared to those with a primary drug problem of either a1cohol or cocaine (Gainey et 
al., 1993; Brower et al., 1994). 
McKay & Weiss (2001) reviewed 12 major studies of a1cohol and drug treatment 
in order to summarize outcome predictors at long-term follow-up. The most frequently 
examined baseline predictor was severity of drug and alcohol use, described in 45 out of 
100 reports reviewed. Pretreatment severity of substance use was related to outcomes in 
30 out of 45 reports, and greater severity predicted worse outcomes in 20 studies, but 
better outcomes in 6 reports. McKay & Weiss underlined the challenge of interpreting 
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outcomes across studies due to methodological differences and multiple outcomes and 
measures. 
Psychological Problem Severity and Distress: Sorne studies have found an 
association between severity of psychological problems at admission and poor treatment 
retention. A Danish study examined factors associated with retention for alcoholics in 
outpatient treatment (Neil son et al., 2000). Participants were randomly assigned to two 
different 12-month individual treatment conditions of high or low structure. The results 
indicated those who had higher scores on the Addiction Severity Index psychological 
composite severity score were less likely to complete the 4-week motivational phase of 
the program, regardless of treatment condition. Other investigators determined that 
psychological di stress was not associated with dropout from treatment (Gottheil et al., 
1997; McKay et al., 1998). In a randomized clinical trial of intensive outpatient treatment 
for cocaine dependence, it was found that 27% of those who had agreed to participate 
dropped out before beginning treatment (Gottheil et al., 1997). These pre-treatment 
dropouts were compared to patients who came to at least one treatment session. The 
investigators found that the pre-treatment dropouts had more recent cocaine use, less 
stable employment, less severe medical problems, and significantly lower scores on 
interpersonal sensitivity, obsessive-compulsive, phobic anxiety, and psychoticism on the 
SCL-90 subscale scores. When pretreatment dropouts were compared to those who 
stayed in treatment for at least 2 months, the differences were even more pronounced on 
the SCL-90 subscales. The pre-treatment dropouts were less psychologically distressed. 
ln the review of factors predicting long-term outcomes for substance abuse 
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treatment McKay & Weiss (2001) found that psychological problem severity was 
significantly associated with substance use outcomes in more than 70% of the studies. Of 
the 20 reports with significant findings, greater severity predicted worse outcomes in 13, 
but better outcomes in 4. In 3 studies, psychologieal problem severity yielded significant 
interaction effects with treatment condition, but no main effects. 
Psychiatrie Diagnoses: ln a DATOS study, investigators found that those with 
concurrent DSM III-R Axis 1 and II diagnoses had shorter retention in an outpatient 
aftercare treatment for veterans with alcohol and/or cocaine dependence (Simpson, Joe, 
Broome, Hiller, Knight, & Rowan-Szal, 1997). Other investigators (McLellan, Luborsky, 
Woody, O'Brien, & Drugley, 1983; Rounsaville, Dolinsky, Babor, et al., 1987) have 
reported that a high level of psychopathology at intake was associated with poorer 
treatment outcomes in alcoholics, but this finding is not universal (Tidey, Mehl-Madrona, 
Huggins, & Badger, 1998). However, integrating conclusions across studies about 
psychiatric severity as a predictor of substance use outcomes is problematic since various 
indices of psychiatric symptomatology and diagnoses examined among studies may, to 
sorne degree, account for the diverse and inconsistent findings. 
Depression: The study of depression as a predictor of dropout and substance use 
outcomes has also led to mixed results. McKay et al. (1998) failed to find an association 
between lifetime and current diagnosis of major depression or anxiety and retention. 
However in this study, veterans had to have stable living conditions and complete the 
intensive outpatient therapy in order to be eligible for the aftercare program, and those 
with more severe depression may have been excluded. The NIDA randomÏzed clinical 
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trial examining predictors of dropout from outpatient cocaine treatment described earlier 
found that early dropouts had higher scores on the Beck Depression Inventory and the 
Hamilton Depression Rating Scale (Siqueland et al., 1998). It was suggested that it may 
be diffieult for depressed patients to initially engage in treatment, but that they could be 
more motivated to continue if they received additional support and treatment for 
depression or other psychiatrie disorders. 
In fact, the provision of appropriate mental health serviees during treatment and 
appropriate referrals post-treatment for those with psychiatrie disorders, has been shown 
to improve substance use outcomes (Moos, NichoI, & Moos, 2002). In a study of 
outcomes in 15 Veterans Affairs substance programs, Ritsher, Moos & Finney (2002) 
examined the relationship of patients' age, education, marital status, motivation, severity 
of substance use, severity of psychiatric problems, and substance-related cognitions at 
intake to remission at two years. Remission was defined as abstinence from illicit drug 
use and either abstinence or non-problem use of alcohol. In contrast to findings at the1-
year follow-up point, severity of psychiatrie problems was negatively associated with 
remission at two years (Ouimette, Gima, & Moos, 1999). The authors aiso examined 
whether continuing outpatient mental health care during the first follow-up year predicted 
remission at two years. They found that half of the patients who received 12 months of 
outpatient treatment were in remission compared to one third who received 5 to Il 
months of treatment, and one quarter who received 4 months of treatment. The authors 
also found that the overall duration of additionai outpatient care was more predietive of 
positive outcomes than the intensity and total number of sessions. 
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Another study conducted Addictions Unit of the MUHC examined the effect of a 
CUITent diagnosis of depression on treatment retention and change in substance use 
(Chamey, Paraherakis, & Gill, 2001). The participants were 75 men and 45 women 
seeking treatment for substance use disorder. The patients were assessed for depression at 
intake with the Beck Depression Inventory, Hamilton Rating Scale for Depression, 
Symptom Checklist-90, and a psychiatric evaluation using the SCID and DSM-IV 
criteria. During the 6-month treatment depressed patients received more treatment in the 
form of psychiatric appointments, initiation of new antidepressant regimes, and inpatient 
detoxification than non-depressed patients. Substance use outcomes were equivalent for 
depressed and non-depressed patients at 6-month follow-up. The study illustrates that the 
provision of appropriate and timely psychiatric interventions, in addition to standard 
addiction treatment, may improve substance use outcomes for depressed patients with 
substance abuse disorders. Substance abuse treatment services vary in their assessment 
and expertise in the treatment of psychiatric comorbidity, and variations in the 
availability of services targeted to meet patients' needs may account for inconsistent 
results in terms of the association between severity of psychological problems, retention, 
and substance use outcomes (Alterman & McLellan, 1993; Simpson et al., 1999). 
Personality Disorders: The association between personality features and retention 
in treatment and substance use outcomes is complex and not weIl understood. DSM-IV 
Axis II disorders have frequently been found to co-exist in patients with substance 
dependence and may predict poorer treatment outcomes (Pettinati, Pierce, Belden, & 
Meyers, 1999). A number of studies have found that a diagnosis of personality disorder 
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predicts poorer outcomes for alcoholics (Verheul, van den Brink, Hartgers, 1998; 
Brutscheidt, Redner, Schwarz, & Gabel, 2002), drug dependent individu ais (Compton, 
CottIer, Jacobs, Ben-Abdallah, & Spiznagel, 2003), and a mixed sample of drug and 
alcohol abusers (Galen et al., 2000). More specificaIly, the presence of antisocial and 
borderline personality disorder has been associated with poorer substance use outcomes 
(Wolwer, Burtscheidt, Redner, Schwarz, & Gaebel, 2001; Links, Heslegrave, Mitton, van 
Reekum, & Patrick, 1995; Compton et al., 2003). 
Clinicians in alcohol and drug populations frequently miss the diagnosis of 
personality disorders, but these patients may be more challenging to engage in the 
treatment pro gram (Bowden-Jones, Iqbal, Seive Wright, Judd, & Weaver, 2004). Rather 
than a global diagnosis of personality disorder, it may be more meaningful to understand 
how certain personality traits are associated with dropout from treatment. Livesley, Jang, 
and Vernon (1998) developed a four-factor model of personality based on principal 
component analysis of 18 lower-order dimensions of personality from twin, clinical, and 
nonclinical samples. The four higher-order personality factors that emerged were: 
emotional dysregulation, dissocial behaviour, compulsivity, and inhibition. In a 
subsequent study, a subset of traits delineating antisocial personality was found to be 
influenced by genetic factors in common with alcohol abuse (Jang & Livesley, 2000). 
This research is pertinent to the study of addiction because of the multi-faceted etiology 
of addiction involving genetic as weIl as environmental influences. For the purpose of the 
present study, personality factors of antisocial behaviour as weIl as emotional 
dysregulation, which broadly resembles borderline personality disorder, were examined 
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to deterrnine if patients with high scores on these factors were more likely to drop out of 
treatment early. 
Additional Psychological Factors of Motivation and Self-Efficacy: Self-selection 
for treatment is a way of viewing individu al differences in seeking, engaging, or 
remaining in treatment. These individu al differences likely involve emotional, cognitive, 
or decisional processes, but these processes have only recently been examined in relation 
to outcomes in the treatment of addiction (De Leon, 1998). Cognitive and psychological 
processes inc1uding motivation and self-efficacy may influence a person's decision to 
remain in a particular treatment or reduce substance intake. These cognitive processes are 
inc1uded in the repertoire of assets and liabilities that patients bring to the treatment 
experience and will interact with the treatment pro vider and the services offered. 
Therefore, understanding more about what the patient brings to the treatment experience 
in terms of motivation and self-efficacy may enhance understanding about dropout. 
A number of studies have exarnined the role of motivation in treatment retention 
and substance use outcomes. Motivation at intake has been predictive of engagement and 
treatment retention in outpatient a1coholism treatment (Ryan, Plant, O'Malley, 1995). 
Earlier studies made attempts to abstract motivation from indirect and ill-defined 
measures, but more recent work on motivation has evolved into specific measurement of 
motivation and the influence it may have on other key therapeutic factors su ch as 
therapeutic alliance, self-efficacy, and coping skills (Stark, 1992). 
In a series of studies conducted by the DATOS project, patient motivation at 
intake was associated with the formation of better therapeutic alliance, increased session 
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attendance and a more positive Vlew of counsellor competence and peer support 
(Simpson, Joe, Rowan-Szal, & Broome et al., 1997). Treatment readiness, a measure of 
motivation at intake, was predictive of 90-day retention for long-term residential 
programs and outpatient methadone treatment programs, but not for the outpatient drug-
free programs (Joe, Simpson, & Broome, 1998; Broome, Simpson & Joe, 1999; Joe, 
Simpson, & Broome, 1999). This illustrates the fact that in order to understand the effect 
of motivation on outcomes, information regarding the treatment provided is also 
necessary. hnportantly, motivation, readiness to change, and the conceptually-linked 
variable of self-efficacy were the most consistent predictive pre-treatment variables for 
substance use outcomes at the l-year and 3-year follow-up points in Project MATCH, a 
large multisite V.S. clinical trial designed to test patient-treatment matching hypotheses 
for patients with alcohol dependence (Project MA TCH, 2003). 
However, the association between motivation at intake and retention has not been 
upheld in other studies for outpatient substance abuse treatment (Fiorentine, Nakashima, 
& Anglin, 1999; Blanchard, Morgenstern, Morgan, Labouvie, & Bux, 2003; Patkar et al., 
2004). Sorne of the contradictory findings about the association between pretreatment 
motivation and retention may be due to the use of different instruments of measurement 
and varying treatment durations and modalities examined. Motivation and treatment 
readiness are dynamic processes that change over time (Prochaska & DiClemente, 1992). 
It has been found that the intention to carry out a behaviour is likely to be a better 
predictor if the time interval between measurement of the intention and the behaviour is 
shorter (Ajzen, 1985; Ajzen, 1991, DeWeert-Van Oene, Schippers, Jong, & Schrijvers, 
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2000). Therefore, pretreatment motivation is most likely to be associated with early 
engagement in treatment, but may not be related to longer treatment retention or 
substance use outcomes at follow-up. 
The concept of self-efficacy arising from a cognitive-social leaming perspective 
refers to the belief that one can carry out the behaviours necessary to achieve a desired 
outcome (Bandura, 1977, Bandura, 1986). According to sociallearning theory, perceived 
self-efficacy is linked with initiation and maintenance of behaviour change. Although 
positive change in substance use self-efficacy has been found to be associated with 
reduced drug and a1cohol use after outpatient treatment (McKay, Maisto, & o 'Farrell , 
1993~ Maisto, Connors, & Zwyiak, 2000~ Long, Williams, Midgeley, & Hollin, 2000; 
Brown, Seraganian, Tremblay, & Annis, 2002a), little research has examined the role of 
pre-treatment self-efficacy in prediction of outpatient treatment retenti on (L'Abbe, 1999). 
The following section presents the rationale, objectives, and hypotheses for the 
present study based on the pertinent features of the literature review on predictors of 
retention in treatment and reduction of substance use. 
Rationale for the Present Study 
There are few consistently reproduced findings conceming the relationship 
between patient characteristics and retention in outpatient substance abuse treatment or 
substance use outcomes. Sorne studies have found that patients who are more socially 
stabile (older age, being married, employed) are likely to remain in treatment longer and 
show better outcomes. Severity of substance abuse has been identified as a factor 
associated with poorer retention and outcomes in sorne studies, although not consistently. 
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The findings on psychological and psychiatric problem severity are also mixed, since 
sorne patients may remain in treatment if they also receive help for depression, anxiety, 
or other psychiatric disorders. If psychiatrie disorders are untreated, people may leave 
treatment early or show deterioration at follow-up (Moos, Moos, & Finney, 2001). 
Personality factors have only recently been explored, and there is sorne indieation that the 
diagnosis of a personality disorder may be associated with poorer treatment retention and 
outcomes. Pretreatment motivation has shown sorne association with retenti on , but not 
consistently across studies. Although a number of studies have found an association with 
positive changes in self-efficacy and improved substance use outcomes at follow-up, little 
research has been conducted on the association between pretreatment self-efficacy and 
dropout. It is important to note that patient characteristics including sociodemographic, 
substance use, and psychological problems, generally account for only a very small 
proportion of the variance in outcomes, leaving a great deal of room for exploration of 
other relevant factors. 
Despite the fact that sorne reviewers state that the most consistently replicated 
finding in drug abuse treatment outcome studies is that patients with more severe 
impairments, such as dual substance dependence and psychologieal impairments have 
lower retention rates and poorer post-treatment outcomes (Etheridge & Hubbard, 2000), 
no firm conclusions can be drawn because the nature of services provided and continuity 
of care available is also associated with outcomes (Ritsher, Moos, & Finney, 2002). In 
addition, studies have used different independent and outcome variables, samples, and 
durations of follow-up, thereby reducing generalizability of results (McKay & Weiss, 
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2001). The result of these methodological differences is that the research on factors 
predicting substance use outcomes is somewhat inconclusive, with no clear consensus on 
which variables are the best predictors (Kedia & Williams, 2003). 
Despite the lack of consistency in predictors of treatment retention and substance 
use outcomes, most studies confirm findings about low rates of treatment completion as 
weil as a positive association between longer treatment attendance and improved 
substance use outcomcs. However, in nonrandomized studies, although patient 
characteristics may be associated with outcomes of dropout and substance use, differing 
treatment characteristics across programs including philosophy, goals, and actual services 
offered require cautious interpretation of findings. The answer to the question of "Is 
treatment effective?" must be based on an understanding of the interface between the 
characteristics of the patients using the services as weIl as the services provided. 
Evaluation of Treatment from a Health Services Perspective 
Demonstration of the success of treatment and measures taken to improve 
treatment will promote a dialogue for discussion of future funding and treatment 
planning. Another important reason for conducting research from a health services 
perspective is that evidence required for clinical decision-making about the design and 
operation of treatment services will likely be more relevant, appealing, and utilized by 
clinicians when it has been gained from research conducted in the field. The purpose of 
this thesis was to gather empirical data about retention in treatment and substance use 
outcomes for adults who sought treatment in an outpatient clinic in order to guide 
practical decisions about treatment services. An exploration of the most frequently 
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examined predictors of dropout and substance use outcomes was conducted in order to 
determine if client characteristics could be identified so that practical strategies and 
possible changes in treatment delivery could be implemented. 
Objectives and Hypotheses 
The main study was designed to determine factors associated with early dropout, 
survival in treatment, and examine substance use outcomes for patients with alcohol and 
drug dependence who sought treatment in a hospital-based outpatient community 
treatment setting. Pive objectives were examined within the context of a naturalistic 
prospective follow-up study. 
The first objective of the research was to determine whether patients who left 
treatment before 6 weeks (Early Dropouts) differed from those who stayed in treatment 
longer than 6 weeks (Retained) on sociodemographic, substance use, and psychological 
variables at baseline. Hypotheses based on this objective were: 
=> H ypothesis 1-Y ounger age, and greater severity of social and substance abuse 
problems at intake would be associated with early dropout from treatment. 
Based on the literature review and background studies conducted III the 
Addictions Unit, it was expected that the strength of the associations between 
sociodemographic characteristics and substance use problem severity at intake with 
dropout would be modest, stillleaving unanswered questions about predictors of dropout. 
Thus, the second objective of the study was to examine the relationships between 
dropout, and other factors including motivation, self-efficacy, and personality traits 
measured at intake. The primary variables were based on scores from the Stages of 
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Change, Readiness, and Treatment Eagerness Scale (SOCRA TES), the Drug Taking 
Confidence Questionnaire (DTCQ), and the Dimensional Assessment of Personality 
Pathology (DAPP). These variables were assessed in a subset of the main study sample. 
Hypotheses based on this objective were: 
~ Hypothesis 2- Lower motivation and self-efficacy scores at intake would be 
associated with early dropout from treatment. 
~ Hypothesis 3- Higher scores on personality factors of antisocial behaviour and 
emotional dysregulation would be associated with early dropout from treatment. 
The third objective was to examine the predictors of survival in treatment over the 
entire 6-month follow-up period. The hypothesis based on this objective was: 
~ Hypothesis 4- Severity of substance dependence at intake would be associated 
with survival in treatment over time. 
The fourth objective was to examine the association between retention in 
treatment and substance use outcomes and psychological and social functioning at 6 
months. The primary variables related to substance use outcomes were: drug and alcohol 
composite severity scores on the Addiction Severity Index (ASI), the number of days of 
primary drug use in the past month, the number of days of any drug use in the past 
month, and days of continuous abstinence from the primary drug. The secondary 
variables related to psychological and social outcomes included the number of days of 
psychological problems in the past month, the Global Severity Index (GSI) scores, and 
the ASI employment composite severity scores. The hypotheses based on this objective 
were: 
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=> Hypothesis 5- The Retained group would show significantly less problems in 
aIl measures of substance use outcome at 6 months compared to the Early Dropouts. 
=> Hypothesis 6- The Retained group would show significantly less psychological 
distress and employment problems at 6 months compared to the Early Dropouts. 
The fifth objective was to determine the relative association among demographic, 
substance use, psychological variables, as weIl as treatment attendance and substance use 
outcomes at 6 months. The primary outcome variable was the number of days of primary 
drug use in the past 30 days at 6 months. The hypotheses based on this objective were: 
=> Hypothesis 7- More severe substance abuse at intake would be associated with 
poorer drug and a1cohol outcomes at 6-month foIlow-up. 
=> Hypothesis 8- Longer treatment retention would be associated with less drug 
and alcohol use at 6 months. 
The following chapter describes the methodology of the study conducted in order 
to evaluate the above hypotheses. 
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Chapter2 
Methodology and Procedures 
The Research Site 
The research was conducted at the Addictions Unit of the Mc Gill University 
Health Center (MUHC), Department of Psychiatry, in Montreal, Quebec, Canada. The 
Addictions Unit is the only designated hospital-based substance abuse treatment program 
for adult English-speaking residents of Quebec and all treatment is covered by the 
Quebec health insurance plan. The treatment pro gram is primarily outpatient, with a four-
bed capacity for inpatient detoxification on a psychiatry unit in the hospital. An average 
of 450 patients receive treatment annually. The waiting time for entry to treatment after 
the initial telephone contact varies from 8 to 12 weeks. Patients may be self-referred, or 
may be referred by a health care pro vider, but must initiate the request for treatment on 
their own. A multidisciplinary mental health care team comprised of psychiatrists, 
psychologists, psychoeducators, nurses, and occupational therapists staff the Unit. 
Patients and Procedures 
Approval for the study was granted by the MUHC ethics committee (see 
Appendix A). AlI patients who contacted the Addictions Unit for treatment were eligible 
to participate in the study. A total of 411 patients were enrolled in the study following the 
procedures outlined below. The 6-month follow-up rate was 79% (N = 326): 293 attended 
interviews in person; 33 provided information only by telephone and did not retum 
follow-up questionnaires; 39 refused to participate at 6 months; and 46 were unreachable. 
The procedure for enrollment into the study consisted of the following steps: 1) standard 
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Addictions Unit baseline assessment 2) obtaining informed consent; 3) psychiatrie 
interview and application of study inclusion/exclusion criteria; 4) collecting additional 
measures including self-report instruments; 5) delivery of treatment; 6) follow-up 
interview and questionnaires at 6 months. 
Detailed Procedures 
1) Conducting the baseline assessment: Prior to assessment aIl patients received 
an information letter that described the clinic's abstinence-oriented treatment program 
and the research pro gram. The initial interview consisted of the standardized assessment 
of approximately 2 hours duration. Data collected included sociodemographic 
information, treatment history, and severity of substance-related problems in a variety of 
areas covered by Addiction Severity Index (ASI) (McLeIlan, Parihk, & Braff, 1990). 
Depression was assessed using the Beek Depression Inventory (BDI) (Beek & Steer, 
1987), and psychological distress was assessed using the Symptom Checklist-90 (SCL-
90) (Derogatis, 1983). These core questionnaires were administered to aIl patients 
attending the Addictions Unit, as part of the standard initial clinic assessment. Details on 
the instruments are provided below. 
2) Obtaining informed consent: After the standard clinical assessment, the foIlow-
up study was explained to patients in detail by a research assistant who was independent 
from the treatment team, and consent to participate was requested. Patients were asked to 
sign consent allowing use of the information provided in the first clinical assessment, and 
completion of self-report measures on how the y were feeling and thinking about 
attending treatment. They were also asked to consent to retum for a confidential follow-
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up interview, repeat self-report measures, and to pro vide a urine sample to be tested for 
a1cohol and drugs at 6 months, even if they were no longer in treatment. The refusaI rate 
for participation in the follow-up study was Il %. 
3) Psychiatric assessment and application of study inclusion/exclusion criteria: 
AIl baseline assessments were reviewed by an Addictions Unit psychiatrist, who 
conducted a brief clinical interview with each patient in order to apply 
inclusion/exclusion criteria. Exclusion criteria were based on the Addiction Society of 
Addiction Medicine (ASAM) guidelines for inpatient treatment (Hoffman, Halikas, Mee-
Lee, & Weedman, 1991), and were designed to exclude patients who were experiencing 
severe withdrawal syndromes, medical complications, or severe psychiatrie comorbidity 
such as psychotic symptoms or suicidai ideation requiring admission to the hospital. 
Patients who had been abstinent for more than one mon th, undergone previous substance 
treatment within the past 3 months, or those mandated to treatment by court order were 
excluded from the follow-up study. The sample aimed to be representative of the total 
outpatient population seeking treatment, and onl y 3.5 % (17) patients were ineligible 
based on these exclusion criteria. 
4) Collecting Additional Measures and Self-Reports: A sample of patients 
consenting to participate in the follow-up study were administered an additional battery 
of instruments including: the Stages of Change, Readiness, and Treatment Eagerness 
Scale (SOCRATES), the Drug Taking Confidence Questionnaire (DTCQ), and the 
Dimensional Assessment of Personality Pathology (DAPP). These questionnaires were 
given to a consecutive sample of patients later in the study in the form of a take-home 
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package so that they wou Id not be burdened by the additional time required to complete 
the measures at assessment. 
5) Delivery of treatment: Following assessment, aIl patients entered the standard 
Addictions Unit treatment program. The duration of recommended treatment in the 
Addictions Unit was from 6 to 12 months, based on patient progress and discussion with 
their primary care therapist. The treatment philosophy of the clinic was based on a goal of 
total abstinence from a1cohol and psychoactive drugs (with the exclusion of non-
addictive prescribed medication for co-existing Axis 1 disorders). Treatment was divided 
into the initial phase of engagement (Phase 1) and the second phase of maintenance 
(Phase II). 
The engagement phase (Phase 1) was of 6 weeks duration. During Phase 1 each 
patient was treated by a single therapist and attended one group therapy session and one 
individual therapy session per week. The goal of Phase 1 was to achieve abstinence from 
a1cohol and aIl drugs. Interventions during this phase were primarily based on 
motivational enhancement strategies, psychoeducation, cognitive-behavioural techniques, 
and coping skills training. The 50-minute individual therapy sessions covered a series of 
themes including: motivation for seeking treatment, coping with urges and cravings, 
identifying and preparing for high risk situations, and strategies to prevent relapse. A 
support group was available for the patient' s significant others. The 90-minute group 
therapy sessions were comprised of similar themes and interventions, but included more 
psychoeducation about substance dependence, and an introduction to working in groups. 
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This engagement phase of treatment was followed by the maintenance phase (Phase II) 
that lasted 6 to 12 months. 
Phase II of treatment consisted primarily of group therapy once or twice weekly. 
Groups were comprised of 6 to 8 members and led by a therapist with training in 
addiction and psychiatry. The therapeutic orientation of the groups in Phase II was a 
combination of supportive, cognitive-behavioural, and insight-oriented interventions. The 
groups were aimed at helping patients to adjust to a drug-free lifestyle, examine the 
function and consequences of substance abuse in their lives, develop new coping skills, 
identify high risk situations to prevent relapse, develop or maintain an appropriate social 
support system, and identify factors that could interfere with ongoing sobriety. Discharge 
planning was discussed between the patient and primary therapist. 
Due to the heterogeneous nature of the population, three groups for patients with 
special needs were also available. These were the senior' s group for patients 55 and 
older, a women's group, and a dual diagnosis group. Further psychiatrie evaluation or 
short-term treatment was provided on an as-needed basis during the course of treatment. 
In the event that long-term psychiatrie follow-up was needed, it was provided by the 
patient's psychiatry sector services in the community. 
Therapists and Psychiatrists 
The therapists who delivered the Phase 1 individu al and group sessions remained 
consistent throughout this study. They were two Master's level trained therapists with 
from 8 to 15 years of experience working in addiction treatment. The therapists discussed 
cases and therapeutic procedures on a regular basis to ensure consistency of approach and 
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treatment delivery in individual and group sessions in Phase I of the treatment. 
Therapists delivering Phase II group therapy were all experienced mental health 
practitioners with backgrounds in nursing, social work, and occupational therapy, with an 
average of 15 years experience working in addiction treatment or mental health. 
Psychiatrists on staff met with aIl therapists weekl y at team rounds to discuss case 
management, foIlow-up, or referral for psychiatric evaluation. 
6) Follow-up procedures at 6 months: At the time of assessment consenting 
patients were asked to provide the names of three contact persons who wou Id know 
where to reach them at follow-up but wou Id not be given any information about the 
nature of the contact. A trained research interviewer who was not part of the treatment 
pro gram conducted the follow-up interviews. Patients were compensated with $ 20 gift 
certificates for attending the interview, or completion of questionnaires in the case of a 
phone contact. Follow-up efforts were begun 2 weeks before the 6-month date and were 
extended up to 2 months in the event that patients were unreaehable at the time. In these 
cases, retrospeetive interviews were eondueted, using the timeline followbaek method 
(Sobell & Sobell, 1996b). When patients had eancelled or did not show for two seheduled 
in-person interviews, attempts were made to conduet phone interviews. 
Measures 
Substance Use: Demographie eharacteristies including age, gender, marital status, 
living situation, education, employment status, were eollected using the Addiction 
Severity Index (ASI) (MeLellan, Parikh, & Braff, 1990). The ASI is a 45 to 60 minute 
structured interview that measures lifetime and recent (past 30 days) problem severity in 
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seven categories: drug and alcohol use, family/social functioning, and medical, 
employment, legal, and psychological status. Within each of these categories, items 
measuring the severity of the problem in the last 30 days and are combined into a 
composite score. The composite scores are computed on a range from 0 (no 
significant problem) to 1 (extreme problem) to reflect problem severity for each 
category. The ASI composite scores have shown acceptable internaI consistency 
(Cronbach's alpha ranging form .68 to .87) and test-retest reliability (kappas ranging 
.88 to .99) in opiate, alcohol and cocaine-dependent populations (McLellan et al., 
1994). The ASI has been found to have high inter-rater reliability for aIl composite 
scores (Alterman, Brown, Zaballero, & McKay, 1994), and clinical dimensions have 
been shown to retain concurrent and predictive validity across a wide range of 
substance dependent patients (Alterman et al., 2000). 
Psychological Distress: The Beck Depression Inventory: The BDI (Beck & 
Steer, 1987) is a 21-item self-report questionnaire designed to assess the severity of 
depression. For each item there is a series of four statements on a 4-point scale to 
reflect the range of severity of symptoms for affective, cognitive, behavioural, 
somatic, and interpersonal aspects of depression experienced over the past se ven 
days. The inventory takes from 5 to 10 minutes to complete. Total scores range form 
o to 63. A score of over 20 has been used to define moderate to severe depression 
(Kendall, Hollon, Beek, Hammen, & Ingram, 1987). Psychometrie studies found high 
internaI consistency in clinical and nonclinical populations, including outpatient and 
heroin samples with coefficient alphas of .90 and .88, respectively. 
The Symptom Checklist-90-R (SCL-90): The SCL-90-R (Derogatis, 1983) is 
a 90-item self-report symptom inventory that measures psychological di stress 
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experienced in the past seven days. The subscales include interpersonal sensitivity, 
somatization, obsessive-compulsiveness, depression, anxiety, phobie anxiety, 
hostility, paranoid ideation, and psychoticism. Each item ranges from 0 to 4. Three 
global indices of pathology are provided. The Global Severity Index (GSI) indicates 
the overall intensity of subjective distress, the Positive Symptom Total (PST) 
represents the total number of symptoms experienced, and the Positive Symptom 
Distress Index (PSDI) is a score that combines the intensity and the number of 
symptoms. InternaI consistency for various subscales ranges from 0.77 - 0.90, and 
test-retest reliability ranges from 0.78 - 0.90 (Derogatis, 1983). 
Additional Measures Administered to the Subset of the Total Sample 
ln addition to the core questionnaires, a subset of patients was given 
additional questionnaires at baseline to assess motivation, self-efficacy, and 
personality factors. The self-efficacy questionnaire was re-administered at 6-month 
follow-up. 
Motivation: The Stages of Change, Readiness, and Treatment Eagerness Scale 
(SOCRATES) (Miller et al., 1991; Miller & Tonigan, 1996) is a self-report inventory 
designed to assess readiness for change in alcohol and drug abusers. It is a 40-item 
scale that produces scores on 5 sc ales corresponding to Prochaska and DiClemente's 
(1992) five Stages of Change theory. The instrument yields three factorally-derived 
scale scores: Recognition, Ambivalence, and Taking Steps. Cronbach's alpha for the 
scales are: Ambivalence: 0.60 - 0.88; Recognition: 0.85 - 0.95; and Taking Steps: 
0.83 - 0.96. 
Self-Efficacy: The Drug Taking Confidence Questionnaire (DTCQ), (Annis, 
Sklar, & Turner, 1997; Sklar, Annis, & Turner, 1997) is a 50-item self-report 
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inventory that was developed for people seeking treatment for drug and alcohol 
problems. It is grounded in Bandura's (1977) theory of self-effieacy, but is specifie to 
drinking and drug-use situations. The eight subscales are based on Marlatt & 
Gordon's (1985) category classifications of relapse precipitants. Each subscale is 
rated by increments of 20 from 0 to 100 on a 6-point scale. Respondents rate their 
confidence in ability to resist drinking or taking drugs in each of the situations. The 
scales are subdivided into two major types of situations: personal states, and 
situations involving other people. The subscales included in "personal states" are: 
unpleasant emotions (10 items), physical discomfort (5 items), pleasant emotions (5 
items), testing personal control (5 items), and urges and temptations (5 items). The 
subscales included in the "situations involving others" are: conflict with others (10 
items), social pressure to use (5 items), and pleasant times with others (5 items). 
Cronbach's alpha for the two 1O-item scales on the DTCQ (unpleasant emotions and 
conflict with others) each had alphas of at least 0.94. All six of the 5-item scales had 
alphas ranging from 0.79 - 0.95. 
Personality Factors: The Dimensional Assessment of Personality (DAPP) is 
an abbreviated 69-item form of the original 291-item inventory (Livesley, Jang, & 
Vernon, 1998; Jang, Vernon, & Livesley, 2000). It consists of 18 dimensions that are 
combined to derive four factorally-derived factors of personality. The research 
involved in the development of the personality inventory was based on evidence that 
personality traits are hierarchically organized with more specifie lower-order traits 
combined to form more general higher-order traits. The DAPP was constructed from 
factor analysis based on three samples: a clinical sample of patients with a DSM-IV 
diagnosis of personality disorders, a general population sample, and a sample of twin 
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pairs. The four factors that emerged through principal component analysis were 
similar across the three samples. The emotional dysregulation factor represents 
unstable and reactive tendencies, dissatisfaction with self and life experiences, and 
broadly represents DSM-IV cluster B diagnosis of borderline personality disorder. 
The lower-order dimensions included in this factor are: submissiveness, cognitive 
dysregulation, identity problems, affective lability, oppositionality, anxiousness, 
suspiciousness, social avoidance, and insecure attachment. The dissociaI behaviour 
factor includes personality dimensions of stimulus-seeking, callousness, rejection, 
narcissism, and conduct problems, and resembles the DSM-IV cluster B diagnosis of 
antisocial personality disorder. The inhibitedness factor is defined by intimacy 
problems and restricted expression, and resembles the DSM-IV diagnosis of avoidant 
and schizotypal personality disorders. The compulsivity factor is most similar to the 
obsessive-compulsive personality disorder of DSM-IV, marked by compulsivity. The 
DAPP has internaI consistency (Chronbach's alpha) ranging from 0.83 - 0.94, and 
test-re-test reliability ranging from 0.81 - 0.93. 
Measures Related to Treatment Attendance and Participation 
Information collected during treatment was obtained from medical charts and 
included: the frequency and amount of substance use reported by patients, results of 
urine screening, clinical notes of the treating team consisting of individual therapy 
session reports as welI as primary therapist monthly progress notes. Attendance 
records were used to verify aIl treatment contacts, including individual therapist and 
psychiatrist appointments, group sessions, and the total number of days in treatment. 
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Statistical Plan and Data Analyses 
For each patient, data collected during the baseline and follow-up interviews 
and aIl variables recorded from Addictions Unit charts were coded and entered by the 
research assistant into a database using Microsoft Excel, and checked for accuracy by 
the principal investigator. AIl subsequent statistical analyses were conducted using 
the microcomputer version of SPSS (11.5). Two groups were created using a cutoff of 
6 weeks as the time point for distinguishing Early Dropout (EDO) patients from those 
who were Retained (RTD) longer in treatment. This time point was chosen based on 
the design of the treatment pro gram in the clinic. As outlined in the section describing 
the treatment, the therapy was divided into two phases, the first phase of engagement 
was 6 weeks and the second phase of maintenance was 6 to 12 months. Therefore, a 
natural time frame for examining early dropout in the clinic was to look at retention 
based on completion of the engagement phase of treatment. 
The first objective of the research was to determine whether patients who left 
treatment before 6 weeks (Early Dropouts) differed from those who stayed in 
treatment longer than 6 weeks (Retained) on important sociodemographic, substance 
use, and psychological variables at baseline. Descriptive analyses were conducted on 
all baseline and follow-up data in order to compare the two groups on demographic, 
social, substance use, and psychological factors. Associations were examined using 
Chi-square analysis for categorical data and Student' st-tests for continuous data, with 
a Bonferroni correction for multiple comparisons. Subsequently, variables relating to 
age, gender, employment, primary drug of abuse, severity of substance abuse, 
psychiatric diagnoses, and psychological distress were used as predictors of early 
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dropout in a multiple logistic regression analysis to examine predictors of early 
dropout. This analysis was chosen because while the dependent variable is 
dichotomous, it accepts a mixture of nominal, ordinal, and interval independent 
variables and is useful for exploratory and predictive research (Hosmer & Lemeshow, 
1989). 
The second objective was to determine if motivation, self-efficacy, and 
personality factors assessed at intake were related to early dropout from treatment. 
The primary variables were based on scores from the Stages of Change, Readiness, 
and Treatment Eagemess Scale (SOCRATES), the Drug Taking Confidence 
Questionnaire (DTCQ), and the Dimensional Assessment of Personality Pathology 
(DAPP). Separate analyses were carried out on the subset of patients who completed 
the SOCRATES, DTCQ, and the DAPP. These analyses inc1uded Student's t-tests 
and Chi-square analyses in order to examine associations between motivation, self-
efficacy, and personality factors and retention in treatment. 
The third objective was to determine if predictors of attrition from treatment 
over time differed from those of early dropout. The primary variable for this objective 
was survival in treatment up to 6 months. Separate survival analyses were conducted 
in order to compare males and females, as weIl as the different primary drug groups 
(a1cohol, drugs, alcohol + drugs). In addition, comparisons were made between those 
patients with and without depression at intake, as determined by Beck Depression 
Inventory scores> 20. The survival functions for the different groups were compared 
using the Wi1coxon (Gehan) statistic provided by SPSS, yielding comparisons of the 
median survival time in treatment. Subsequently a Cox proportional hazards 
regression analysis was used to determine the relative association among 
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demographic, substance use, psychological variables, and rate of attrition from 
treatment over 6 months. 
The fourth objective was to examine the association between retention in 
treatment and substance use outcomes and psychological and employment problems 
at 6 months. Primary outcome variables were analyzed using a two-way ANOV A 
with repeated measures, with retention status (Early Dropouts versus Retained) X 
time (intake, 6 months) as factors. The primary outcome variables for measurement of 
the substance use outcomes were: the drug and alcohol composite severity scores on 
the Addiction Severity Index (ASI), the number of days of primary drug use in the 
past month, and the number of days of any drug use in the past month. 
Secondary outcome variables were also analyzed using a two-way ANOV A 
with repeated measures, with retention status (Early Dropouts versus Retained) x time 
(intake, 6 months) as factors. The secondary outcome variables for measurement of 
the objective for psychological functioning and employment problems were: the 
number of days of psychological problems in the past month, the Global Severity 
Index (GSI) scores, and the ASI employment composite severity scores. 
The fifth objective was to determine the relative association among 
demographic, substance use, psychological variables, as weIl as treatment attendance 
and substance use outcomes at 6 months. The primary outcome variable was the 
number of days of primary drug use in the past 30 days, as measured -at the 6-month 
foIlow-up interview. Variables relating to age, gender, employment, primary drug of 
abuse, severity of substance abuse, psychological distress at intake, and treatment 
attendance were used as predictors in a hierarchical linear regression analysis. The 
stepwise model of entry for this analysis sequentially tests independent variables for 
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their contribution to explaining variation in the independent variable and the predictor 
that accounts for the largest portion of the variance is entered into the equation at that 
point. The variance accounted for by that variable is removed from the equation, 
providing and opportunity to test remaining variables for their independent 
contribution to explaining the remaining variance. The results therefore provide a test 
of individu al contribution of subsequent variables, adjusting for the contribution of aIl 
previous variables. These subsequent predictors are then tested and entered in order 
of their contribution to the explanation of the variance in the particular outcome 
criterion (McLeIlan, 1994). 
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Chapter3 
Predictors of Treatment Retention 
A total of 411 patients participated in the foIlow-up study. The sample was 
initially stratified into two groups based on treatment attendance. The Early Dropout 
(EDO) group left treatment before 6 weeks, and the Retained (RTD) group stayed in 
treatment beyond this time period. Twenty-six per cent of patients (109) left treatment 
before 6 weeks. 
Tables 1 through 5 display the demographic, social, substance use, and 
psychological characteristics of the sample at intake, stratified by Early Dropout 
classification. Table 1 shows that the total sample was two thirds male. Almost aIl 
patients (93%) were Caucasian. Patients in the EDO group were significantly younger 
than those in the RTD group [t (409) = -3.88, P = 0.001]. The ASI employment 
composite severity scores demonstrate that the EDO group had more employment 
problems [t (406) = 2.57, P = 0.011], but it is evident that aIl patients were generally 
experiencing a moderately high degree of problems related to work. Less than 50% in 
both groups were employed full or part-time. Table 2 shows that the sample was 
largely single, and most patients were living with a family member. There were no 
significant differences between groups on any of the social variables examined. 
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Table 1: Demographie Characteristics of the Sample at Intake 
Early Dropouts Retained > 6 weeks 
N= 109 N=302 
Age* 37.5 (0.86) 41.4 (0.67) 
Gender 
Male 64.2% 60.3% 
Employment status 
Unemployed 43.5% 36.9% 
Employed (full or part-time) 41.7% 49.8% 
StudentIRetiredIHomemaker 14.8% 13.3% 
Number of years of education 13.0 (0.3) 13.5 (0.18) 
Groups were compared using Student's t-tests, and Chi-square analysis. 
Values are percentages or means (± SEM). 
* p < 0.05 corrected for multiple comparisons. 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
Table 2: Social Variables at Intake 
Early Dropouts Retained > 6 weeks 
N= 109 
Marital Status 
Single 47.7% 
MarriediCommon Law 24.8% 
WidowediSeparatediDivorced 26.8% 
ASI Social Composite Severity score 0.26 (0.02) 
Living arrangements 
Family 62.4% 
Friends 5.5% 
Alone/Other 32.1% 
Number of days of family problems 2.6 (0.63) 
(past month) 
Number of days of problems with people 1.7 (0.46) 
(past month) 
ASI Legal Composite Severity score 0.07 (0.01) 
Groups were compared using Student's t-tests, and Chi-square analysis. 
Values are percentages or means (± SEM). 
* P < 0.05 corrected for multiple comparisons. 
N=302 
41.4% 
36.8% 
22.1% 
0.22 (0.01) 
59.9% 
3.3% 
36.8% 
3.0 (0.4) 
1.3 (0.27) 
0.04 (0.01) 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
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Substance Use Variables 
Patients reported their primary and secondary drugs of abuse as part of the 
ASI intake interview. For the total sample (N = 411) the overall distribution of 
primary drug of abuse was as follows: alcohol, 55%; cocaine, 24%; cannabis, 10%; 
benzodiazepines, 6%; opiates, 4%. Fort y-six per cent had a secondary drug of abuse 
and 52% were using a second substance. Patients wère further classified into three 
mutually exclusive groups 
based on primary and secondary drugs of abuse. Patients in the alcohol alone group 
were dependent only on a1cohol. The drug group was comprised of patients 
dependent on cocaine, cannabis, opiates, or benzodiazepines, with sorne abusing more 
than one drug. The alcohol plus drug group was comprised of those dependent on 
a1cohol as weIl as another drug. 
As shown in Table 3, the ASI aIcohol and drug composite severity scores 
supported the accuracy of primary group assignment. The aIcohol composite severity 
scores were elevated in the a1cohol only and a1cohol + drug groups compared to the 
drug only group [F (2, 404) =141.53, P < 0.0001]. The drug composite severity scores 
were elevated in the drug only and the alcohol + drug groups compared to the a1cohol 
only group [F (2,403) = 206.64, P < 0.0001]. Table 4 shows that there were no 
significant differences at intake between the EDO and RTD groups for either a1cohol 
or drug severity measured by the ASI alcohol and drug composite severity scores. 
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Table 3: Mean ASI Alcohol and Drug Composite Severity Scores for Primary 
Drug Group for Total Sample at Intake (N = 411) 
A1cohol alone (N = 134) 
Drugs (N =111) 
A1cohol + Drugs (N = 166) 
Groups were compared using ANOV A. 
Values are means (± SEM). 
ASI A1cohol Composite 
Severity Score 
0.54 (0.02) 
0.08 (0.01) 
0.47 (0.02) 
ASI Drug Composite 
Severity Score 
0.03 (0.005) 
0.24 (0.01) 
0.19 (0.01) 
Table 4: Substance Use Variables Stratified by Early Dropout 
Earl y Dropouts 
N= 109 
Retained > 6 weeks 
N=302 
Number of years of problem use 
drug 
of primary 9.3 (0.77) 
Primary drug of abuse 
A1cohol alone 
Drugs 
A1cohol + Drugs 
Number of days of primary drug intake 
(past month) 
Previous treatment for substance abuse 
ASI A1cohol Composite Severity score 
ASI Drug Composite Severity score 
ASI Medical Composite Severity score 
Secondary drug of abuse 
27.5% 
30.3% 
42.2% 
14.9 (1.12) 
48.1% 
0.36 (0.03) 
0.15 (0.01) 
0.16 (0.03) 
53.2% 
Groups were compared using Student's t-tests, and Chi-square analysis. 
Values are percentages or means (± SEM). 
* P < 0.05 corrected for multiple comparisons. 
11.1 (0.51) 
34.4% 
25.8% 
39.7% 
15.0 (0.69) 
50.7% 
0.40 (0.02) 
0.15 (0.01) 
0.21 (0.02) 
42.7% 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
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Psyehologieal Variables 
The psyehologieal variables shown in Table 5 demonstrate that there were few 
signifieant differences between groups at intake. Two thirds of patients in both groups 
had a lifetime history of anxiety, depression, or both. The Beek Depression Inventory 
(BOl) total score was elevated for patients who dropped out early [t (382) = 1.98, P = 
0.048], but the value was not signifieant when eorreeted for multiple eomparisons. 
Patients who dropped out before 6 weeks were less likely to be taking psychiatrie 
medication at intake [X2 (1) = 7.43, P = 0.006]. 
Treatment Attendance 
Table 6 summarizes the rates of treatment attendance for both groups. The 
EDO group stayed in treatment for an average of 23 days and attended an average of 
6 therapy sessions in total: 2 individual sessions, 4 group sessions, and less than one 
session with a psychiatrist. The RTD group stayed an average of 147 days and 
attended an average of 27 therapy sessions in total: 5 individu al sessions, 18 group 
sessions, and 3 sessions with a psychiatrist. As expeeted, attendance to total, 
individu al, group, and psychiatry sessions eonfirmed that the EDO group attended 
significantly fewer sessions in each category eompared to the RTD group. 
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Table 5: Psychological Variables at Intake 
aSI (SCL-90) 
History of anxiety or depression 
(lifetime) 
None 
Depression only 
Anxiety only 
Depression + anxiety 
Beck Depression Inventory total score 
ASI Psychological 
Composite Severity score 
Previous treatment received for 
psychological problems (lifetime) 
Inpatient 
Outpatient 
Taking medication for psychiatrie 
disorder* 
Early Dropouts 
N= 109 
1.25 (0.07) 
31.8% 
24.3% 
12.1% 
31.8% 
20.14 (1.07) 
0.37 (0.02) 
22% 
71.3% 
35.5% 
Groups were compared using Student's t-tests, and Chi-square analysis. 
Values are percentages or means (± SEM). 
* P < 0.05 corrected for multiple comparisons. 
Retained > 6 weeks 
N=302 
1.17 (0.04) 
33.6% 
26.2% 
13.0% 
27.2% 
17.84 (0.59) 
0.36 (0.01) 
19% 
73.6% 
50.8% 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
GSI-Global Severity Index on the Symptom Checklist-90. 
Table 6: Comparison of Treatment Attendance Between Early Dropout and 
Retained Groups 
Length of time in treatment* 
Total number of therapy sessions* 
Number of group sessions* 
Number of individu al sessions* 
Number of psychiatry sessions* 
Early Dropouts 
N= 109 
22.94 (1.30) 
6.42 (0.72) 
3.93 (0.6) 
2.01 (0.15) 
0.53 (0.11) 
Groups were compared using Student's t-tests. 
Values are percentages or means (± SEM). 
*p < 0.05 corrected for multiple comparisons. 
Retained > 6 weeks 
N=302 
146.87 (3.36) 
26.69 (2.68) 
18.55 (0.84) 
5.48 (0.23) 
2.76 (0.22) 
66 
Based on preliminary comparisons of sociodemographic characteristics, it was 
found that patients who dropped out early were significantly younger and 
experiencing more employment problems compared to those retained longer than 6 
weeks. Social and living situations did not differ between groups. There were no 
significant differences evident for severity of substance use or primary drug group 
between EDO and RTD groups. Patients who left treatment before 6 weeks were less 
likely to be taking psychiatrie medieation, but did not differ signifieantly from those 
retained on any other psychological variables. 
Predietors of Early Dropout 
Based on the above comparisons, there were few baseline differences 
identified between the EDO and RTD groups, however, there may have been 
confounding variables, for example, age and severity of substance use. In order to 
control for confounding variables, and to explore the relative contribution of 
predictors of early dropout, a stepwise logistic regression using SPSS (2002) was 
carried out. The question addressed by the analysis was "How do Early Dropouts 
differ from those retained longer in treatment?" The analysis sought to determine the 
extent to which demographic characteristics, substance use severity, and 
psychological problems coincided with early dropout. Each set of variables was 
entered stepwise into the regression model, with the dependent variable set as 
Retained> 6 weeks (0 = no, 1 = yes). Since t-tests had shown that ASI employment 
composite severity scores were elevated in the EDO group, this variable was entered 
in the first step of the model along with other sociodemographic variables of age, 
gender, and marital status. The primary drug group and the ASI alcohol and drug 
composite severity scores were entered in the second step. In the third step of the 
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model the Global Severity Index (GSI) from the SeL-90 and the ASI psychological 
composite severity score were entered. 
Table 7 shows that only the sociodemographic variables of age, marital status, 
and the ASI employment composite severity score were associated with early 
dropout. None of the substance use or psychological variables in the model were 
significantly associated with early dropout. Results indicated, as hypothesized, that 
less social stability, i.e., younger age, divorced, separated or widowed marital status, 
and more severe employment problems, were associated with early dropout. More 
psychological problem severity at intake, specifically, higher scores on the ASI 
psychological composite severity score, and the GSI score, was not associated with 
early dropout. Similarly, those with more severe substance use problems at intake 
were not more likely to drop out of treatment early. 
Motivation, Self-Efficacy, and Personality Factors and Treatment Retention 
Psychological problem severity measured by the ASI composite scores and 
the GSI scores were not predictive of early or later dropout. When patients were 
assessed, they were asked why they were seeking treatment at that time. "Family" 
was the most frequent response given by 24% of participants as the reason for seeking 
treatment, followed by health for 18%, then work, for 6%, and financial or legal 
concerns, 5%. The other reasons given included more general kinds of motivators for 
treatment (46%) su ch as being tired of the lifestyle, feeling "stuck" in a cycle, losing 
time due to substance abuse, or no longer getting the same pleasure from aIcohol and 
drugs. There were no significant differences in reasons for seeking treatment between 
the EDO and RTD groups [i (5) = 5.035, P = 0.412]. Since level of motivation, self-
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Table 7: Summary of Results of Logistic Regression for Early Dropout (N = 391) 
Variable B 
Step 1 
Nagelkerke R2 = 0.081 
Step:;: = 22.15 (5) p = 0.0001 
Age 0.044 
Gendert 0.368 
Marital statustt 
Single 
Marriedl Commonlaw -0.148 
Di vorced/Separated/ Widowed -0.721 
ASI Employment Composite Severity score -1.050 
Step2 
Nagelkerke R2 = 0.085 
Step: i (2) = 23.17, P = 0.006 L1i (4) = 1.017 P = 0.924 
Primary drug groupttt 
Akohol alone 
Drugs 0.061 
Akohol + Drugs -0.088 
ASI Drug Composite Severity score 0.936 
ASI Alcohol Composite Severity score 0.104 
Step 3 
Nagelkerke R2 = 0.085 
Step: i (3) = 23.21, P = 0.017 L1;: (2) = 0.041, P = 0.980 
ASI Psychological Composite Severity score 0.130 
GSI score (SCL-90) 0.118 
t Males served as reference group 
tt Single served as reference group 
ttt Alcohol served as reference group 
ASI-Addiction Severity Index 
GSI-Global Severity Index on the Symptom Checklist-90 
Wald (dt) p value 
10.00(1) 0.002 
1.98 (1) 0.159 
5.413 0.067 
4.47 (2) 0.575 
0.209 (1) 0.648 
4.98 (1) 0.026 
6.24 0.012 
0.204 (2) 0.903 
0.01 (1) 0.909 
0.053 (1) 0.916 
0.379(1) 0.538 
0.035 (1) 0.851 
0.039 (1) 0.843 
0.006(1) 0.937 
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efficacy regarding resistance to substance use, and personality features have been 
associated with poorer treatment outcomes of retention and change in substance 
abuse, additional information about these factors was gathered in a subset of the main 
sample. 
In order to examine associations between motivation, self-efficacy, 
personality features, and treatment retention, a subset of the main sample of 411 
participants was given additional questionnaires at assessment. The Stages of Change, 
Readiness, and Treatment Eagemess Scale (SOCRA TES) was administered to assess 
motivation. The Drug Taking Confidence Questionnaire (DTCQ) was administered to 
assess self-efficacy in specific substance-using situations. The Dimensional 
Assessment of Personality Pathology (DAPP) (Livesley et al., 1998) was 
administered to assess personality factors. The DTCQ and SOCRATES were given to 
199 participants. The DAPP was added later and was given to 165 patients. Not aIl 
patients who were given questionnaires retumed them, and data obtained for the 
questionnaires at intake were as follows: SOCRATES, 168; DTCQ, 166; and DAPP, 
120. 
These additional questionnaires were given to consecutively entered patients 
after subject # 211. Previous studies conducted in the Addictions Unit demonstrated 
that patients seeking treatment over the past 5 years have had very similar 
demographic, substance use, and psychiatrie profiles. However, the subset was 
compared with the larger sample to determine if there were significant differences on 
important demographic or substance use characteristics. There were no significant 
differences on ASI employment, social, legal, medical, and drug severity composite 
scores. Although the means of the ASI alcohol composite severity scores for the 
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subset (M = 0.427, S.E.M. 0.022) and the earlier part of the sample (M = 0.346, 
S.E.M. 0.019) were significantly different [t (398) = 2.76, P = 0.006], there were no 
significant differences on the number of days of primary drug intake or the number of 
days of any substance use in the past 30 days. The ASI psychological composite 
severity scores for the subset (M = 0.333, S.E.M. 0.016) and the first half of the 
sample (M = 0.402, S.E.M. = 0.017), were significantly different [t (405) = -2.912, P 
= 0.004], but there were no significant differences on the SCL-90 or Beek Depression 
Inventory scores. 
Motivation and Self-Efficacy 
As shown in Table 8, the scores on the SOCRA TES scales of Recognition, 
Taking Steps, and Ambivalence, and the average DTCQ subscale scores for the EDO 
and RTD groups were very similar, and analyses using t-tests comparing the means 
yielded no significant differences at baseline. Nor were there differences on the 
individual subscales of the DTCQ between groups. Therefore, the hypothesis that 
lower motivation and self-efficacy scores at intake would be associated with early 
dropout was not supported. 
Personality Factors 
For the subset of patients who were given additional questionnaires to assess 
motivation and self-efficacy, clinic files were reviewed and coded for a DSM-IV 
diagnosis of any personality disorder being "present" or "not present" based on initial 
psychiatrie assessment. Based on this coding, 23.6% of this subset had an Axis II 
disorder (n = 47). There was no significant difference between the EDO (28.6%) and 
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Table 8: Comparison of scores on the SOCRATES and DTCQ for Early 
Dropout and Retained Groups at Intake 
SOCRATES (N = 168) 
Ambivalence 
Recognition 
Taking Steps 
DTCQ (N = 166) 
Average subscale score 
Early Dropouts 
N=44 
14.84 (0.58) 
29.64 (0.79) 
30.34 (1.13) 
N=40 
55.94 (3.86) 
Groups were compared using Student's t-tests. 
Values are percentages or means (± SEM). 
* p < 0.05 corrected for multiple comparisons. 
Retained > 6 weeks 
N= 124 
14.39 (0.37) 
29.54 (0.50) 
30.36 (0.71) 
N= 126 
56.57 (2.16) 
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RTD (22.4%) groups for presence of a personality disorder [X2 (1) = 0.884, P = 
0.347]. The prevalence of Axis II disorders coded was: 9.5% borderline, 2.5% 
antisocial, 2.5% narcissistic, 1.5% histrionic, 1.5% dependent, 1 % avoidant, and 5% 
"not otherwise specified". 
AlI 7 ASI composite scores were examined using t-tests to determine if the 
diagnosis of a personality disorder was associated with greater problem severity in 
any of these are as at intake. As expected, higher ASI psychological composite 
severity scores were significantly associated with the presence of a personality 
disorder [t (193) = -2.914, P = 0.004]. The diagnosis of personality disorder was 
associated with higher ASI drug composite severity scores [t (192) = -2.048), P = 
0.042], although this value was not significant when corrected for multiple 
comparisons. There were also significant differences in the prevalence of personality 
disorders for the primary drug groups. Twelve per cent of those in the alcohol alone 
group had a diagnosis of a personality disorder, compared to 25% in the alcohol and 
drug group, and 37% in the drug only group [i (2) = 9.338, P = 0.009]. 
Since the ASI psychological composite severity score was significantly 
elevated in those with a diagnosis of an Axis II disorder, and the co-existence of both 
Axis I and Axis II disorders is common, a Chi-square analysis was conducted to 
determine if there was a relationship between diagnosis of Axis I and Axis II 
disorders but no significant association was found [X2 (1) = 0.383, P = 0.536]. 
The diagnosis of a personality disorder per se may be less predictive of poorer 
outcomes than the particular traits associated with a specific personality disorder. The 
DAPP questionnaire was administered in order to examine an association between 
certain personality factors and early dropout from treatment. These 4 personality 
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factors were: emotional dysregulation, dissociaI behaviour, inhibition, and 
compulsivity. It was predicted that those with higher scores on emotional 
dysregulation, and dissociaI behaviour would be more likely to drop out of treatment 
early. T-tests confirmed a significant association between the inhibition factor and 
early dropout [t (117) = 2.015, P = 0.046], although this was not significant when 
corrected for multiple comparisons. The scores for factors of emotional dysregulation 
and dissociaI behaviour were not significantly elevated in the early dropouts 
compared to those retained, as had been hypothesized. 
Factors Associated with Survival in Treatment Over Time 
Since the primary focus of the research was based on a health servIce 
perspective, questions of interest in this study included those related to the percentage 
of patients completing the recommended treatment and the patient characteristics 
associated with completion of the program. To examine addition al characteristics 
associated with overall rates of attrition from treatment over time, several survival 
analyses were conducted. The survival functions for the different groups were 
compared using the Wilcoxon (Gehan) statistic provided by SPSS, yielding 
comparisons of the median survival time. 
Analyses were conducted in order to determine if there were differential rates 
of attrition from treatment for males and females. The results of the survival analysis 
showed that the median survival time for males (117 days), and females (158 days) 
was not significantly different (Gehan statistic (1,411) = 1.34, P = 0.247]. 
A survival analysis was conducted to examine rates of attrition from treatment 
based on BDI scores. The outcome criterion used was "Depressed" or "Not 
Depressed", with a total BDI score of 20 or more as the cut-off for depression. The 
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results of the survival analysis comparing the Depressed and Not Depressed groups 
showed no significant difference for median survival time [Gehan statistic (1,411), = 
2.34, P = 0.126]. 
A third survival analysis was conducted to examine median lengths of stay in 
treatment for each of the primary drug groups. A comparison of the primary drug 
groups in terms of rates of survival in treatment over the 6-month follow-up period is 
represented in Figure 1. There was a significant difference among the three primary 
drug groups for median length of stay in treatment [Gehan statistic (2, 411) = 7.08, P 
= 0.03]. Pairwise comparisons indicated that the rate of attrition was significantly 
higher in the drug group compared to the alcohol alone group [Gehan statistic (1,245) 
= 7.51 P = 0.006], but not between the alcohol alone and alcohol + drugs groups 
[Gehan statistic (1,300), = 0.133], or the drug group and the alcohol + drug groups 
[Gehan statistic (1,277) = 0.231]. 
Based on the results of the logis tic regression conducted on early dropout, and 
the survival analysis indicating significant differences in median lengths of stay 
among the primary drug groups, chi-square analyses and ANOVA's were conducted 
comparing age, marital status, and ASI employment composite severity scores among 
the primary drug groups. When corrected for multiple comparisons, only age 
remained significantly different among the three drug groups, with the alcohol alone 
group being significantly oIder than the drug and the drug + alcohol groups [F (2, 
410) = 27.363, P < 0.0001] (Scheffe post hoc tests). 
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Figure 1. A comparison of the primary drug groups in terms of rates of survival in 
treatment over the 6-month follow-up period 
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Cox proportional hazards regression (SPSS) was utilized to determine factors 
associated with the rate of attrition from treatment over 6 months. Sociodemographic, 
substance use, and psychological variables at intake were examined for an association 
with the rate of attrition from treatment. The variables were selected using the same 
rationale as the model for logistic regression for early dropout, based on the literature 
showing an association with these variables and dropout. The logistic regression had 
examined predictors of early dropout and found a significant association with age, 
marital status, and severity of employment problems. The Cox regression model was 
conducted to examine patient factors at intake that were associated with survival in 
treatment over time, with the dependent variable set as the number of days in 
treatment. 
As Table 9 demonstrates, in the final step of the Cox regression model, 
younger age, male gender, and higher severity of employment problems were 
significant determinants of attrition from treatment up to 6 months. Drug and alcohol 
severity and psychological distress were not predictors of attrition. 
There were sorne differences between males and females in terms of primary 
drug of abuse, as weIl as problem severity in several areas measured by the ASI 
composite severity scores. For women, the most common primary drug of abuse was 
alcohol (60%), followed by cocaine (17%), then benzodiazepines (9%), cannabis 
(6%), and opiates (6%). For men, alcohol was also the most commonly used primary 
drug (52%), followed by cocaine (29%), then cannabis (12%), benzodiazepines (4%), 
and opiates (2.4%). There were no differences between males and females in terms of 
dependence on alcohol [i (1) = 3.04, P = 0.081] and opiates [X2 (1) = 2.98, P = 
0.084]. However, women were more likely to be dependent on benzodiazepines [X2 
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(1) = 4.15, P = 0.042], and less likely to be dependent on cocaine [X2 (1) = 7.61, P = 
0.006] and cannabis [X2 (1) = 3.92, P = 0.048]. 
T -tests used to compare differences between gender on the ASI composite 
severity scores at intake found that psychological [t (405) = -1.990, P = 0.047], and 
medical [t (405) = -1.75, P = 0.004] problem severity were greater in the females. 
Females were also more likely to be taking psychiatrie medieation at intake [X2 (1) = 
15.086, P = 0.0001] and to have lifetime history of anxiety or depression [i (3) = 
9.94, P = 0.002]. 
The analyses conducted on early dropout and survival in treatment had not 
identified robust predictors among demographic, substance use, and psychologieal 
variables examined. The next chapter describes substance use outcomes at 6 months, 
with comparisons between the EDO and RTD groups. 
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Table 9: Summary of Cox Regression Proportional Hazards Survival for 
Determinants of Number of Days in Treatment up to 6 Months (N =391) 
Variable B Wald (dt) 
Step 1 
Step: i = 26.911 (5) P = 0.0001 
Age -0.023 9.655(1) 
Gendert -0.320 4.721(1) 
Marital statustt 
Single 4.370(2) 
Marriedl Commonlaw -0.005 0.001(1) 
DivorcedlSeparatedl Widowed 0.334 3.391(1) 
ASI EmEl0l:ment ComEosite Severitl: score 0.625 7.186 
Step2 
SteE: i (7) =29.023, ~ X2 (2) = 2.321, E = 0.313 
ASI Drug Composite Severity score 0.924 2.281 (1) 
ASI Alcohol ComEosite Severitl: score 0.176 0.521(1) 
Step 3 
SteE: X2 (10) =29.185, ~ X2 (2) = 0.144, E = 0.931 
ASI Psychological Composite Severity score -0.210 0.32 (1) 
GSI (SCL-90) score -0.029 0.03 (1) 
Total BDI score 0.005 0.21 (1) 
t Males served as reference group 
tt Single served as reference group 
ASI-Addiction Severity Index 
GSI-G1obal Severity Index on the Symptom Checklist-90 
Evalue 2LL 
2454.32 
0.002 
0.030 
0.113 
0.977 
0.066 
0.007 
2452.001 
0.131 
0.470 
2451.858 
0.575 
0.857 
0.647 
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Chapter4 
Substance Use Outcomes at Six Month Follow-up 
The next series of analyses were conducted to examine factors associated with 
substance use outcomes at 6-month follow-up. A total of 21 % of the sample was lost 
to follow-up at 6 months. In general, patients lost to follow-up were younger [F (1, 
403) = 4.239, P = 0.040], with more social problems [F (5, 394) = 0.039, p = 0.007], 
however, analysis using MANOV As determined that there were no other significant 
differences at intake for demographic [F (4,396) = 0.189, P = 0.111], substance use [F 
(7,380) = 1.156, p = 0.327], orpsychological variables [F (6,361) =1.195, p = 0.308]. 
There were significant differences in follow-up rates between the Early 
Dropout (EDO) and Retained (RTD) groups. Twenty-nine per cent of the patients in 
the EDO group were lost to 6-month follow-up, compared to 18% in the RTD group 
[X2 (1) = 5.96, P = 0.015], leaving sample sizes of 109 and 302, respectively. 
Nevertheless, analysis using MANOV As also determined that there were no 
significant differences at intake between the EDO and RTD groups for those 10st to 
follow-up on demographic [F (4,396) = 0.579, P = 0.678], substance use [F (7,380) = 
0.835, p = 0.558], social [F (5,394) = 0.384, P = 0.860], or psychological variables [F 
(6,361) = 2.032, P = 0.061]. 
The RTD group reduced their substance use more than the EDO group, as 
indicated by the fact that at 6 months 54.3% of the RTD group compared to 28.4% of 
the EDO gro~p were abstinent from the primary drug of abuse [X2 (1) = 17. 972, P = 
0.0001]. The mean number of days of continuous abstinence from the primary drug 
of abuse was 95.6 ± 4.17 for the RTD group, and 44.5 ± 7.5 for the EDO group [t 
(344) = -5.35, p = 0.0001]. 
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Comparison between Early Dropout and Retained Groups on Primary Outcome 
Variables of Substance Use 
Two-way ANOV As with repeated measures were used to compare the EDO 
versus RTD groups on a number of measures of substance use outcomes including the 
ASI alcohol and drug composite severity scores, the number of days of primary drug 
intake, and the number of days of any substance use in the past month at intake and 6-
month foIlow-up. 
As shown in Figure 2, analysis of ASI alcohol composite severity scores 
yielded no main effect for group [F (1,323) = 0.531, P = 0.467], a significant group by 
time interaction [F (1, 323) = 17.65, P = 0.001], as weIl as a significant effect for time 
[F (1, 323) = 66.233, P = 0.0001]. Post hoc analysis using t-tests with a Bonferroni 
correction were conducted on significant ANOV A findings. Post hoc analysis 
indicated that there were significant differences between the EDO and RTD groups 
only at foIlow-up [t (324) = 3.254, P = 0.001]. Further post hoc analysis indicated that 
there were significant differences between the means for the EDO group at intake 
compared to 6-month foIlow-up [t (75) = 2.492, P = 0.015]. These results indicated 
that despite a short stay in treatment, Early Dropouts did show sorne improvement in 
alcohol abuse at 6 months. 
The results of the analysis of the ASI drug composite severity scores, the 
number of days of primary drug intake, and the number of days of any substance use 
aIl yielded significant group by time interaction effects as weIl as significant main 
effects for group and time, as presented in Figures 3 to 5. Figure 3 shows the results 
of a two-way ANOV A with repeated measures comparing ASI drug composite 
severity scores at intake versus foIlow-up between EDO and RTD groups. The 
81 
analysis yielded a significant main effect for group [F (1,322) = 12.031, P = 0.001], a 
significant group by time interaction [F (1,322) = 14.84, P = 0.0001] and a significant 
effect for time [F (1,322) = 37.061, P = 0.0001]. Post hoc analysis showed that there 
were significant differences between the EDO and RTD groups only at follow-up [t 
(324) = 4.54, P = 0.0001]. For the EDO group, post hoc analysis indicated that there 
were no significant differences between means at intake and follow-up [t (75) = 
1.132, P = 0.261]. 
The results of a two-way ANOVA with repeated measures comparing the 
number of days of primary drug use in the past month at follow-up versus intake 
between EDO and RTD groups are shown in Figure 4. There was a significant main 
effect for group [F (1,323) = 14.74, P = 0.0001], a significant group by time 
interaction [F (1, 323) = 20.56, P < 0.0001], and a significant effect for time [F 
(1,323) = 39.06, P = 0.0001]. Post hoc analysis showed that there were significant 
differences between the EDO and RTD groups only at follow-up [t (324) = 6.209, P 
= 0.0001]. As for the ASI drug composite severity score, for the EDO group, post hoc 
analysis indicated no significant differences between the mean number of days of 
primary drug use at intake and follow-up [t (75) = 1.035, P = 0.304]. 
Figure 5 shows the results of a two-way ANOV A with repeated measures 
comparing the number of days of any substance use in the past month at follow-up 
versus intake between EDO and RTD groups. There was a significant main effect for 
group [F (1,323) = 14.27, P = 0.0001], a significant group by time interaction [F (1, 
323) = 25.36, P = 0.0001], and a significant effect for time [F (1,323) = 35.06, P = 
0.0001]. Post hoc analysis indicated that there were significant group differences only 
at follow-up [t (324) = 6.111, P = 0.0001]. 
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Overall, the analyses revealed that the RTD group had a greater degree of 
improvement in substance abuse than the EDO group at 6 months follow-up, as 
indicated by the significant group by time interactions for ASI alcohol and drug 
composite severity scores, as well as the number of days of primary drug use, and the 
number of days of any substance use in the past 30 days. Therefore, the hypothesis 
that the RTD group wou Id show significantly less problems in measures of substance 
use outcome at 6 months compared to the EDO group was supported. 
Psychological Problem Severity and Distress 
Two-way ANOV As with repeated measures were used to compare the 
EDO and RTD groups at intake and follow-up on the number of days of 
psychological problems in the past month, and the GSI scores from the SeL-90. As 
shown in Figure 6, analysis of the number of days of psychological problems in the 
past month yielded no significant main effect for group [F (1,321) =1.447, P = 0.230], 
or group by time interaction effect [F (1,321) = 0.209, P = 0.648]. There was a 
significant main effect for time [F (1,321) = 18.686, P = 0.0001]. The same pattern 
was seen for the analysis of GSI scores which yielded no significant main effect [F 
(1,281) = 0.689, p = 00407] or group by time interaction effects [F (1,281) = 0.014, P 
= 0.907]. There was a significant time effect [F (1,281) = 66.932, P = 0.0001]. These 
results pointed to a dec1ine in psychological distress in both groups at 6 months 
compared to intake, raising the possibility that even the Early Dropouts received 
sorne psychological benefit in attending a brief amount of treatment. The hypothesis 
that the RTD group would show significantly greater improvements in psychological 
distress compared to the EDO group was not supported. 
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Figure 2. Results of two-way ANOV A with repeated measures comparing ASI 
alcohol composite severity scores at follow-up versus intake between EDO and RTD 
groups. Analysis indicated that there was a significant group by time interaction. 
Data are the means ± SEM 
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Figure 3. Results of two-way ANOV A with repeated measures comparing ASI drug 
composite severity scores at follow-up versus intake between EDO and RTD groups. 
There was a significant main effect for group, a significant group by time interaction, 
and a significant effect for time. 
Data are the means ± SEM. 
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Figure 4. Results of two-way ANOV A with repeated measures comparing the 
number of days of primary drug use in the past 30 days at follow-up versus intake 
between EDO and RTD groups. There was a significant main effect for group, a 
significant group by time interaction, and a significant effect for time. 
Data are the means ± SEM. 
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Figure 5. Results of two-way ANOV A with repeated measures comparing number of 
days of any substance use in the past 30 days at folIow-up versus intake between 
EDO and RTD groups. There was a significant main effect for group, a significant 
group by time interaction, and a significant effect for time. 
Data are the means ± SEM. 
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Figure 6. Results of two-way ANOV A comparing the number of days of 
psychological problems in the past month at follow-up versus intake between EDO 
and RTD groups. Analysis revealed no main group or group by time interaction 
effect. There was a significant time effect. 
Data are the means ± SEM. 
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Employment Problems 
Given that severity of employment problems had been a predictor of early 
dropout as weIl as attrition from treatment over time, the ASI employment composite 
severity score was also examined. Results of two-way ANOVA with repeated 
measures comparing ASI employment composite severity scores at follow-up versus 
intake between the EDO and RTD groups yielded no significant main group [F 
(1,323) = 0.211], or group by time interaction effects [F (1,323) = 0.26, P = 0.609]. 
There was a significant time effect [F (1,323) = 8.85, p = 0.003]. 
However, it is of note that post hoc analysis indicated that the mean ASI 
employment composite severity scores at intake were higher in the EDO group than 
in the RTD group [t (406) = 2.566, P = 0.011]. 
Factors Associated with Substance Use at Six Months 
The preceding analyses indicated that the RTD group had significantly 
reduced ASI alcohol and drug composite severity scores at foIlow-up compared to 
intake, as well as significantly fewer days of primary drug and other substance use 
compared to the EDO group. At 6-month follow-up, psychological problems were 
significantly reduced for both the EDO and RTD groups. Both groups had reductions 
in mean ASI employment composite severity scores, although the scores for both 
groups were still moderately high at 6 months. 
In order to determine factors associated with substance abuse at follow-up, a 
hierarchicallinear regression analysis was conducted, with the mean number of days 
of primary drug use in the past month as the dependent variable. The variables 
selected for inclusion were based on the literature review indicating that 
sociodemographic, substance use, and psychological factors have been found to be 
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associated with substance use outcomes, as weIl as data from this sample indicating 
that longer time spent in treatment was associated with reduced substance use. The 
order of entry of the predictor vruübles was as follows: age, gender, marital status, 
and ASI employment composite severity score were entered in the first step; the ASI 
drug and alcohol composite severity scores as measured at intake were entered in the 
second step; the ASI psychological composite severity scores and the GSI scores at 
intake were entered in the third step; the total number of days of treatment and the 
total number of therapy sessions attended were entered in the fourth step of the 
model. 
Table 10 presents a summary of the hierarchical linear regression. In the first 
step of the regression, but not in the final step of the model, age was significant, 
accounting for 2% of the variance in the number of days of primary drug use at 
follow-up. The results indicated that higher ASI alcohol and drug composite severity 
scores at intake were significantly associated with more days of primary drug use at 
foIlow-up. The ASI alcohol and drug composite severity scores at intake accounted 
for 9% of the variance in the mean number of days of primary drug use at foIlow-up. 
The hypothesis that severity of substance abuse at intake would be associated with 6-
month outcomes was supported. Psychological problem severity as measured by the 
ASI psychological composite severity score at intake was not associated with the 
number of days of primary drug use at 6 months. At 6-month follow-up, the strongest 
predictors of the number of days of primary drug use in the past month were the 
number of days spent in treatment and the number of therapy sessions attended. The 
attendance variables accounted for 19% of the variance in the number of days of 
primary drug use in the past month, with the total model accounting for 30% of the 
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variance in days of primary drug use at 6 months. Therefore, the hypothesis that 
longer treatment retention would be associated with less drug and alcohol use at 6 
months was supported. 
The following chapter summarizes the results on retention and outcomes at 6 
months, and discusses how these findings were used in order to proceed to the next 
step in the research. 
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Table 10: Summary of Hierarchical Linear Regression for Variables Predicting 
Days of Intake of Primary Drug (past 30 days) at 6-Month Follow-up 
Variable 
Step 1 
Step: F (4,311) = 1.641, P = 0.164 NS 
Age 
Gender 
Marital status 
Single 
Marriedl Commonlaw 
Di vorcedlSeparatedl Widowed 
ASI Employment Composite Severity Score 
Step 2 
Step: Ffl (2,309) = 15.198, P = 0.0001 
ASI Drug Composite Severity Score 
ASI Alcohol Composite Severity Score 
Step 3 
Step: F fl (2, 307) = 0.404, P = 0.668 NS 
ASI Psychological Composite Severity Score 
GSI score 
Step4 
Step: F ~ (2,305) = 41.168, P = 0.0001 
Days in treatment 
Total number of treatment sessions 
t Males served as reference group 
tt Single served as reference group 
ASI-Addiction Severity Index 
GSI-G1obal Severity Index on the Symptom Checklist-90 
R R2change Beta 
0.144 0.021 
-0.032 
0.025 
0.005 
-0.002 
0.329 0.088 
0.262 
0.126 
0.333 0.002 
-0.022 
0.080 
0.547 0.189 
-0.292 
-0.192 
p value 
0.564 
0.626 
0.929 
0.975 
0.0001 
0.015 
0.737 
0.207 
0.0001 
0.005 
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Chapter5 
1. Discussion of Results 
Analysis of the data on retention presented in Chapter 3 indicated that 
approximately twenty-seven percent of the sample left treatment before 6 weeks, and 
only 40% remained in treatment for the recommended period of 6 months. Chapter 4 
presented results that supported the hypothesis that patients retained longer than 6 
weeks in treatment would have greater reductions of substance abuse at follow-up 
compared to those who left treatment early. Both the Retained and Early Dropout 
groups showed a decrease in the severity of a1cohol problems at follow-up compared 
to intake. However, at foIlow-up, patients who remained in treatment longer than 
those who dropped out before 6 weeks had a greater reduction in severity of a1cohol 
abuse, and no clinically meaningful reductions in the severity of drug abuse, the 
number of days of primary drug intake, or the number of days of any drug use in the 
past month compared to intake. Clearly, those who remained longer in treatment were 
using less drugs and a1cohol at 6 months. Contrary to the hypothesis stating that 
improved psychological and social functioning at follow-up would be associated with 
greater time spent in treatment, both Early Dropout and Retained groups had 
improvements in psychological problems at follow-up. Although the both groups 
showed significant reductions in severity of employment problems, at follow-up the 
early dropouts as weIl as the retained patients were still experiencing moderately high 
levels of employment difficulties. 
Younger, divorced, separated, or widowed patients, as well as those with more 
severe employment problems, were more likely to drop out of treatment before 6 
weeks. Therefore, the hypothesis that patients who were younger and less socially 
stable would be more likely to drop out of treatment early was supported. The 
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hierarchical linear regression analysis examining factors associated with substance 
use at 6 months indicated that client characteristics of age, gender, marital status, or 
employment problems were not associated with the frequency of primary drug use at 
follow-up. A previous study conducted at the Addictions Unit that had examined the 
impact of social support on substance use outcomes and retention found that those 
with low social support tended to drop out of treatment sooner, but that the 
association between functional social support and reduced drug and alcohol 
consumption was modest (Dobkin et al., 2002). In that study, however, the role of 
specific support for reduced substance intake was not examined. Although improved 
treatment retention has been reported by including a significant other or spou se in the 
therapy (McCrady, 1986; Sisson & Azrin, 1986; Higgins et al., 1994), during the first 
phase of treatment in the Addictions Unit fewer than 20% of patients examined 
complied with the request of having a support person accompany them to a session 
with the primary therapist, indicating that inclusion of a significant other in the 
treatment is a challenge. In addition to many factors that could interfere with 
participation of a significant other, it is also possible that sorne patients lack a 
supportive ally as they endeavour to reduce drug and alcohol consumption, and in this 
sample patients who were married or cohabitating were less likely to drop out of 
treatment early. Longabaugh et al. (1993) found that alcoholic patients were more 
likely to experience problems during recovery when they were strongly committed to 
relationships with significant others who provided little support for abstinence. 
Support for reduced substance intake from family and friends has been associated 
with better substance use outcomes (Beattie et al., 1997), and it is possible that 
younger patients had a reference group of peers who were less supportive of 
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abstinence or were themselves engaged in abusive drug or alcohol behaviours. The 
fact that married or cohabitating patients were less likely to drop out of treatment 
early may indieate that support from a spou se is a motivator for remaining in 
treatment, but the majority of patients attending the treatment did not include a 
support person in the therapy when invited. The complexity of interactions among 
patients' social networks, resources specifie for support of abstinence, and how these 
factors influence treatment retention rates and substance use outcomes deserves 
further research attention. 
Many patients were experiencing employment problems, and greater problems 
in this area were associated with treatment attrition. Additional services or referral for 
employment counselling, job search, or vocational training may be added incentives 
for sorne patients to remain in treatment. At 6 months, many patients in both groups 
were still experiencing a moderately high degree of employment problems, and 
amelioration of the se problems may only become apparent over longer periods of 
time with remission of substance dependence or provision of specifie training. 
Although gender was not associated with early dropout, the Cox proportional 
hazard regression analysis exarnining predictors of attrition over time revealed that 
males dropped out of treatment sooner than females over the 6-month follow-up 
period. Gender may also be related to primary drug of abuse. Women were less 
likely than men to be dependent on cocaine and cannabis, and more likely to be 
dependent on benzodiazepines. DifferentiaI survival rates in treatment over 6 months 
between males and females may have been a reflection of different lifestyles, patterns 
of use, and requirements for medieal intervention associated with dependence on 
prescribed medication versus illicit drugs. It is possible that a combination of primary 
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drug, gender, and personality factors may have contributed to men leaving treatment 
sooner, and these factors could be explored in future research. Another factor related 
to differential rates of attrition over time between men and women could have been 
the greater degree of psychological distress in females. The women in this study had 
more medical, psychological, and employment problems than men, similar to other 
studies showing greater social and emotional problem severity in females in 
substance dependence treatment (Brown et al. 1994; McCaul et al., 2001). In contrast 
with the present results, sorne studies have shown that women with more severe 
psychiatric problems, unstable mood, and interpersonal deficits were less likely to 
complete treatment (Brown, Huba, & Melchior, 1995; Brown, Melchior, & Huba, 
1999; Haller, Miles, & Dawson, 2002). At the present time it is not possible to 
resolve the discrepancy in findings regarding differential treatment attrition for men 
and women. In the CUITent study greater medical and psychological problem severity 
was associated with longer treatment stays for women. Perceived utility of services 
and an empathetic therapist counselling style have been identified as in-treatment 
factors associated with greater treatment retention for women (Fiorentine et al., 
1998). Given that treatment at the Addictions Unit afforded the opportunity to access 
services for medical and psychiatric problems in addition to substance dependence, 
provision of care for these problems may have played a role in retaining women 
longer in treatment. The availability of a women's group offering support for gender-
specifie problems in the second phase of therapy may have also had an impact on 
retaining women longer in treatment. 
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Severity of Substance Dependence 
The examination of factors associated with early dropout from treatment 
indicated that severity of substance abuse was not associated with early dropout, 
therefore, this hypothesis was not supported. However, the hypothesis that more 
severe substance abuse at intake would be associated with poorer drug and alcohol 
outcome variables at 6-month follow-up was supported. Hierarchicallinear regression 
showed that drug and alcohol severity at intake were modestly associated with the 
number of days of primary drug use in the past month at follow-up, similar to 
findings in other reports (Carroll, Power, Bryant, & Rounsaville, 1993; Simpson, Joe, 
& Broome, 2002). 
Other studies have failed to find an association between severity of substance 
dependence, primary drug group, and retention in treatment (McCaul et al., 2001; 
Patkar et al, 2004). However, a previous study conducted at the Addictions Unit had 
determined that patients dependent on opiates were at higher risk for dropout during 
the first month of treatment (Paraherakis et al., 2000). In the Paraherakis et al. study 
(2000), 12% of patients were dependent on opiates, whereas in the present study, 
opiate addicts were only 3.6% of the 411 patients in the sample, so that differences in 
retention for opiate dependent patients were likely not discernable due to the small 
number of patients. Survival analysis conducted on the three primary drug groups 
showed that those who were dependent on drugs, versus alcohol, were found to be 
more likely to leave treatment sooner over the 6 months of treatment. 
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Severity of Psychological Problems 
Patients who had more severe psychological distress at intake, based on ASI 
psychological composite severity scores, Global Severity Index or Beck Depression 
scores were not more likely to drop out of treatment early. Aiso in the hierarchical 
linear regression model, the ASI psychological composite severity scores and the GSI 
scores were not associated with the number of days of primary drug use at follow-up, 
indicating that severity of psychological problems at intake was not associated with 
drug and alcohol outcomes at follow-up. The reason for the lack of association 
between psychological problem severity at intake and substance use outcomes may 
be, as stated above, that the clinic provided psychiatric services of assessment, early 
treatment, and referral for concurrent psychiatric disorders. The Addictions Unit 
multidisciplinary approach consisted of clinicians with expertise in addiction and 
mental illness. The psychiatrists on staff were addiction specialists who worked 
closely with primary therapists and were actively involved in assessment and ongoing 
evaluation of patient progress. It is possible that the lack of differential rates of 
dropout for patients experiencing more psychological di stress were related to the 
availability of treatment for comorbid psychiatrie disorders at the Addictions Unit 
(Chamey et al., 2001). Other investigators have noted improved outcomes when 
appropriate services and referrals are provided for patients with co-existing 
psychiatric disorders (McLellan et al., 1994; Moos et al., 2001; Moos & Moos, 2002). 
Information about patient characteristics inc1uding motivation, self-efficacy, 
and personality features were obtained in order to enhance understanding of 
additional psychological factors that cou Id be associated with early dropout. 
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Motivation and Self-Efficacy 
Having explored the commonly examined sociodemographic, substance use, 
and psychological predictors of treatment retention, the subsequent analyses explored 
associations between motivation, self-efficacy and treatment retention in a subset of 
the main study sample. These analyses indicated that baseline motivation and self-
efficacy were not associated with early dropout; therefore these hypotheses were not 
supported. 
Motivation at intake, which was examined in the subset of the main sample, 
was not associated with early dropout from treatment, and this negative finding has 
also been reported in other studies of outpatient treatment (Fiorentine et al., 1999; 
Blanchard et al., 2003; Patkar et al., 2004). One reason for the lack of association 
between pre-treatment motivation and early dropout may be that treatment-seeking 
patients, by the very fact of presenting for treatment, report relatively high levels of 
motivation at intake. Equally plausible is the notion that motivation has an indirect 
effect on other factors such as therapeutic alliance and level of engagement during the 
therapy sessions that in tum impact retention (Simpson, Joe, Rowan-Szal, & Greener, 
1997). The mediating effects of motivation on variables related to within-treatment 
processes were not analyzed in this study. 
The lack of association between scores on the DTCQ and early dropout 
indicates that whether or not a patient stays in treatment is likely more related to 
change in self-efficacy that is occurring over time, rather than pre-treatment levels of 
self-efficacy. Congruent with help-seeking behaviour, patients starting treatment 
would likely believe that they are unable to resist aIl high-risk drinking or drug use 
situations. However, over time, if there is !iule improvement in self-efficacy, patients 
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may become discouraged and leave treatment, or give up efforts to reduce substance 
intake. 
Personality Factors 
Inhibition, a personality factor measured by the DAPP, approached a 
significant level of association with early dropout from treatment in the subset of 
patients who completed this questionnaire at intake [t (117) = 2.015, P = 0.046], 
although the value was not significant when corrected for multiple comparisons. It 
would not be surprising that patients with a restricted range of expression and 
intimacy problems had more difficulty remaining engaged in treatment, especially 
since group therapy was the main treatment modality offered in the program. Sorne 
patients may not be good candidates for group therapy, and if staffing resources 
permit, may be more likely to remain engaged in treatment if offered the option of 
individual counselling. Contrary to the hypothesis, patients with higher scores on 
personality factors of emotional dysregulation and dissociaI behaviour were not more 
likely to drop out of treatment early. Rather than having a direct impact on rates of 
retenti on, it is possible that affective instability and antisocial traits of personality 
interact with other variables in the treatment process, su ch as the therapeutic alliance, 
that were not measured in this study. A confrontation al versus supportive therapist 
style has been associated with poorer drinking outcomes (Miller, Benefield, & 
Tonigan, 1993), but response to the therapist may be associated with factors of the 
patient's personality as weIl. To date, similar to the psychotherapy literature, 
inconsistent results have been found on associations between clinician personality 
characteristics and outcomes in substance dependence treatment (Najavits, Crits-
Cristoph, & Dierberger, 2000). Examination of the interaction between patient and 
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therapist personality characteristics and therapist style may provide more clues about 
how the dynamics of this relationship may influence retention. A more in depth 
assessment of personality features of patients and exploration of intervening 
processes that are associated with therapist effects could pro vide useful information 
about patient-therapist matching. 
After exploration of a wide array of patient factors, it was determined that 
demographic characteristics, but not severity of substance abuse or psychological 
problems, were modestly associated with early dropout from treatment. Motivation 
and self-efficacy and the personality factors of emotional dysregulation and dissociaI 
behaviour examined were not directly associated with early dropout from treatment. 
Factors associated with attrition over time were similar to those associated with early 
dropout, in that demographic characteristics, but not severity of substance use and 
psychological problems, showed modest associations. 
Treatment Attendance 
The hierarchical Iinear regression also supported the hypothesis that longer 
time in treatment and more session attendance would be associated with reduced 
primary drug intake at 6 months. Greater treatment attendance demonstrated the 
strongest association with fewer days of primary drug intake in the past month at 
follow-up. Since the method of the research was a naturalistic follow-up study, 
without control for treatment conditions or other influencing factors, no conclusions 
about improved outcomes resulting from treatment can be drawn, but the association 
between better treatment attendance and improved outcomes described in the majority 
of the literature was supported. 
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II. Discussion of the Results on Retention and Substance Use Outcomes from a 
Health Services Perspective 
The evidence gathered up to this point in the study revealed the following: 
close to 30% of patients left treatment before completing 6 weeks; only 40% 
completed 6 months of treatment; there were no robust predictors for early dropout 
and attrition over time; longer stays in treatment were associated with improved 
substance use outcomes at 6 months. These facts were then examined from the 
perspective of service provision. Criteria used to assess the success of health care 
provision include effectiveness, equity, acceptability, and efficiency (Liddell, 1990; 
Crombie, 1996; Beck & Miners, 2001). These criteria were used to review the results 
from the naturalistic follow-up study. 
Effectiveness measures the outcome of an intervention as part of routine 
clinical treatment and care. Since this was a naturalistic study, the reasons for 
improvement cannot be attributed to treatment, nevertheless, the substance use 
outcomes at 6 months clearly showed that those who stayed in treatment longer had 
reduced their substance use compared to those who dropped out early. Therefore, for 
the 40% who remained in treatment at 6 months, attending treatment was associated 
with reductions in drug and alcohol consumption. However, the fact that less than 
half of those who sought treatment completed it as designed translates into reduced 
treatment effectiveness for the majority of patients. Treatment effectiveness measures 
the success of an intervention based on routine care, and although better outcomes 
were associated with longer treatment, only a minority adhered to the 
recommendation of 6 months of treatment. Outcomes for the Early Dropout group 
indicated sorne reduction in alcohol severity, as weIl as a reduction in psychological 
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distress, and a slight improvement in employment problems. Therefore, even a 
minimal amount of treatment was associated with sorne improvements at 6 months. 
Equity refers to accessibility of treatment services to a wide range of clientele 
in need of the service. To ensure that services intended for particular groups are used, 
information on the prevalence of a disorder and sociodemographic and cultural 
characteristics of those who use the services should be routinely collected (Beck & 
Miners, 2001). Patients receiving treatment at the Addictions Unit were representative 
of a typical treatment-seeking population in Montreal. This is confirmed by similar 
sociodemographic, and substance use characteristics in comparison to those patients 
in a three-site study of substance abuse treatment in the Montreal area (Brown et al., 
2002; Brown et al., 2002a). However, women, minorities, and those with less 
education were underrepresented in the sample. Inclusion of other services su ch as 
child care, translators, volunteers, and social resources with links in the community 
could be explored as methods to potentially reduce barriers to treatment that may 
arise from social, language, and cultural differences. 
The acceptability criterion relates to the extent to which treatment is 
acceptable not only to those who provide it, but also to those intended to receive it 
(Beek & Miners, 200 1). Patient satisfaction surveys are one method of determining 
acceptability of the intervention. Another method to infer acceptability may be to 
evaluate the number of patients who complete the planned intervention. This 
naturalistic study of 411 patients followed at the Addictions Unit demonstrated that 
many patients participated in treatment for much shorter periods than the planned 6-
month intervention. It has been estimated that up to 90% of substance abusers do not 
seek specifie treatment for addiction at specialized centres (Sobell, 2000). However, 
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many people seek other medical, social, or psychological services for complications 
resulting from drug or a1cohol dependence. Reasons why substance abusers avoid 
specialized treatment are not well understood, but one suggestion has been that 
available addiction services lack appeal and acceptability to the majority of people 
with substance use disorders (Marlatt & Kilmer, 1998). Provision of consumer-
friendly services may be an effective way of encouraging people to seek treatment, by 
reducing stigma associated with substance dependence and providing alternative 
interventions (Marlatt & Kilmer, 1998; Sobell & Sobell, 2000). These points may be 
viewed from the perspective of the self-selection concept (De Leon, 1998). It is 
possible that patients who remained in treatment at 6 months had selected to continue 
in the program because of a "good fit" between the services offered and compatibility 
with their own views of change. Adherence to treatment over 6 months required 
regular attendance to group therapy for 6 months, acceptance of the goal of total 
abstinence, and demonstrated reduction in substance use through participation in 
mandatory urine screening. Sorne patients may not have agreed with these conditions 
for continued participation in the program. Patients may be more likely to reduce 
substance use if the treatment approach is consistent with their preferences (De Leon, 
1998; Brown et al., 2002). Although evidence was obtained in the present study for 
an association between improved substance use outcomes and better retention in 
treatment, it seemed that the treatment pro gram was not "a good fit" for the majority 
of patients. Therefore, patients and therapists alike were working within a system of 
treatment delivery that benefited those who were able to remain in the pro gram until 
completion, but the majority did not complete the treatment as it was designed. 
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Efficiency relates to the resources required to provide a specific service and 
achieve a specific outcome. Costs refer to expenses incurred to provide the 
intervention or the service (Beck & Miners, 2001). Cost-effectiveness analysis of 
addiction treatment is complex due to the fact that addiction treatment can lead to 
several, not necessarily correlated, important outcomes (Sindelar, Jofre-Binet, French, 
McLellan, 2004). A study of cost-effectiveness conducted on a rc:tndom sample of 99 
drug treatments in the V.S. comparing four treatment modalities found that outpatient 
drug-free treatment was more co st-effective than inpatient, residential, and outpatient 
detoxification, underlining the fact that more intensive treatment is not always more 
effective or efficient (Mojtabai & Zivin, 2003). A preferable method of analyzing 
long-term economic value of treatment for the individual and the society is a co st-
benefit analysis, but this area of research is highly specialized and is only beginning 
to become standardized and based on real-life treatment services (Cartwright, 2000; 
French, Salome, Sindelar, & McLellan, 2002). An in-depth analysis of efficiency and 
costs were beyond the sc ope of this study, but several facts about efficiency related to 
the use of services were noted. A potential loss in terms of efficiency was that 
although sorne patients may not have needed the full 6 months duration of treatment, 
\ 
an alternative for shorter treatment was not available. Therapists were working within 
a service that recommended longer durations of care. Although many patients may 
have self-selected to leave treatment, dropout is not equivalent to therapeutic 
discussion about treatment needs, options, and preferences. There was also a loss of 
efficiency in services as a result of dropout since therapists were spending time with 
phone caUs attempting to track down nonattenders, and leaving files "open" in the 
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event that patients might retum to treatment. Both of these facts resulted in fewer new 
patients being taken into treatment over a period of time. 
III. Implications of the Results for Treatment Services 
The question that arose as a result of the data analysis on outcomes on 
retention and substance use presented above was how to offer effective interventions 
for most people seeking treatment. The analysis of early dropout had not provided 
cIues about strong predictors that could be used to plan changes in the treatment 
program. A pragmatic response to the question of dropout was formulated based on 
rates of treatment retention gathered up to this point. 
Substance dependence is a chronic disorder with periods of remission and 
relapse, and man y people will participate in more than one treatment episode over a 
long period of time. Offering treatment approaches of varying intensity and duration 
may increase the likelihood of more people receiving at least sorne effective 
treatment. A "stepped care" approach operates under the assumption that the initial 
treatment of choice is the procedure that is the least intrusive to the patient's lifestyle, 
is efficient in terms of treatment resources, and has a reasonable chance of being 
effective (Sobell & Sobell, 1993). Since decision-making about further treatment in a 
stepped care model is based on outcomes, this approach may be co st-effective 
because as interventions become more extensive, the proportion of patients needing 
each successive level of intervention is relatively small compared to the original 
population entering treatment (Sobell & Sobell, 1993). Since the waiting period for 
treatment at the Addictions Unit of the MUHC was an average of 3 months, an 
obvious benefit to providing a stepped care approach wou Id be a reduction in the 
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waiting period, given that only those needing additional interventions would receive 
longer treatment. 
An additional advantage of a stepped care approach is that patients may be 
more likely to accept a treatment approach that they perceive as less lengthy or 
demanding, and one that is based on their progress in treatment. Since the findings 
from the data on treatment retention in this study indicated that the majority of 
patients participated in a much shorter duration of treatment than the planned 6-month 
intervention, a practical approach to improving treatment was to examine methods of 
delivering services in the way that they were being used by most patients. From the 
perspective of health services research, the practical results and implications of 
research include changing, adding, or removing certain elements of the existing 
treatment pro gram that are amenable to change with a reasonable amount of resources 
and effort (Pendergast et al., 2000). Therefore, the creation of a self-contained brief 
intervention was a natural development based on the already existing structure and 
interventions of the 6-week Phase 1 treatment program. The major difference would 
be that the treatment would be designed to be effective and completed by 6 weeks. 
This approach cou Id respond to sorne patients' preferences and requirements for 
shorter treatment, and include evaluation for additional treatment on an as-needed 
basis. 
A major caveat to pro vi ding brief intervention for substance dependence is 
that treatments requiring less commitment may have higher acceptance and retenti on 
rates, but they may also be less likely to produce clinically meaningful treatment 
effects (De Leon, 1998). Henceforth, an evaluation of the effectiveness of a brief 
intervention for patients with drug and alcohol problems was needed before this could 
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be introduced into the standard treatment program, and the next step in this 
programmatic research involved the development, implementation, and evaluation of 
a brief intervention in the clinic. The next chapter provides the background literature 
review, the methodology, and outcomes for the randomized trial of brief intervention 
that was conducted in the Addictions Unit. 
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Chapter6 
Brier Intervention 
Introduction 
There is growing evidence that brief interventions are as effective as more 
intensive therapy for alcohol problems. The research into the effectiveness of brief 
interventions has a long history, albeit it is not without controversy (Heather, 1995, 
Drummond, 1997, 2002). Brief interventions focus on changing specifie behaviours, 
and may range from a short advice session up to seve~al structured counselling 
sessions (Babor, 1994). Over the years, numerous studies of brief interventions have 
been conducted in primary health care and specialized treatment settings, with 
patients varying in degree of alcohol severity. Brief interventions can be classified 
into two distinct approaches based on the setting and the population receiving the 
interventions (Heather, 1995, 1996 Moyer et al., 2002). In primary health care 
settings with patients seeking medieal care rather than specific treatment for alcohol 
problems, brief interventions may include a brief assessment with feedback, 
behavioural modification, setting goals, and writing a contract for change (Bames & 
Samet, 1997). Brief interventions in these settings are adviee-driven, low in structure, 
and delivered by treatment providers not specialized in substance abuse (Heather, 
1995, 1996). By comparison, brief interventions delivered in substance abuse 
treatment settings are more structured, based on theories of alcohol dependence 
treatment, and are provided by addiction specialists (Heather, 1995, 1996). In 
primary health care settings brief interventions are most often compared with "no 
treatment" control conditions, whereas in specialized addiction treatment settings, 
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brief interventions are usually compared to existing extended treatment (Moyer et al., 
2002). 
Edwards, Orford, & Egert (1977) conducted one of the first studies examining 
brief intervention delivered in a treatment setting. Their study was conducted in an 
outpatient alcoholism clinic in Britain, with 100 married male patients randomly 
assigned to the "Ad vice" condition" or to the "Standard Treatment" condition. Both 
groups were followed prospectively up to 12 months. The Advice condition consisted 
of one session with the patient and his wife. The need for abstinence was stressed 
and strategies that could be applied toward this goal were outlined. The Standard 
Treatment condition included sessions with a psychiatrist, medications, social worker 
assistance with employment and housing problems, inpatient detoxification if 
necessary, and an introduction to Alcoholics Anonymous. Their results showed no 
significant differences in outcomes between the two treatment conditions at the 12-
month follow-up assessment, nor were there interactions between treatment intensity 
and degree of dependence on alcohol, demonstrating that those severely dependent on 
alcohol improved in both conditions (Edwards & Taylor, 1994). 
The Effectiveness of Brief Intervention 
A handful of studies have examined the effectiveness of brief interventions by 
comparing outcomes to extended treatments in specialized treatment settings. Sorne 
studies have demonstrated that there were no significant differences between brief 
and extended treatment in terms of reduction in alcohol consumption (Harris & 
Miller, 1990; Bien, Miller, & Tonigan, 1993; Langenbucher, 1994; Heather, 2001; 
Project MATCH, 2003). In a meta-anal y tic review conducted by Moyer et al. (2002) 
the effect sizes for 34 studies in non-treatment-seeking and 20 studies in treatment-
110 
seeking populations were examined. The investigators found that in 20 studies of 
treatment-seeking populations, there were parallei improvements in outcomes for 
brief intervention and extended treatment, and effect sizes over four follow-up points 
were equivalent, without differences due to the severity of alcohol dependence. The 
results of the meta-analysis indicated that brief interventions performed as weIl as 
extensive treatments for foIlow-up periods of up to 6 months (Moyer et al., 2002). 
Despite the many positive reports of outcomes for brief intervention, there are 
caveats to consider before drawing conclusions about the effectiveness of brief 
interventions in treatment settings. In many studies, small sample sizes, poorly-
defined outcome measures, and a restricted range of problem severity reduce the 
generalizability of findings to clinical settings (Heather, 1995). In Moyer et al.'s 
(2002) meta-analytic review, of the 20 studies of brief intervention in treatment-
seeking populations, only seven studies were adequately powered, and 50% of the 
studies excluded patients who met diagnostic criteria for alcohol dependence, drank at 
high levels or for a long period of time, or had received previous treatment. Still little 
is known about the effectiveness of brief interventions in "typical" clinical settings. 
Project MATCH pro vides an example of the use of a brief intervention in an 
efficacy trial for the treatment of alcoholism (Project MATCH, 2003). This was the 
largest muIti-site randomized clinical trial of psychotherapies ever conducted and was 
designed to test a priori patient-treatment matching hypotheses for patients with 
alcohol problems. The three outpatient treatment modalities chosen for comparison 
were: Motivational Enhancement Therapy (MET), Cognitive Behavioural Therapy 
(CBT), and Twelve-Step Facilitation (TSF). MET consisted of 4 individu al sessions 
conducted over 12 weeks, and can therefore be classified as a brief intervention. Both 
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CBT and TSF were conducted in 12 individu al sessions over a 12-week period. A 
total of 1726 patients were enrolled in nine community sites across the United States. 
Findings indicated that patients in aIl three treatment conditions showed equal 
improvements at one and three-year follow-ups. Unfortunately, the trial provided only 
limited conclusions about the effectiveness of brief intervention. The study sample 
was restricted in terms of substance dependence and psychiatrie problem severity, and 
the extensive research interviews and special attention provided by participation in 
the research reduced the generalizability of findings to "real world" clinical situations 
and typical treatment-seeking patients (Finney, 1999; Heather, 1999). 
Most of the studies evaluating outcomes of brief interventions have focused 
exclusively on individu aIs with alcohol problems. Few data are available on the 
effectiveness of brief interventions for the "typical" treatment-seeking individual. In 
reality, as the description of the study sample in Chapters 3 and 4 showed, over 50% 
of patients seeking treatment are abusing a secondary substance, over 30% are 
dependent on illegal or prescription drugs, and up to two thirds have co-existing 
DSM -IV Axis 1 or Axis II disorders. These figures are consistent with other 
investigations (Kranzler & Rounsaville, 1997; Verhuel, Van Den Brink, Hartgers, 
1995; Paraherakis et al., 2000; Charney et al., 2001; Dobkin et al., 2002; Verheul et 
al., 2002). In a small nonrandornized study (N = 33) it was found that cannabis 
abusers who participated in a brief intervention reported a reduction of cannabis use 
and improved health and social functioning post-treatment (Lang, Engelander, & 
Brooke, 2000). Few studies have been designed to evaluate the optimal duration of 
treatment for cocaine users and, in general, research is lacking concerning patient 
predictors of response to various treatment lengths (Carroll, 2000). 
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Rationale for Conducting a Brief Intervention Study 
As described above. there is limited evidence for the effeetiveness of brief 
intervention in a typical substance dependence treatment-seeking population. Brief 
intervention as an alternative to conventional therapy of longer duration may make 
treatment more inviting to first time patients or to those not willing to commit to 
abstinence-oriented treatment of longer duration. Brief intervention for sorne patients 
could also reduce the over-aIl cost of treatment. Therefore, availability of an 
empirically supported brief intervention eould potentially improve acceptability, 
equity, and efficiency of treatment services in an outpatient community treatment 
setting for substance dependence. However, in order to offer brief intervention as an 
alternative to standard treatment, the effectiveness of the intervention needed to be 
established. The study described in Chapters 3 and 4 demonstrated that Early 
Dropouts had less improvement in substance dependence compared to the Retained. 
Nevertheless. the Early Dropouts had sorne improvements in a1cohol abuse, and 
equivalent improvements to the Retained group in psychologie al distress at 6 months. 
The standard clinic treatment was designed to be conducted over a duration of 6 
months, and the implicit message of less attendance was that treatment was "not 
successful". The literature on brief intervention indicates that brief intervention may 
be as effective as extended treatment for a1cohol problems, but there are inconclusive 
outcomes for typical patients seeking treatment under usual clinical conditions. The 
study on retention and outcomes had also shown that 60% of patients did not 
complete treatment. Therefore, the study was designed to determine if patients 
assigned to a specific brief intervention would show substance use outeomes similar 
to those in conventional treatment 
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Study Objectives 
The objective of the present study was to evaluate the effectiveness of brief 
intervention (BI) in comparison to conventional therapy (CT) in terms of outcomes 
for substance use and psychological distress. This was accomplished by conducting a 
randomized clinical trial where patients were assessed at intake, randomly assigned to 
treatment condition, and then re-assessed 6 months after intake. 
Hypotheses and Outcome Variables 
The primary outcome variables were: (1) the total days of continuous 
abstinence from primary drug; (2) the ASI alcohol and drug severity composite 
scores; and (3) the number of days of drug and alcohol problems in the past month. 
=> Hypothesis I-Patients dependent on alcohol and drugs in the CT condition 
would show significant improvements on primary outcome variables at 6-
month follow-up compared to patients in the BI condition. (Predicted CT > 
BI) 
The secondary outcome variable was related to change in psychological 
distress, measured by the Global Severity Index (GSI) on the Symptom Checklist-90 
(SCL-90). The following hypothesis was based on the results from the follow-up 
study indicating that the Retained and Early Dropout groups had equivalent 
improvements in measures of psychological distress at 6-month follow-up. 
=> Hypothesis 2- Patients in the CT and BI treatment conditions would show 
significant and equal improvement on the GSI scores at 6 months. 
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Description of Treatment Conditions 
The study had a comparison group rather than a control group. In a clinical 
setting where provision of sorne form of treatment is required and expected, a no-
treatment control condition was not an ethieally or practically viable option. 
In the BrieC Intervention (BI) condition, each patient was treated by a single 
therapist and attended one individu al session per week, for a total of 5 individual 
sessions. Table Il outlines the main themes covered in each of the individual 
sessions. The BI was designed to be administered over a period of 6 weeks, however 
sorne flexibility allowed patients to complete the sessions over a slightly longer 
period of time when necessary (e.g. due to scheduling conflicts or need to cancel 
sessions). The sessions designed by senior Addictions Unit staff, derived partially 
from the principles of motivational interviewing (Miller & Rollniek, 1991), and used 
concepts and materials from the Project Match Treatment Manuals (Volume 2-
Motivational Enhancement Therapy; Volume 3-Coping Skills Therapy; 1995). The 
sessions had the following characteristics: 1) emphasis on promoting the concept of 
self-efficacy and personal responsibility for change; 2) evaluation and enhancement 
of the patient's motivational level and readiness for change through an empathetic 
(non-judgmental) counselling style; 3) education of the patient about strategies to 
produce change and prevent relapses. Thus, the therapist recognized, accepted, and 
worked with ambivalence and reluctance for change. The objective was to move the 
client toward acknowledging CUITent problems, developing a desire to change, setting 
specifie goals, and developing action plans for dealing with high-risk situations. The 
intervention employed a number of tools throughout therapy including alcohol/drug 
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self-monitoring records, risk/benefit analysis, reading and homework assignments 
related to identifying high-risk situations. The entire BI pro gram was placed in a 
treatment manual, along with descriptions of each session's goals and methods, client 
handouts, and homework assignments. 
The Conventional Therapy (CT) condition was comprised of the standard 
treatment program described in Chapter 2, consisting of an initial 6-week period 
(Phase 1) followed by Phase II with a total expected treatment duration of 6 months. 
During Phase 1 each patient was treated by a single therapist and attended one group 
psychotherapy session + one individual session per week. The group sessions were 
open, and comprised of 8 to 10 members with mixed primary substances of abuse. 
The individual sessions comprising the Phase 1 CT and BI conditions were the same 
as those outlined in Table Il. This procedure was instituted in order to be able to 
produce a BI pro gram that differed from CT on the dimensions of treatment intensity 
and duration, while controlling for content and therapeutic style in so far as possible. 
Therefore, patients in the BI condition received the same messages regarding 
treatment goals (e.g. abstinence), exposure to the same concepts (coping with 
cravings, identifying triggers) and the same motivational counselling style as those in 
CT, over the five individual sessions. 
At the end of the 6-week Phase 1 period, CT patients were transferred to Phase 
II where they attended group psychotherapy, once or twice weekly. As described in 
Chapter 2, group therapy was eclectic, combining psychodynamic, supportive, and 
relapse-prevention interventions. 
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Table 11. Surnrnary of thernes addressed in individual therapy sessions 
for BI and CT 
Session 1 -Establishing rapport through discussion and feedback from the 
assessmentintervievv 
-Addressing motivation for changing substance use 
-Conducting an Advantages 1 Disadvantages analysis vvith the patient 
-Addressing ambivalence as a natural part of change 
-Providing a rationale for coping strategies in the upcoming therapy 
sessions 
-Setting goals for treatment 
Session 2 -Providing education about the phenomena of urges and cravings 
-Introducing behavioural strategies inc1uding monitoring of urges, record-
keeping about alcohol and drug use, activity scheduling 
-Introducing cognitive strategies inc1uding rehearsed coping statements 
and visu al imagery 
Session 3 -Inc1uding a significant other in the session in order to evaluate the 
patient' s support netvvork 
-Sharing goals of treatment and approaches for reducing substance use 
vvith the significant other 
-Discussing and practicing alcohol and drug refusaI skills 
Session 4 -Identifying high-risk situations 
-Fine-tuning of coping for urges and cravings 
-Problem-solving for high-risk situations: handling triggers by choosing 
strategies of avoidance, postponement, preparation, or seeking social 
support, vvhere appropriate 
Session 5 -Providing education about the relapse process and vvaming signals 
-Discussing relapse prevention strategies and development of a personal 
plan 
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Study Procedure and Patients 
Approval for the study was obtained from the MURC ethies eommittee (see 
Appendix B). Since the study was designed for outpatients, exclusion criteria were 
similar to those for the naturalistic follow-up study. Rowever, for this study, patients 
requiring additional input from a psychiatrist were excluded in order to keep the 
number of individual therapeutic meetings to 5 sessions. Specifically, patients 
requiring any medical or psychiatrie intervention for control of withdrawal 
symptoms, or initiation or titration of medication were excluded. These exclusion 
criteria resulted in 35.7% of patients who were assessed being excluded from the 
study. In addition, patients who were legally mandated to treatment, abstinent from 
substances for more than one month, or had received substance abuse treatment in the 
previous 6 months were excluded. The flow diagram in Figure 7 lists the reasons for 
exclusion from the study. 
After the standard clinic assessment was condueted (as described in Chapter 2, 
page 47), eligible patients were invited by the research assistant to participate in the 
study. Informed consent was obtained, and randomÏzation was carried out by the 
research assistant according to study protocol. Following randomization the patient 
was informed of treatment assignment and given an appointment with the available 
primary therapist to start treatment the following week. Patients and staff were not 
blind with regards to the assigned treatment conditions. 
A total of 72 patients were entered into the study. Thirty-eight patients were 
randomized to the CT group and 34 were randomized to the BI group. 
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Figure 7. Brier Intervention Study Alogorithm 
238 assessments booked 
! 
56 DNA or cancelled 
! 
182 assessments conducted-+ 110 excluded 
72 randonllzed: 
CT 
38 
6-month follow-up: 
CT 
21(55.3%) 
Reasons for exclusion 
Needed psychiatric intervention 49 
Needed medical management 16 
of withdrawal 
Other treatment in past 6 months 19 
> 1 month abstinence 15 
Refused participation in the study 7 
Legally mandated to treatment 2 
Unknown 2 
BI 
34 
BI 
19 (55.9%) 
Total 110 
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The interview, questionnaires, and follow-up procedures were identical to those of 
the naturalistic follow-up study sample (N = 411) described in Chapter 2. In summary, all 
patients were assessed with the Addiction Severity Index, a DSM-IV interview with a 
psychiatrist, and were administered the Beck Depression Inventory (BDI), and the Symptom 
Checklist-90 (SCL-90) at intake. 
Total therapy contact in both the BI and CT conditions was carefully monitored 
throughout treatment. The type and duration of aIl visits to the c1inic (i.e. individu al sessions 
with primary therapist, group therapy sessions, psychiatrist visits) were automatically 
registered in a database by the c1inic receptionist. Additional information on patient contact 
(i.e. by telephone) was recorded in the Primary Care Record, filled out by each therapist on 
a monthly basis. Total c1inic contact was tabulated on weekly basis throughout treatment. In 
addition, the results of random urine screens (dates, number of urine samples requested and 
provided, number of drug tests, number and drug c1ass of positive results) were obtained 
from the clinic charts on a monthly basis. 
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Data Analyses 
T -tests and Chi-square analyses were used to describe sample characteristics 
stratified by treatment condition, as well as substance abuse outcomes and rates of 
treatment attendance. Subsequently, treatment groups were compared on substance 
abuse and psychological functioning over time using two-way ANOV A for repeated 
measures [between factors of group (CT versus BI) and time [intake versus 6-month 
follow-up]. Primary outcome variables were assessed using an intention-to-treat 
analysis, with data analyzed according to randomly assigned treatment condition. The 
decision was made that missing data would not be imputed from the first session to 
follow-up since there was only one follow-up point at 6 months. In addition, the two-
way ANOV A for repeated measures required a complete data set for each patient at 
both time points. The plan was that outcome data would also be analyzed according 
to patient compliance with treatment condition. However, despite attempts to retrieve 
patients at 6 months, low follow-up rates prohibited analysis of substance use 
outcomes based on compliance. 
Calculation of sample size and power was based on data from the follow-up 
study comparing outcomes for primary drug of abuse between the Early Dropout and 
the Retained groups as described in Chapters 5 and 6. The effect size was determined 
from the following equation (Streiner, 1990): Effect size = XT - XC/SDc 
Where XT is the mean of the treatment group, Xc is the mean of the control group, 
and SDc is the standard deviation of the outcome measure of the control group. 
Based on this equation, comparing outcomes for primary drug of abuse 
between the Retained and the Early Dropout groups, the effect size was 0.88. 
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Although the differences in outcomes from the follow-up study could not be 
attributed to treatment, the sample was comprised of similar patients to this 
randomized trial, and the objectives of the first study were also to examine outcomes 
for brief versus longer durations of treatment. Therefore, 0.85 was used as an estimate 
of effect size to determine the required sample size for the study. The Dupont Power 
and Sample Size Program (Dupont & Plummer, 2003) was used to calculate sample 
size based on the following parameters: alpha level set at 0.05; power of 0.80; effect 
size of 0.85; and a 1:1 ratio. Power calculations indicated that comparison of groups 
using independent paired t-tests would require 23 patients per group. Based on the 
previous study described in Chapters 3 and 4 in which the overall follow-up rate was 
79%, taking an approximate 20% loss to follow-up into account, at least 54 patients 
would be required for the trial. A total of 72 patients were recruited in order to 
pro vide an adequate sample size for this initial trial of BI in the clinic. However, as 
the following section will describe, loss to follow-up in this sample was greater than 
expected, with the result that the study was underpowered to conduct sorne of the 
planned analyses, and additional treatment effects may not have been detected. 
Characteristics of the Sample at Intake 
Tables 12, 13, and 14 display the demographic, social, substance use, and 
psychological characteristics of the sample at intake, stratified by treatment condition. 
Table 12 shows the sociodemographic characteristics indicating that the sample was 
almost two thirds male, over half were working full or part-time, and most patients 
had completed basic high school education. When compared to BI group, the CT 
group did have significantly more social problems at intake, as measured by the ASI 
social composite severity scores [t (70) = 2.90, P = 0.005]. However, the groups were 
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Table 12: Sociodemographic Characteristics at Intake Stratifled by Treatment 
Group 
CT 
N=38 
Age 39.61 (1.85) 
Gender 
Male 60.5% 
Number of Years of education 14.11 (0.46) 
ASI Employment Composite Severity score 0.408 (0.05) 
Employment Status 
Unemployed 23.7% 
Employed (full or part-time) 63.2% 
Retired/homemakerlstudent 13.2% 
ASI Social Com12osite Severitï score* 0.32 (.04) 
Marital Status 
Single 36.8% 
MarriediCommon Law 42.1% 
WidowedlSe12aratediDivorced 21.1% 
Living situation 
Spouse/Children 52.6% 
Parents/siblings 21.1% 
Friends 2.6% (1) 
Alone/other 23.7% 
Daïs of fami1ï 12roblems (12ast month) 5.2 (1.28) 
Daïs of 12roblems with 12eo12le (12ast month) 2.1 (0.74) 
ASI Leial Com2osite Severit~ score 0.067 (0.02) 
Groups were compared using Student's t-tests, and Chi-square analysis 
Values are percentages or means (± SEM) 
* P < 0.05 corrected for multiple comparisons 
BI 
N=34 
37.50 (1.64) 
61.8% 
13.23 (0.42) 
0.445 (0.06) 
26.5% 
58.8% 
14.7% 
0.16 (.03) 
38.2% 
41.2% 
20.6% 
45.5% 
12.1% 
12.1% 
30.3% 
2.1 (1.0) 
0.71 (0.25) 
0.051 (0.02) 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
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not different in terms of marital statu s, living situation, legal problems, or days of 
conflict experienced with other people in the past mon th. 
Substance Use Variables at Intake 
There were no significant differences between groups at intake in terms of the 
majority of substance abuse variables as shown in Table 13. Having a secondary 
substance of abuse was more frequent in the CT group, although this difference was 
not significant when corrected for multiple comparisons. In addition, the BI group 
had a lower mean ASI drug composite severity score at intake, but this was not 
significant when corrected for multiple comparisons. About one third of both groups 
had received sorne form of treatment for substance abuse in the past. 
Psychological Variables at Intake 
Table 14 indicates that there were no significant differences between the CT 
and BI groups for variables related to psychological distress at intake. The most 
commonly occurring additional DSM-IV Axis 1 disorders were mood disorders and 
anxiety disorders. More than half of the patients in both groups had undergone 
previous outpatient treatment for psychological problems. 
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Table 13: Substance Use at Intake Stratified by Treatment Group 
Number of years of problem drug use 
Primary drug 
Akohol 
Drugs 
Akohol + Drugs 
Number of days of primary drug use (past 30 days) 
Previous substance abuse treatment 
Secondary drug of abuse 
ASI Akohol Composite Severity score 
ASI Drug Composite Severity score 
ASI Medical Composite Severity Score 
Groups were compared using Student's t-tests, and Chi-square analysis 
Values are percentages or means (± SEM) 
* P < 0.05 corrected for multiple comparisons 
CT 
N=38 
8.6 (1.14) 
31.6% 
23.7% 
44.7% 
17.0 (1.75) 
31.6% 
44.7% 
0.45 (0.05) 
0.13 (0.02) 
0.27 (0.05) 
BI 
N=34 
9.8 (1.53) 
50.0% 
11.8% 
38.2% 
14.4 (1.80) 
33.3% 
20.6% 
0.44 (0.04) 
0.08 (0.02) 
0.23 (0.06) 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem se verity. 
Table 14: Psychological Variables at Intake Stratified by Treatment Group 
Presence of DSM-IV Axis I disorder other than 
substance dependence 
Previous treatment for psychological problems 
(lifetime) 
Inpatient 
Outpatient 
GSI SCL-90 
Beck Depression Inventory score 
ASI Psychological Composite Severity score 
Taking medication for psychiatrie disorder 
(past 30 days) 
CT 
N=38 
39.5% 
16.2% 
57.1% 
0.98 (0.11) 
15.53 (1.76) 
0.22 (0.035) 
10.5% 
Groups were compared using Student's t-tests, and Chi-square analysis 
Values are percentages or means (± SEM) 
* P < 0.05 corrected for multiple comparisons 
BI 
N=34 
44.1% 
12.1% 
66.7% 
0.84 (0.12) 
14.32 (1.90) 
0.22 (0.032) 
17.6% 
ASI-Addiction Severity Index, composite scores range from 0 to 1.0, with higher scores indicating 
greater problem severity. 
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Treatment Attendance and Status at Follow-up 
Table 15 provides the results of t-tests and Chi-square analyses comparing 
rates of attendance between groups. Twenty-one per cent of CT patients, and 44% of 
BI patients completed the 5 individual therapy sessions over 6 weeks [X2 (1) = 4.391, 
P = 0.036]. 
Adherence to treatment condition was examined by determining the number 
of patients who completed their assigned treatment. Chi-square tests determined that 
42% of patients randomized to the CT group remained in treatment up to 6 months, 
and 65% of the patients randomized to the BI group completed the 5 individu al 
therapy sessions [X2 (1) = 3.68, P = 0.055]. As expected, the CT group did receive 
substantially more therapy than the BI group in the first 6 weeks and up to 6 months. 
Follow-up data at 6 months was provided by 55.3% of the CT group and 
55.9% of the BI group [t (70) = 0.052, P = 0.959]. Analysis using MANOV A 
determined that there were no significant differences at intake between those lost to 
follow-up on demographic [F (5,64) = 0.737, P = 0.978], social [F (6,60) =1.932, P = 
0.090], substance use [F (7,60) =1.218, P = 0.307], or psychological variables [F 
(6,44) = 0.592, P = 0.735] compared to those who were retained at follow-up. 
Those who had completed randomized assignment to either CT or BI 
treatment conditions were more likely to attend 6-month follow-up. Among the CT 
group 76.2% of those attending the 6-month follow-up interview had completed the 
standard treatment of 6 months. Among the BI group 78.9% who attended follow-up 
had completed the 5 sessions of the BI. Therefore, the intention-to-treat analysis on 
outcomes pro vides results primarily for those who were adherent to treatment 
condition. 
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Table 15: Therapy Attendance and Additional Treatment at 6-month Follow-up 
Remained in CT for> 6 weeks 
Completed 5 individual sessions over 6 weeks 
Completed 5 individu al sessions over 3 months 
Remained in CT treatment up to 6 months 
Number of sessions attended in 6 weeks* 
Total number of sessions attended over 6 months* 
CT 
N=38 
68.4% 
21.1% 
47.4% 
42.1% 
6.2 (0.79) 
(group + ind.) 
18.50 (2.96) 
Groups were compared using Student's t-tests and Chi-square analysis 
Values are percentages or means (± SEM) 
* P < 0.05 corrected for multiple comparisons 
BI 
N=34 
44.1% 
64.7% 
3.6 (0.31) 
(ind.only) 
3.91 (0.31) 
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Results 
Comparison of Outcomes at Six Months Between the BI and CT Groups 
Substance Use at Six Months 
Table 16 provides the overall rates of primary and secondary drug 
consumption for the CT and BI groups at 6-month follow-up. There were no 
significant differences between groups on any of the substance use outcomes. The CT 
and BI groups appeared to be equivalent in terms of abstinence from primary drug of 
abuse, the number of days of primary or secondary drug use, and the number of days 
of alcohol and drug problems in the past month. The results demonstrate that 
approximately half of the patients in both treatment conditions were abstinent from 
their primary drug of abuse at 6 months, and that about haIf were still using a 
secondary drug. Importantly, there were no significant differences in the percentage 
of CT or BI patients who had an additional treatment episode in the Addictions Unit 
or elsewhere by 6 months. 
Two-way ANOV A with repeated measures with the factors of group (CT 
versus BI) and time (intake versus 6-month follow-up) was used to examine measures 
of substance use outcomes, inc1uding the ASI alcohol and drug composite severity 
scores, as weIl as the number of days of alcohol and drug problems in the past month. 
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Table 16: Substance Use Outcomes at 6-Month Follow-up 
At6 months 
Abstinent from primary drug 
Continuous days abstinence from primary drug 
Use of a secondary drug 
Additional treatment episode 
Based on past 30 days 
Number of days of primary drug intake 
Number of days of any substance intake 
Number of days of alcohol problems 
Number of days of drug problems 
Number of days of intake of secondary drug 
CT 
N=21 
57.7% 
90.0 (13.9) 
42.9% 
25% 
3.90 (2.01) 
6.45 (2.47) 
3.86 (2.01) 
5.14 (2.37) 
5.00 (2.17) 
Groups were compared using Student's t-tests and Chi-square analyses 
Values are percentages or means (± SEM) 
* P < 0.05 corrected for multiple comparisons 
BI 
N= 19 
47.4% 
89.21 (16.8) 
47.4% 
21.1% 
5.47 (1.79) 
9.79 (2.14) 
1.11 (0.55) 
4.42 (2.32) 
5.30 (2.04 
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As shown in Figures 8 and 9, both the CT and BI groups had significantly 
reduced the severity of a1cohol abuse at the time of 6-month follow-up. Results of the 
two-way ANOV A with repeated measures comparing ASI alcohol composite severity 
scores (Figure 8) indicated that there was a significant effect for time [F (1,38) = 
24.604, P = 0.0001], but no significant main effect for group [F (1,38) =0.23, P = 
0.633], or group by time interaction [F (1,38) = 2.403, P = 0.129]. Similarly, results of 
the two-way ANOVA with repeated measures comparing the mean number of days of 
a1cohol problems in the past 30 days (Figure 9) demonstrated a significant effect for 
time [F (1,38) = 0.344, P = 0.0001], and no significant main effect for group [F (1,38) 
= 1.873, P = 0.179], or group by time interaction [F (1,38) = 0.228, P = 0.636]. 
Figure 10 shows that there were no differences between groups for the 
severity of drug problems over time. Two-way ANOV A with repeated measures 
comparing ASI drug composite severity scores at intake versus follow-up for the CT 
and BI groups yielded a significant effect for time [F (1,38) = 7.87, P = 0.008], and no 
significant main effect for group [F (1,38) = 0.501, p = 0.483] or group by time 
interaction [F (1,38) = 0.19, p;::: 0.658]. Comparison of the mean number of days of 
drug problems in the past month at intake and follow-up resulted in no significant 
reduction for either the CT or BI patients, as demonstrated by the results of the two-
way ANOVA with repeated measures shown in Figure Il. The analysis yielded no 
main effect for group [F (1,38) = 0.523, P = 0.474], no significant group by time 
interaction [F (1,38) = 0.498, P = 0.485], and no significant effect for time [F (1,38) = 
0.116, P = 0.735]. 
The preceding analyses suggested that there were equivalent reductions in 
a1cohol consumption for both the CT and BI groups at follow-up compared to intake. 
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Therefore, the hypothesis that the CT group wou Id show significant improvements in 
alcohol abuse compared to the BI group at follow-up was not supported. The 
reduction of drug abuse was less evident for both groups at follow-up. Renee, the 
hypothesis that the severity of drug abuse wou Id be significantly redueed in the CT 
group compared to the BI group at follow-up was not supported. 
Psychological Distress at Six Months 
A two-way ANOV A with repeated measures was conducted to compare the 
CT and BI groups on the OSI scores calculated from the SCL-90 at follow-up versus 
intake. The analysis for the OSI scores resulted in a significant effect for time [F (1, 
27) = 7.5, P = 0.011], and no significant main effect for group [F (1,27) = 0.067, P = 
0.798], or group by time interaction [F (1, 27) = 0.168, P = 0.685]. Therefore, the 
hypothesis that there wou Id be no differenees between the CT and BI groups was 
supported, however, the sample size for this analysis was small (n = 30). 
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Figure 8. Results of the two-way ANOV A with repeated measures comparing ASI 
alcohol composite severity scores at follow-up versus întake between CT and BI 
groups. Analysis indicated that there was a significant effect for time, and no 
significant main effect for group, or group by time interaction. 
Data are the means ± SEM. 
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Figure 9. Results of two-way ANOV A with repeated measures comparing the mean 
number of days of alcohol problems in the past 30 days at follow-up versus intake 
between CT and BI groups, demonstrating a significant effect for time, and no 
significant main effect for group, or group by time interaction. 
Data are the means ± SEM. 
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Figure 10. Two-way ANOV A with repeated measures comparing ASI drug 
composite severity scores at follow-up versus intake between CT and BI groups 
yielded a significant effect for time, and no significant main effect for group, or group 
by time interaction. 
Data are the means ± SEM. 
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Figure 11. Results of the two-way ANOV A with repeated measures comparing the 
mean number of days of drug problems in the past 30 days at follow-up versus intake 
between CT and BI groups. The analysis yielded no main effect for group, no 
significant group by time interaction, and no significant effect for time. 
Data are the means ± SEM. 
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Summary and Discussion 
Both treatment groups reduced a1cohol consumption at 6-month follow-up, as 
measured by significant decreases in primary outcome measures of the ASI a1cohol 
composite severity scores, and the number of days of problem a1cohol use. Although 
the ASI drug composite severity scores showed a decrease over time, there were no 
significant decreases in the number of days of drug problems over time for either 
group. Thus, the hypothesis that the CT group wou Id show greater improvements on 
substance use outcomes compared to the BI group was not supported for a1cohol 
problems and inconclusive for drug problems. The lack of significant findings for 
drug problems may have been due to the low severity of drug dependence in the 
sample due to the exclusion of patients requiring any medical intervention for 
withdrawal symptoms, thereby exclu ding patients dependent on high dose opiates or 
benzodiazepines. In summary, outcomes based on an intent-to-treat analysis of the BI 
compared to the CT indicated that patients in both treatment conditions had 
equivalent reductions in a1cohol abuse at 6-month follow-up, but that no definitive 
conclusions about improvement in drug abuse cou Id be made. In a meta-analysis of 
addiction treatment, it was determined that the effect sizes for specific treatment 
versus treatment as usual were considerably higher for a1cohol dependence (0.26-
0.92) than in corresponding studies on opiate (0.19-0.65) and cocaine (0.24-0.67) 
dependence (Berglund, 2005). Therefore, the finding that a1cohol-dependent patients 
in both the CT and BI groups fared better than drug-dependent patients at 6 months 
fails to support the superiority of CT, and indicates that further investigation of the BI 
as an effective treatment for other drug dependence is warranted. 
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Attrition occurred in both treatment conditions. Forty-seven per cent of BI 
patients completed 5 individual therapy sessions, and 42% of CT patients completed 
treatment according to primary therapist or remain in treatment up to 180 days. 
Examination of rates of attendance in the BI and CT groups showed that 44% of the 
BI patients, and 21 % of the CT patients completed the 5 individual sessions over 6 
weeks. These rates of attendance may indicate that patients assigned to a brief 
intervention are more likely to maximize the time available to them in treatment, but 
that sorne flexibility in scheduling may increase session attendance. 
Improvements on the GSI score at follow-up were evident for the CT and BI 
groups, but the resulting sample was inadequately powered and an interaction effect 
may have been undetected. 
The sample size limited the analytic strategy since the use of regression 
models for prediction of differential outcomes between treatment groups was 
prohibited. A more robust study evaluating the effectiveness of the intervention for a 
larger number of patients would permit exploration of other variables associated with 
differential substance use, including primary drug of abuse, patients satisfaction with 
treatment, personality factors, concurrent DSM -IV Axis 1 disorders, and additional 
support for abstinence outside treatment. Examination of the se factors would enhance 
prediction of who would benefit from brief intervention thereby enabling clinicians to 
make treatment recommendations based on empirical data. 
Although the number of patients in the study precludes drawing definitive 
conclusions about the effectiveness of the BI, the improved and equivalent substance use 
outcomes for alcohol problems that were evident justify further work in this area. Key 
questions about the delivery and effectiveness of brief intervention that need to be addressed 
137 
include: the optimal number of sessions in order to maximize attendance and effectiveness, 
the differential effects for drug and alcohol problems, the effectiveness of brief intervention 
delivered in a group format, the types of patients who will benefit, and the time period for 
follow-up and monitoring (Anderson, 2002). 
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Chapter7 
Summary of the Research and Discussion 
This research was prompted by questions about the delivery and utilization of 
treatment services in an outpatient chemical dependency clinic, with a view to 
evaluating the process of dropout and implementing a solution based on research 
findings. Data derived from this clinic sample were used to answer key questions 
about the nature of predictors for early dropout from treatment and substance use at 6 
months. 
The naturalistic follow-up study found that close to 30% of patients left 
treatment before 6 weeks, and 60% of patients left treatment before 6 months. Age, 
marital status, and severity of employment problems were associated with early 
dropout. Similarly, age, gender, and employment problems were associated with 
attrition from treatment over 6 months. Greater severity of substance abuse and 
psychological problems at intake were not associated with early or Iater attrition from 
treatment. Aiso not associated with early dropout from treatment were measures of 
motivation, self-efficacy, and personality factors of emotional dysregulation and 
dissociaI behaviour examined in a subset of patients. These findings supported the 
conclusion that few client characteristics predictive of dropout can be identified at 
treatment onset. 
The treatment variables of the length of time spent in treatment and the 
number of treatment sessions attended were the most robust predictors of substance 
use at 6 months, accounting for 19% of the variance in the days of primary drug 
intake. The severity of drug and alcohol abuse at intake was modestly associated with 
substance use at 6 months, accounting for 9% of the variance in the number of days 
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of primary drug intake in the past month at follow-up. The severity of psychological 
problems and psychological distress at intake were not associated with substance use 
at 6 months. 
The analyses also demonstrated that patients who completed treatment 
showed considerable reduction in severity of substance abuse. However, only 40% 
received the "recommended" dose of treatment. A pragmatic response to these 
results was undertaken and a new brief intervention was designed. The objectives of 
the brief intervention study were to determine if the standard treatment program 
wou Id be more effective than a planned brief episode of treatment. Despite the limited 
sample size, it was found that patients dependent on alcohol in both the CT and BI 
treatment conditions showed significant and equal improvements on primary 
outcomes for alcohol abuse, but that there was inconclusive evidence to draw 
conclusions on drug abuse outcome variables. 
Methodological Considerations 
There were a number of limitations that deserve consideration in interpreting 
results from both studies described in the thesis. 
The loss to follow-up in the naturalistic sample of 411 was 21 %, and was 
close to 45% in the Brief Intervention study. Attrition from treatment and loss to 
follow-up is a common problem in substance dependence treatment evaluation 
(Desmond, Maddux, Johnson, & Confer, 1995; Edwards & Rollnick, 1997; Brown et 
al., 2002; Brown et al., 2002a). Due to the losses to follow-up in both studies, two 
caveats require attention in interpretation of the results. The first caveat to consider is 
the bias that may have resulted from the fact that those who attended follow-up were 
different in some way from those who did not. It is of note, however, that 
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comparisons between those retained versus those lost to follow-up on a variety of 
intake variables yielded no significant differences between groups. It is possible that 
early treatment experiences were c10sely linked to attendance for research foIlow-up, 
since patients in both studies who were adherent with treatment and attended more 
scheduled sessions were more likely to attend 6-month foIlow-up. Stout, Brown, 
Longabaugh, and Noel (1996) found that patients'baseline characteristics had limited 
impact on attendance to research foIlow-up, but that patients' participation and 
engagement early in treatment was strongly associated with attendance to foIlow-up. 
Efforts were taken to maximize attendance to foIlow-up through several strategies 
including: informing patients about the time for follow-up at intake, obtaining locator 
information, as weIl as a contact list, providing $20 gift certificates for attending the 
interview or return of questionnaires in the case of a phone contact, and providing 
fare for public transport if required (Desmond al., 1995; CottIer, Compton, Ben-
Abdallah, Horne, & Claverie, 1996). In addition to these measures, follow-up efforts 
were begun 2 weeks before the 6-month date and efforts were extended for up to 3 
months. Phone interviews were conducted when patients could not be scheduled for a 
meeting in person. 
The second caveat to consider when interpreting study results is that loss to 
sample size at 6-months in the naturalistic study and the Brief Intervention trial 
resulted in missing data in both studies. Whether patients who do not attend follow-up 
are doing better or worse, than those who do attend cannot be known and both 
assumptions are plausible (Sobell, 1978; Aspler & Harding, 1991). Those doing better 
may not return because they do not see the need, have moved on, and those doing 
worse may be more easily located because they are still in the treatment system and 
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experiencing problems (Desmond et al., 1995). Stout et al. (1996) found that relapse 
rates did not negatively affect attendance to 48-month follow-up, and in fact, those 
with more hospitalizations and more impairment from alcohol were less likely to 
refuse follow-up. Since there was only one time point for evaluation of outcomes at 6 
months in studies conducted in the CUITent research, it was decided not to impute data 
from the baseline assessment. hnputing values for missing data may be a reasonable 
procedure when data have been collected over several follow-up points (Nich & 
Carroll, 2002). Assessment of outcomes at 3 and 12 months could provide additional 
data about progress related to changes over time. However, adding follow-up 
interviews requires consideration of the increased costs and the potential influence of 
the research interviews versus treatment on outcomes, especially in the evaluation of 
a brief intervention. An example of how research interviews can overshadow 
treatment is demonstrated by the results of Project MATCH (2003). Of considerable 
importance in interpretation of positive "treatment" outcomes in Project MATCH was 
the fact that patients in the three treatment groups participated in numerous research 
interviews over the course of the study. This clouded the ability to distinguish the 
impact of treatment versus research contact on the outcomes observed. 
Although treatment studies have typically followed patients for 6 months 
following discharge (McLellan et al., 1994), a longer follow-up period would add 
information about the short and long term predictors of substance use outcomes. It 
has been noted that in studies with short evaluation periods, dependence severity at 
baseline and treatment variables account for a larger proportion of the variance in 
outcomes (Alterman et al., 1997) compared to historical variables and posttreatment 
factors that have greater explanatory power in studies with longer evaluation periods 
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(Moos, Finney, & Cronkite, 1990). However, it has also been reported that short-term 
outcomes of alcohol and drug intake may be predictive of long-term outcomes, 
indicating that those who do weIl at 6 months are likely to be improved at later 
follow-up (Weisner, Ray, Mertens, Satre, and Moore, 2003; Bottlender & Soyka, 
2005). Weisner et al. (2003) found that abstinence from drugs and alcohol at 6-month 
foIlow-up was a strong predictor of abstinence at 5 years. In their study, other positive 
factors influencing 5-year abstinence were alcohol dependence versus other drug 
dependencies, 12-step meeting attendance, female gender, specific social support for 
abstinence and readmission to treatment. Similarly, Bottlender & Soyka (2005) 
reported that patients who had improved during the course of treatment and 
completed treatment had less risk of relapse at 3-year foIlow-up. 
A methodological issue related to extemal validity of the results is that 
psychiatric expertise was available on site at assessment and throughout treatment, 
which is not always the case in chemical dependency treatment programs. In the U.S., 
50% of treatment facilities registered in the National Survey of Substance Abuse 
Treatment Services were found to offer dual diagnosis treatment, but even sorne of 
these programs did not offer supplementary services for mental, social, or health 
services often required by these patients (Mojtabai, 2004). A survey of the Veterans 
Administration addiction treatment programs in the U.S. reported that most had 
dedicated psychiatric, psychological, social work, and nursing staff, but 17% had no 
dedicated access to a psychiatrist, 20% had no social workers, and 26% did not have 
psychology services (Willenberg et al., 2004). In the CUITent studies, having 
psychiatrists on staff as weIl as therapists with expertise in mental illness and 
addiction may have resulted in improved treatment outcomes and a lower dropout rate 
143 
for those with co-existing psychiatrie disorders. Patients may also have sought 
treatment at the Addictions Unit rather than other treatment sites because of the 
availability of assessment and treatment for psychiatrie problems, although the 
percentages of comorbid Axis 1 and Axis II disorders were not higher than in other 
community outpatient treatment samples. Multi-site trials comparing outcomes based 
on availability of psychiatrie treatment would be useful in examining how availability 
of psychiatrie treatment may influence rates of retention and substance use outcomes. 
Other facts to consider about generalizability of outcomes based on the current 
studies is that patients attending the Addictions Unit were mainly Caucasian, 
relatively weIl educated, English-speaking or bilingual (English and French), and 
primarily male. 
Data reported on substance use outcomes were based on a combination of 
urine screen results, self-reports, and therapist notes from patient charts. Compliance 
with provision of urine screens during the treatment was below the treatment 
guidelines, but at follow-up assessment patients were asked to provide a urine screen 
and less than 1 % refused this request. Due to the fact that urine screening has low 
sensitivity for alcohol, future research could be improved by adding a b100d test or 
breath analysis for confirmation of self-reported alcohol intake. Other investigators 
have noted that, contrary to assumptions about deception, omission or poor recall, 
self-report on drug and alcohol intake is frequently corroborated by collaterals 
(Brown et al., 2002), urine testing (Weisner et al. 2003), and has been reported to 
have high levels of consistency over a 3-month period (Adair, Craddock, Miller & 
Turner, 1996). 
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Examination of the association between patient' s choice of treatment, 
retention in treatment and substance use outcomes in would add valu able information 
about treatment outcomes. Although patients will not always be accurate in 
determining their needs for treatment, in a study examining predictors of deterioration 
among substance abusers, Moos et al. (2001) found that patients who had more severe 
drug, psychiatrie, and social problems were aware of their dysfunctions, and were in 
agreement with therapists about needing treatment. Although choice of treatment 
condition is precluded in a randomized trial, additional information about whether or 
not patients had been randomized to preferred treatment, and inclusion of a group 
who refused randomization but accepted convention al treatment and follow-up would 
add useful information about whether or not patient choice had an effect on retention 
and substance use outcomes (Brown et al., 2002). 
Despite the limitations described above, the studies included in the thesis had 
the strength of being conducted in a "real world" clinical setting, with a typical 
treatment-seeking population. The studies addressed pertinent questions about the 
nature of dropout and the implications for treatment effectiveness and the efficiency 
of services. An additional strength of the research was the introduction of a brief 
intervention into the culture of a clinic where the standard duration of therapy was 6 
months. The design of the Brief Intervention, production of the treatment manual, and 
implementation of the study was conducted in close collaboration with the treating 
team, which may reduce barriers for the transfer of knowledge from research into 
clinical practice (Carroll & Rounsaville, 2003). 
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Further research on the effectiveness of a brief intervention in a larger sc ale 
study cou Id address questions of format, number of sessions, and differential 
responses to treatment. However, conducting this study was a "first step" towards 
changing treatment services in the clinic. The National Forum on Health (Health 
Canada, 1997) made the point that although decisions ought to be made based on the 
"best" evidence, waiting for "perfect" evidence is not an excuse for ignoring available 
information or not taking action. 
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Chapter8 
Conclusion 
Clinical hnplications: The hnpact of Findings on Planning Treatment Services and 
Health Care 
For many clinicians, a continuum of care approach to treatment has an 
intuitive appeal, and also has the potential to increase cost-effectiveness by limiting 
the amount of time patients spend in relatively intensive and expensive rehabilitation 
programs (lto & Donovan, 1986). AlI cases of addiction are not progressive; sorne 
people recover without specialized treatment; others have long periods of remission; 
while others do poorly and experience multiple relapses and negative consequences 
(McLelIan, 2002). This perspective implies that the most useful paradigm is to 
consider substance dependence as a chronic, rather than an acute disorder. It has been 
pointed out that the medical community and the public do not expect a medication or 
treatment for chronic disorders, such as hypertension, diabetes, or asthma, to continue 
to be effective once the treatment has stopped (McLelIan, 2002; McKay & Weiss, 
200 1). Nonetheless, this unrealistic expectation prevails in the evaluation of treatment 
services for addiction (McKay & Weiss, 2001). Clearly, multi-disciplinary treatment 
cannot pro vide a "cure", but when it takes into account the individual's characteristics 
and those of the social milieu, it may reduce the severity of the disorder, and in sorne 
cases, eliminate concomittant problems. 
A shift away from thinking about "treatment effects" is necessary in order to 
appreciate the reality that many other factors including informaI help, social 
resources, and life events play a longer lasting role in behaviour change than 
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treatment. Sustained improvement after treatment is not attributable to treatment 
alone, but is maintained by common factors associated with the process of change 
required for problem resolution (Moos, Finney, & Cronkite, 1990). This perspective 
is enlightening when examining treatment retention and substance use outcomes. It 
raises the question of how treatment can help patients find ways to develop a life 
context that is conducive to reduced substance use. This is a more realistic and 
practical expectation of what treatment can offer than the notion that treatment per se 
will resolve substance use disorders. 
Empirical evidence suggests that there are several critical features needed to 
create an "autonomy supportive" environment (Ryan, 1982; Koestner, Ryan, Bernieri, 
& HoIt, 1984; Williams, Grow, Freedman, Ryan, & Deci, 1996). These are: positive 
feedback concerning competence, absence of pressure to act in a certain way to 
achieve a particular outcome, acknowledgement and acceptance of the other' s 
perspective, and provision of a meaningful rationale (Foote et al., 1999). Autonomous 
motivation has been shown to predict self-initiation and persistence of target 
behaviours in a range of diverse study populations (Deci & Ryan, 1985). Fitting with 
a perspective that treatment is not equated with "cure", the goals of treatment become 
promotion of beliefs and behaviours conducive to change and include the patient's 
acceptance of responsibility for dealing with substance dependence over time. 
Evaluation of within-treatment and external factors that influence motivation and self-
efficacy and how these relate to treatment condition (CT versus BI) are questions that 
could be examined in future research. 
From the patient's point of view, starting treatment with a brief intervention 
may be a positive and productive experience. Leaving a brief treatment with frank 
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discussion about progress, changes made, assessment of coping skills and resources 
for success in achieving goals is likely to be experienced in a very different way than 
"failing" or "dropping out" of treatment of longer duration. The "take home" message 
that the patient receives from a treatment experience may have an impact on the 
decision to accept additional treatment in the short or long term, and may even 
influence motivation and self-efficacy related to reducing drug and a1cohol 
consumption. 
It has been found that the duration of treatment and continuity of care are 
more strongly associated with positive outcomes than the intensity or amount of care 
(Ritsher, Moos, & Finney, 2002). A "stepped care" approach can improve 
accessibility of services as weIl as pro vide a treatment that may be more appealing to 
people with different needs (Breslin, 1997; SobeIl & SobeIl, 2002). People with less 
severe problems might seek help before more serious medical, legal, and social 
consequences are experienced if they know that treatment will not place major 
restrictions, demands, or negative labels on them (Marlatt, 1997). People with more 
severe problems could be provided with additional medical, social, and psychiatrie 
services in order to address their needs. The availability of "brief interventions" 
within a ran~e of treatment services has the potential to improve overall efficiency 
and make treatment accessible to a greater number of patients. Although dropout will 
not be eliminated through implementation of a brief intervention, shorter planned 
treatment durations would open up more spaces for new clients, and reduce waiting 
lists. Patients judged inappropriate for brief intervention at assessment or during the 
initial weeks of treatment would be offered more intensive treatment on an as-needed 
basis. In the Brief Intervention study, 35.7% of patients attending the Addictions Unit 
149 
were excluded from the trial due to the need for additional medical or psychiatrie 
intervention. With an average of 450 admissions per year, approximately 282 (64.3%) 
patients cou Id benefit from a brief intervention, opening treatment services to patients 
on the waiting list more rapidly. In order to pro vide the most efficient treatment 
delivery, the effectiveness of a group format for brief intervention would also need to 
be evaluated. As previously stated, more research is needed to determine the 
effectiveness of brief intervention across a wider range of patients before this service 
is implemented. 
The implications of the above findings are relevant to the recommendations 
from the Commission on the Future of Health Care in Canada (Romanow, 2002). 
This report stressed the need to remove obstacles that prevent the optimal use of 
primary care. These obstacles included: the focus on hospitalization, increased 
specialization among physicians, fragmentation of services, the public's lack of health 
information, the limited control of patients over their own care, and marginal 
prevention and health promotion. How can a specialized service for the treatment of 
substance dependence play a role in improving utilization of primary care services? 
The answer lies in a long-range perspective of change in the health care system. 
Changes in attitudes and beliefs are required to achieve the goal of more efficient use 
of primary care in the treatment for substance dependence. 
Both the public and health professionals alike have been accustomed to 
equating the "best" treatment with specialists, and with hospitals and University 
medical centres providing the latest technological advances in health care. In Canada, 
the number of general practitioners has decreased since 1993, and the number of 
specialists has increased to an all-time high (Romanow, 2002). It is a fact of life that 
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rapid technological advances in medicine and health care require specialized 
expertise, but there may be many aspects of health care that can be provided by 
knowledgeable, consistent, and available generalists in primary care. This may seem 
contrary to what is proposed in this thesis, which is the inclusion of a brief 
intervention into a specialized substance dependence treatment program. However, 
change progresses in steps over time, and in order to change beliefs and attitudes 
about health care and provision of quality services, empirical support for new 
treatment interventions is a necessary first step. 
Since there is a shortage of general practitioners and nurses in primary health 
care at the present time, it is an unrealistic expectation that these overtaxed health 
care providers will have the time, patience, and expertise to begin initiatives to 
evaluate and implant additional services for substance dependence into their busy 
practices (Booth et al., 2001). Therefore, specialists with expertise in addiction need 
to lead the way in order to develop interventions and training in the field that will 
eventually be transplanted into primary care settings. A study of technology transfer 
within the field of addiction services found that clinicians given more credibility and 
considered as "opinion leaders" were those with relevant professional credentials, 
more postgraduate education, years of experience in mental health treatment, and 
greater knowledge of the dynamics of treatment and co-occurring disorders (Moore, 
et al., 2004). The study suggested that these professionals could be important for the 
transfer of knowledge from research into practice in community treatment settings. 
Therefore, the first step is introduction of change within the system of addiction 
treatment, the use of brief intervention as a sanctioned and effective treatment, 
followed by transfer of knowledge into primary health care settings. The wider 
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availability of brief interventions in primary health care may eventually make 
treatment available and accessible to a large number of people. For the successful 
transfer of empirically supported treatments into primary care, evidence of who will 
benefit from the treatment, who will need referral to additional or specialized 
treatment, co-ordination of services, and availability for consultation must be 
considered (Broner, Franczak, Dye, & McAllister, 2001; Iowa Practice Improvement 
Collaborative, 2003). In practice, effective treatments su ch as brief intervention for 
substance dependence that have been developed and evaluated by clinician specialists 
can be introduced to physicians, nurses, social workers, and psychologists in primary 
health care through on-site training in various treatment milieus. 
Sorne progress in the introduction of brief counselling for a1cohol abuse has 
been made in Quebec with the initiation of education and services of Educa1cool, a 
non-profit agency comprised of members of the a1coholic beverage industry and 
concerned individu ais with a goal of promoting responsible drinking. Educational 
materials and short-term counselling about moderation in drinking provided by front 
line health workers are available at sorne CLSC' s throughout the province. Combined 
research and communication with primary care health professionals will continue to 
improve treatment, co-ordination of services, and reduce duplication, thereby 
increasing efficiency of services for substance dependence. 
A phenomenon that is occurring throughout the Canadian health care system 
is the emergence of private health care. The con cern of Federal policy makers about 
privatization is that the credibility and effectiveness of the public system may be 
eroded (Romanow, 2002). Private treatment has been available for the treatment for 
substance dependence for many years, potentially leading to fragmentation, a lack of 
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co-ordination and quality control, as weIl as the possibility of reduced governmental 
funding for public services for addiction. Delivery of appropriate, efficient, and 
effective treatment for substance dependence within the public sector will reduce 
fragmentation of services, increase the public's awareness about methods to reduce 
substance abuse, and help people assume more responsibility for their own care. 
These goals can only be reached if a seamless continuum of co-ordinated care 
involving primary and specialized services in the health care system is provided for 
the treatment of substance dependence. 
A possible response of treatment providers and administrators to deal with the 
phenomenon of people leaving substance abuse treatment early is to place the onus on 
the patient and adopt the attitude that he or she will return "when ready", requiring no 
change in treatment services. Another response to the high percentage of people 
leaving treatment early involves finding out more about who leaves treatment early 
and why, as weIl as comparing changes in substance use for those who are retained 
versus those who leave, and considering ways to make practical changes in existing 
treatment programs. This latter response adopts an interactional view of dropout, 
examining the fit between patients' characteristics and the treatment service and 
formed the basis of the research conducted in the thesis. 
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Table 4: Substance Use Variables Stratified by Early Dropout 
Number of years of problem use of primary 
drug 
Primary drug of abuse 
Alcohol alone 
Drugs 
Alcohol + Drugs 
Number of days of primary drug intake 
(past month) 
Previous treatment for substance abuse 
AS! Alcohol Composite Severity score 
AS! Drug Composite Severity score 
AS! Medical Composite Severity score 
Secondary drug of abuse 
Early Dropouts 
N= 109 
9.3 (0.77) 
27.5% 
30.3% 
42.2% 
14.9 (1.12) 
48.1% 
0.36 (0.03) 
0.15 (0.01) 
0.16 (0.03) 
53.2% 
Retained > 6 weeks 
N=302 
11.1 (0.51) 
34.4% 
25.8% 
39.7% 
15.0 (0.69) 
50.7% 
0.40 (0.02) 
0.15 (0.01) 
0.21 (0.02) 
42.7% 
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